<SEC-DOCUMENT>0001683168-25-004929.txt : 20250703
<SEC-HEADER>0001683168-25-004929.hdr.sgml : 20250703
<ACCEPTANCE-DATETIME>20250703172140
ACCESSION NUMBER:		0001683168-25-004929
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250627
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250703
DATE AS OF CHANGE:		20250703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BITMINE IMMERSION TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001829311
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				843986354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42675
		FILM NUMBER:		251106394

	BUSINESS ADDRESS:	
		STREET 1:		10845 GRIFFITH PEAK DR. #2
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89135
		BUSINESS PHONE:		562-310-0160

	MAIL ADDRESS:	
		STREET 1:		10845 GRIFFITH PEAK DR. #2
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89135

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sandy Springs Holdings, Inc.
		DATE OF NAME CHANGE:	20201021
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bitmine_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:BMNR="http://bitmineimmersiontech.com/20250627">
<head>
     <title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_BMNR_bitmineimmersiontech.com_20250627 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250627_20250627 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001829311 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000004" name="dei:EntityCentralIndexKey">0001829311</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bmnr-20250627.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001829311</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-27</xbrli:startDate>
        <xbrli:endDate>2025-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt">FORM <span id="xdx_90C_edei--DocumentType_c20250627__20250627_zWekpn1WwaR2"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90E_edei--DocumentPeriodEndDate_c20250627__20250627_zl6skZZrPEg5"> <ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 27, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_901_edei--EntityRegistrantName_c20250627__20250627_zzRRLm0l6Lva" style="font-size: 15pt"><b><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000011" name="dei:EntityRegistrantName">BITMINE
IMMERSION TECHNOLOGIES, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250627__20250627_zcxQqo4wTeG"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation or organization)</p></td>
    <td style="width: 34%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityFileNumber_c20250627__20250627_zemppg9Ef3u6"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000013" name="dei:EntityFileNumber">001-42675</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</p></td>
    <td style="width: 33%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20250627__20250627_zpy6D3c4o7Nj"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000014" name="dei:EntityTaxIdentificationNumber">84-3986354</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-align: center"><span id="xdx_906_edei--EntityAddressAddressLine1_c20250627__20250627_zm2PLijHIr1"><b><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000015" name="dei:EntityAddressAddressLine1">10845
Griffith Peak Dr. #2</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20250627__20250627_zomAxO7Mtj4h"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000016" name="dei:EntityAddressCityOrTown">Las
Vegas</ix:nonNumeric></span></b><b>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20250627__20250627_zqdI5ytgzv4d"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000017" name="dei:EntityAddressStateOrProvince">NV</ix:nonNumeric> </span></b><b><span id="xdx_90D_edei--EntityAddressPostalZipCode_c20250627__20250627_zCLr6ZDrLGYi"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000018" name="dei:EntityAddressPostalZipCode">89135</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--CityAreaCode_c20250627__20250627_z1jk2dvR9GLh"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000019" name="dei:CityAreaCode">(404)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20250627__20250627_zdeU10tquk1b"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000020" name="dei:LocalPhoneNumber">816-8240</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrants&#8217; telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20250627__20250627_zC3w5xQ5aWHa"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20250627__20250627_z520mlznVMNc"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20250627__20250627_zD8XVTsabNZd"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250627__20250627_zCPGolaldA7h"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 36%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 28%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 36%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--Security12bTitle_c20250627__20250627_zxOtXcbpf5C4"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.0001</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--TradingSymbol_c20250627__20250627_ztn9ppVvJZM4"><ix:nonNumeric contextRef="AsOf2025-06-27" id="Fact000026" name="dei:TradingSymbol">BMNR</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--SecurityExchangeName_c20250627__20250627_zigE4CeLZVFc"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></span> American LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company&#160;</span><span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250627__20250627_z6ynOsAlzfSi"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings"><span id="xdx_901_edei--EntityExTransitionPeriod_c20250627__20250627_zJrkKwjDsnu5"><ix:nonNumeric contextRef="AsOf2025-06-27" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Securities Purchase Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">On June 30, 2025, BitMine
Immersion Technologies, Inc. (the &#8220;Company&#8221;) entered into securities purchase agreements (the &#8220;Cash Securities Purchase
Agreements&#8221;) with certain accredited investors (the &#8220;Cash Purchasers&#8221;) pursuant to which the Company agreed to sell
and issue to the Cash Purchasers in a private placement offering (the &#8220;Cash Offering&#8221;) an aggregate of (i) 36,309,592 shares
of common stock of the Company, par value $0.0001 per share (the &#8220;Common Stock&#8221;), at an offering price of $4.50 per share,
and (ii) pre-funded warrants (the &#8220;Pre-Funded Warrants,&#8221; and together with the Common Stock, the &#8220;Securities&#8221;)
to purchase up to an aggregate of 11,006,444 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares,&#8221;) at an offering price
of $4.4999 per Pre-Funded Warrant. In the Cash Offering, the Cash Purchasers will tender U.S. dollars to the Company as consideration
for the Common Stock and Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">Each of the Pre-Funded
Warrants is exercisable for one share of Common Stock at the exercise price of $0.0001 per Pre-Funded Warrant Share, immediately exercisable,
and may be exercised at any time until all of the Pre-Funded Warrants issued in the Offerings are exercised in full. Each Cash Purchaser&#8217;s
ability to exercise its Pre-Funded Warrants in exchange for shares of Common Stock is subject to certain beneficial ownership limitations
set forth therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">On June 30, 2025, the
Company entered into securities purchase agreements (the &#8220;Cryptocurrency Securities Purchase Agreements,&#8221; and together with
the Cash Securities Purchase Agreements, the &#8220;Securities Purchase Agreements&#8221;) with certain accredited investors (the &#8220;Cryptocurrency
Purchasers,&#8221; and together with the Cash Purchasers, the &#8220;Purchasers&#8221;) pursuant to which the Company agreed to sell and
issue to the Cryptocurrency Purchasers in a private placement (the &#8220;Cryptocurrency Offering,&#8221; and together with the Cash Offering,
the &#8220;Offerings&#8221;) an aggregate of (i) 8,804,122 shares of Common Stock, at an offering price of $4.50 per share. In the Cryptocurrency
Offering, the Cryptocurrency Purchasers will tender ETH or BTC (as such terms are defined in the Securities Purchase Agreements) for the
Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">ThinkEquity LLC (&#8220;ThinkEquity&#8221;)
is acting as the sole placement agent in connection with the Offerings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Common Stock, the Pre-Funded
Warrants, and the Pre-Funded Warrant Shares are being offered in reliance upon the exemption from the registration requirement of the
Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation
D promulgated thereunder, and applicable state securities laws. The issuance of the Common Stock, the Pre-Funded Warrants, and the Pre-Funded
Warrant Shares have not been registered under the Securities Act and such securities may not be offered or sold in the United States absent
registration or an exemption from registration under the Securities Act and any applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Securities
Purchase Agreements, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed issuance
of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement thereto,
for a period of 30 days after the effective date (as defined in the Securities Purchase Agreements), subject to certain customary exceptions.
The Company also agreed not to undertake any reclassifications of its Common Stock, such as a reverse or forward stock split, without
the written consent of Purchasers holding a majority in interest of the shares issued or issuable to each Purchaser under the Securities
Purchase Agreements, for a period of one year following the closing of the Offerings, provided such consent will not be required to conduct
a reverse stock split to maintain listing of the Common Stock on the Company&#8217;s applicable trading market, which is the NYSE American
as of the date hereof. Pursuant to the Securities Purchase Agreements, the Company is obligated to reduce its Board of Directors to a
total of five members within 90 days of the closing of the Offerings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company intends to use
the net proceeds from the Offerings to acquire the native cryptocurrency of the Ethereum blockchain commonly referred to as &#8220;ETH&#8221;
and contribute the ETH to the Company&#8217;s treasury operations. At least 20% of the net proceeds from the Offerings will be used in
activities carried on for the production of income from performing services, including but not limited to blockchain validation services,
blockchain lending services or other decentralized finance services. 5% of the net proceeds (after the payment of such fees and expenses)
are expected to be invested into approved validator, wrapping and staking technology in furtherance of the Company&#8217;s business and
its treasury management. None of the proceeds from the Offerings will be used for: (a) the redemption of any Common Stock or Common Stock
equivalents, (b) for the settlement of any outstanding litigation or (c) in violation of the Foreign Corrupt Practices Act of 1977, as
amended or the Office of Foreign Assets Control of the U.S. Treasury Department regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Placement Agency Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also entered into
a Placement Agency Agreement (the &#8220;Placement Agency Agreement&#8221;) with ThinkEquity, dated June 27, 2025, pursuant to which ThinkEquity
agreed to serve as the placement agent for the Company in connection with the Offerings. The Company agreed to pay ThinkEquity a cash
placement fee equal to 2.5% of the aggregate purchase price paid by each Purchaser in the Offerings. The Company also agreed to issue
ThinkEquity warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase up to a number of shares equal to 2.5% of the Securities
sold in the Offerings (the &#8220;Placement Agent Warrant Shares&#8221;), at a price per share equal to $5.40. In addition, the Company
agreed to reimburse ThinkEquity for accountable expenses in an amount of $300,000 for all reasonable travel and other out-of-pocket expenses
incurred in connection with ThinkEquity&#8217;s engagement, including the reasonable fees and expenses of ThinkEquity&#8217;s counsel
and due diligence analysis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Placement Agent Warrants
and the Placement Agent Warrant Shares are being offered in reliance upon the exemption from the registration requirement of the Securities
Act, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.
The issuance of the Placement Agent Warrants and the Placement Agent Warrant Shares have not been registered under the Securities Act
and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities
Act and any applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Registration Rights Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with entering
into the Securities Purchase Agreements and the Placement Agency Agreement, on June 30, 2025, the Company and the Purchasers entered into
a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company agreed to file a registration
statement with the U.S. Securities and Exchange Commission, within 20 days of the closing of the Offerings registering the resale of the
Common Stock sold in the Offerings, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, and certain securities to be issued to the
Company&#8217;s strategic advisor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summaries of
the Pre-Funded Warrants, the Placement Agent Warrants, the Cash Securities Purchase Agreements, the Cryptocurrency Securities Purchase
Agreements, the Placement Agency Agreement, and the Registration Rights Agreement do not purport to be complete and are qualified in
their entirety by reference to the complete text of those agreements, which are attached hereto as Exhibits 4.1, 4.2, 10.1, 10.2, 10.3,
and 10.4 respectively, to this Current Report on Form 8-K and are hereby incorporated by reference into this Item 1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt">(a) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.35pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><b>Number</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="bitmine_ex0401.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="bitmine_ex0402.htm"><span style="font-size: 10pt">Form of Placement Agent Warrant</span></a></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="bitmine_ex1001.htm">Form of Cash
    Securities Purchase Agreement, dated as of June 30, 2025, between BitMine Immersion Technologies, Inc. and each Purchaser (as
    defined therein)</a></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">10.2</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="bitmine_ex1002.htm">Form of Cryptocurrency Securities Purchase Agreement, dated as of June 30, 2025, between BitMine Immersion Technologies, Inc. and each Purchaser (as defined therein)</a></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.3</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="bitmine_ex1003.htm">Placement Agency Agreement, dated June 27, 2025, between BitMine Immersion Technologies, Inc. and ThinkEquity LLC</a></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">10.4</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="bitmine_ex1004.htm">Form of Registration Rights Agreement, dated as of June 30, 2025, between BitMine Immersion Technologies, Inc. and each Purchaser (as defined therein)</a></span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within
    the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.2pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 13.2pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>Bitmine Immersion Technologies, Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><span style="font-size: 10pt">Dated: July 3, 2025</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt">/s/ Jonathan Bates</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">Jonathan Bates</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZF01DddGlpYpYRYqI22hHCbaZMol/R/KWxhZxGBiG9773hIjFguamQYbDrCphh23XaI9Q4RkZ7QmDI1+uMgi3wotxnrX1/fsDcwoMBmYyUuoYhN56Nw7rDORkLKdjlYJMslTBdi2ir56TPZsarTe6AW1r2DJ1bNBrfg0JO/0kS+2rr9ojO0M2g2QkB/kNSiYKNnTXD+Krg7LMRRT3E4kF060LruLp0X5JKBpsQ50b6P9GHwXESos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>bitmine_ex0401.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 4.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<U>SECURITIES ACT</U>&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">BITMINE
IMMERSION TECHNOLOGIES, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="font-size: 10pt">Warrant Shares: [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="font-size: 10pt; text-align: right">Issue Date: [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, __________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is
entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;),
to subscribe for and purchase from Bitmine Immersion Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up
to [&#9;] shares of common stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company (as subject to adjustment
hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 30, 2025, among the Company and the Holder and the other Purchasers named therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in
whole or in part, at any time or times on or after the Initial Exercise Date and, on or before the Termination Date by delivery to the
Company of a duly executed facsimile copy or PDF or DocuSign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise
in the form annexed hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at
any given time may be less than the amount stated on the face hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.75in">For the avoidance
of doubt, there is no circumstance that would require the Company to net cash settle the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the
Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder
shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever. The remaining unpaid exercise price per Warrant Share shall be $0.0001, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>(A)</TD>
    <TD STYLE="text-align: justify">=</TD>
    <TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>(B)</TD>
    <TD STYLE="text-align: justify">=</TD>
    <TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder, in effect on the date of exercise; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>(X)</TD>
    <TD STYLE="text-align: justify">=</TD>
    <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the characteristics of the Warrants being exercised and any holding period of the Warrant Shares being
issued may be tacked on to the holding period of this Warrant. For the avoidance of doubt, in the absence of an effective registration
statement registering the issuance of the Warrant Shares, the Company shall issue, and the Holder agrees to receive, unregistered Warrant
Shares upon a cashless exercise of this Warrant pursuant to this Section 2(c). The Company agrees not to take any position contrary to
this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading Market and if
the Common Stock is then listed or quoted on OTCQB or OTCQX, the volume weighted average price of the Common Stock for such date (or the
nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or
OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to
its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the
fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means any day on which the Trading Market is open for trading, including any day on which the Trading Market is open for
trading for a period of time less than the customary time. If the Common Stock is not then listed or quoted on a Trading Market, Trading
Day means a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on a Trading
Market and if the Common Stock is then listed or quoted on OTCQB or OTCQX, the volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases,
the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a
majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c), subject to the limitations in Section 2(e) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in
the instance of a cashless exercise) is received by the Company by such date, (ii) one (1) Trading Day after delivery of the aggregate
Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the
Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise)
is received by the Company by such date (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, provided that
payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by such date, the
Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such
exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to
$20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver, or cause to be delivered,
the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date
shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in
the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the Warrant Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant
Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total purchase price
of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request
of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form, attached hereto as <U>Exhibit B</U>, duly executed
by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees
to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates, (ii) any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons whose beneficial ownership
of the shares of Common Stock would or could be aggregated with the Holder&rsquo;s for purposes of Section 13(d) (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but
shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrants
that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding
shares of Common Stock that was provided by the Company. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, and the Company
shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrants
that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on the number of outstanding
shares of Common Stock that was provided by the Company. For purposes of this Section 2(e), in determining the number of outstanding shares
of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent
periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a
more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Company shall within two (2) Trading Days confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution
Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership
Limitation</U>&rdquo; shall be [4.99/9.99]% (or, upon election by a Holder prior to the issuance of any Warrants, [4.99/9.99]%) of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the
provisions of this Section 2(e) shall continue to apply, provided further that an Affiliate of the Company may suspend the Beneficial
Ownership Limitation in its entirety if, and for so long as, such Beneficial Ownership Limitation is not required to be in effect to ensure
compliance with applicable Nasdaq listing requirements with respect to stockholder approval. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT> day after such notice is delivered to
the Company. The provisions of this paragraph shall not be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable
as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternative consideration is owing to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock
of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person in which the Company is not the surviving entity (other
than a reincorporation in a different state), (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license,
assignment, transfer, conveyance or other disposition of all or substantially all of the assets of the Company and its Subsidiaries, taken
as a whole, in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares of
the aggregate voting power of all classes of equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of the aggregate voting power of all classes of equity of
the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this
Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and
the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction
Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) [Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If, while the Warrant is outstanding, (A) the Company declares a dividend (or any other distribution in
whatever form) on the Common Stock, (B) the Company declares a special nonrecurring cash dividend on, or a redemption of, the shares of
Common Stock, (C) the Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company is required
in connection with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to
the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)
the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of Common
Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The issuance of a press release or the filing of a Form 8-K or other suitable
filing with the Commission shall satisfy this notice requirement. The Holder shall remain entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment by the Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term
of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, the conditions set forth in Section 4(d) hereof, and the provisions of Section
4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
Subject to compliance with applicable securities laws, this Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are
to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be
involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer Restrictions</U>.
If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not
be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities
or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements
pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant,
as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to
net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.75in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued and delivered as provided herein without violation of any applicable
law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that
all Warrant Shares which may be issued and delivered upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof that would require the application of the laws of any other jurisdiction. Each party agrees that all legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto
or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to
assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an
action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be
reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws, and in such case, by the acceptance
hereof, represents and warrants that the Holder will acquire such Warrant Shares issuable upon such exercise for its own account and not
with a view to or for distributing or reselling Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="text-transform: uppercase">BITMINE IMMERSION TECHNOLOGIES, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">By:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: BITMINE IMMERSION TECHNOLOGIES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(4) <U>Accredited Investor</U>. The undersigned is
an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="white-space: nowrap">Name of Investing Entity:</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap"><I>Signature of Authorized Signatory of Investing Entity</I>:</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap">Name of Authorized Signatory:</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>Title of Authorized Signatory:</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>Date:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 9pt"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 11pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 11pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Phone Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature: _______________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:_______________</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>bitmine_ex0402.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Exhibit 4.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BITMINE
IMMERSION TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">Warrant Shares: [_______]</TD>
  <TD STYLE="text-align: right; padding-left: 0pt; width: 50%">Initial Exercise Date: July 3, 2025</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS WARRANT TO PURCHASE SHARES
OF COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, ___________________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and prior to 5:00 p.m. (New York City time) on July 3, 2030 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Bitmine Immersion Technologies, Inc., a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), up to [______] shares of Common Stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;),
of the Company (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Common
Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant was issued pursuant to Section
2 of that certain Placement Agency Agreement, dated as of June 27, 2025, by and between the Company and the Holder (as may be amended,
amended and restated, supplemented or otherwise modified from time to time in accordance with its terms, the &ldquo;<U>Placement Agency
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&#9;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 30, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to &ldquo;stay at home,&rdquo; &ldquo;shelter-in-place,&rdquo; &ldquo;non-essential employee&rdquo; or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&#9;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office
or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the
books of the Company) of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed
hereto as Exhibit A (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) below) following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified
in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available
hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within two (2) Business Days of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$5.40,</B> subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 75pt"></TD><TD STYLE="width: 20.25pt">(A)</TD><TD STYLE="text-align: justify">= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)
at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(B)</TD><TD STYLE="text-align: justify">= the existing
Exercise Price of this Warrant at the time of such exercise; and</TD></TR>
                                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                     <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(X)</TD><TD STYLE="text-align: justify">= the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</TD></TR>
                                                                                                                     </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised
may be tacked on to the holding period of the Warrant Shares.&nbsp;&nbsp;The Company agrees not to take any position contrary to this
Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, if there is no effective Registration Statement registering, or no current prospectus
available for, the resale of the Warrant Shares by the Holder, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">i. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company&rsquo;s transfer agent
is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume
or manner-of-sale limitations pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the
Warrant Share Delivery Date (as defined below), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise; provided that payment of the aggregate Exercise Price (other than in
the instance of a cashless exercise) is received by the Company by such date, (ii) two (2) Trading Days after delivery of the aggregate
Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the
Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). If the Warrant Shares can be delivered
via DWAC, the transfer agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation
required by it to deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from
the Holder, including with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery
Date, the transfer agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of
the Holder to provide a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares
upon a cashless exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant
Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have
become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company
of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section
2(d)(vi) prior to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the
date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered
or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as
this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard
settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock
as in effect on the date of delivery of the Notice of Exercise.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>,
<U>however</U>, that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise
notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration
of Holder&rsquo;s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate
evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">iv.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases shares
of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">v.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vi.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Charges, Taxes and Expenses</U>. The issuance of Warrant Shares and delivery of Warrant Shares shall be made without charge
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which
taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or
names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name
other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any
transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise
and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">viii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Signature</U>.&#9;This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of
the Holder in order to exercise this Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise this
Warrant. No additional legal opinion, other information or instructions shall be required of the Holder to exercise this Warrant. The
Company shall honor exercises of this Warrant and shall deliver Shares underlying this Warrant in accordance with the terms, conditions
and time periods set forth herein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by
the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion
of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act
and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the
sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For
purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Warrant Shares issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the
provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until
the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&#9;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of
this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price of this Warrant
will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option to purchase, or
sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or
other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
(other than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &quot;<U>Distribution</U>&quot;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such
Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, after giving effect to
such transaction, the stockholders of the Company immediately prior to such transaction own less than 50% of the aggregate voting power
of the Company or the successor entity of such transaction, (ii) the Company (all of its Subsidiaries, taken as a whole), directly or
indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its
assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50%
or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, after giving effect to such transaction,
the stockholders of the Company immediately prior to such transaction own less than 50% of the aggregate voting power of the Company or
the successor entity of such transaction or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a
&ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each sharee of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the
consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence
of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&#9;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-underline-style: double">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Transfer Restrictions</U>. <FONT STYLE="text-decoration: underline double">If</FONT>, at the <FONT STYLE="text-decoration-style: double">time
of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i)
registered pursuant to an effective </FONT>registration <FONT STYLE="text-decoration-style: double">statement under the Securities
Act</FONT> and <FONT STYLE="text-decoration-style: double">under applicable state securities or blue sky laws or (ii) eligible for
resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may
require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the
provisions of Section 4.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&#9;<U>Registration
Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grant
of Right. The Company, upon written demand (a &ldquo;Demand Notice&rdquo;) of the Holder(s) of at least 51% of the Warrants and/or the
underlying Warrant Shares (&ldquo;Majority Holders&rdquo;), agrees to register, on one occasion, all or any portion of the Warrant Shares
underlying the Warrants (collectively, the &ldquo;Registrable Securities&rdquo;). On such occasion, the Company will file a registration
statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its
reasonable best efforts to have the registration statement declared effective promptly thereafter, subject to compliance with review by
the Commission; provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration
statement with respect to which the Holder is entitled to piggyback registration rights pursuant to Section 5.2 hereof and either: (i)
the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration statement relates
to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement has been withdrawn
or until thirty (30) days after such offering is consummated. The demand registration right shall terminate on the fifth anniversary of
the date of the Purchase Agreement. The Company covenants and agrees to give written notice of its receipt of any Demand Notice by any
Holder(s) to all other registered Holders of the Warrants and/or the Registrable Securities within ten (10) days after the date of the
receipt of any such Demand Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.1.2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Terms.
The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 5.1.1, but
the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts to cause the filing
required herein to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably requested
by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a State
in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit
to general service of process in such State, or (ii) the principal shareholders of the Company to be obligated to escrow their shares
of capital stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under Section
5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable Securities
covered by such registration statement are first given the opportunity to sell all of such securities. The Holders shall only use the
prospectuses provided by the Company to sell the Warrant Shares covered by such registration statement, and will immediately cease to
use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used due to a material
misstatement or omission. Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand registration
under this Section 5.1.2 on only one (1) occasion and such demand registration right shall terminate on the fifth anniversary of the date
of the Purchase Agreement (as defined below) in accordance with FINRA Rules 5110(g)(8)(B) and 5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>5.2</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&ldquo;Piggy-Back&rdquo;
Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grant
of Right. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right, for a period
of no more than five (5) years from the date of the Purchase Agreement to include the shares underlying the Warrant, to include the Registrable
Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated
by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely
in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall,
in its reasonable discretion, impose a limitation on the number of shares of Common Stock which may be included in the Registration Statement
because, in such underwriter(s)&rsquo; judgment, marketing or other factors dictate such limitation is necessary to facilitate public
distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable
Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of
Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number
of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable
Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such
securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1 hereof, but
the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish
the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to the proposed date of
filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed by
the Company during the two (2) year period following the Initial Exercise Date until such time as all of the Registrable Securities have
been sold by the Holder. The holders of the Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein
by giving written notice within ten (10) days of the receipt of the Company&rsquo;s notice of its intention to file a registration statement.
Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration under
this Section 5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>5.3</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Terms</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of the Exchange
Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably
incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Securities
Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as the
provisions pursuant to which the Company has agreed to indemnify the Placement Agent contained in Section J of the Placement Agency Agreement
(as defined below). The Holder(s) of the Registrable Securities to be sold pursuant to such registration statement, and their successors
and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including
all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending against any claim
whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished
by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement to
the same extent and with the same effect as the foregoing provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise
of Warrants. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants prior to or after
the initial filing of any registration statement or the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.3 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Documents
Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each underwriter
of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel to the Company,
dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, an opinion
dated the date of the closing under any underwriting agreement related thereto), and (ii) a &ldquo;cold comfort&rdquo; letter dated the
effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter dated the
date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has issued a report
on the Company&rsquo;s financial statements included in such registration statement, in each case covering substantially the same matters
with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants&rsquo; letter,
with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&rsquo;s counsel
and in accountants&rsquo; letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver
promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to the managing
underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating
to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter to do
such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration statement
as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access
to books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditors,
all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.4 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriting
Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any Holders whose
Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably satisfactory to
the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such managing underwriters,
and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily contained in agreements
of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating to an underwritten
sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties and covenants of
the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such Holders shall not
be required to make any representations or warranties to or agreements with the Company or the underwriters except as they may relate
to such Holders, their Warrant Shares and their intended methods of distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.5 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Documents
to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company a completed
and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.6 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Damages.
Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company or the Company
otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions
or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 6</U>.&#9;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive such cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company
be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision
of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws and the conditions set forth in Section 4(d) hereof and the
provisions of Section 4.1 of the Purchase Agreement, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit
of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder. In addition, the Holder reserves the right to reduce any item of compensation or adjust the terms thereof as specified
herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation
is in excess of FINRA Rules or that the terms thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Facsimile and Electronic Signatures</U>. Facsimile and other electronically scanned and transmitted signatures, including by
email attachment, shall be deemed originals for all purposes of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>BITMINE IMMERSION TECHNOLOGIES,
    INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:__________________________________________&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Name:&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To: <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Bitmine
Immersion Technologies, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number or by physical delivery of a certificate to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT><U>Accredited Investor</U>. If the Warrant is being exercised via cash exercise and no registration statement covering the issuance
of the Warrant Shares is effective, the undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: _______________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">Name:</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify"><U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Address:</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration-style: double">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration-style: double">Email
    Address: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration-style: double">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration-style: double">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Dated: _______________ __, ______</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Holder&rsquo;s Signature:<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">Holder&rsquo;s Address:<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change
whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of
authority to assign the foregoing Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>bitmine_ex1001.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 30, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June 30, 2025, between Bitmine Immersion Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder (the &ldquo;<U>Securities Act</U>&rdquo;), and Rule&nbsp;506(b) of Regulation&nbsp;D promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, Shares and/or Pre-Funded Warrants as more fully described in this Agreement (the &ldquo;<U>Offering</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the securities hereunder, the parties hereto (the &ldquo;<U>Parties</U>&rdquo;) will execute and deliver a Registration
Rights Agreement, in the form attached hereto as <U>Exhibit&nbsp;A</U> (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;), pursuant
to which the Company will agree to provide certain registration rights in respect of the Shares (as hereinafter defined), the Pre-Funded
Warrants (as hereinafter defined), the Pre-Funded Warrant Shares (as hereinafter defined), the Strategic Advisor Warrants (as hereinafter
defined) and the Strategic Advisor Warrant Shares (as hereinafter defined) under the Securities Act, and the rules and regulations promulgated
thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the aggregate gross
proceeds from the sale of the securities sold in the Offering will be a minimum of $200&nbsp;million (the &ldquo;<U>Minimum Offering Amount</U>&rdquo;)
on a &ldquo;commercially reasonable best efforts, all or none&rdquo; basis (provided that no assurance can be given that all or any portion
of the securities offered hereby will be sold); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, each Purchaser and
the Company intend that each purchase pursuant to the Offering will be treated as part of an integrated transaction described under Section
351(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, ThinkEquity LLC (the
&ldquo;<U>Placement Agent</U>&rdquo;), a U.S.-registered broker-dealer, has been engaged by the Company as the Company&rsquo;s exclusive
placement agent, on a reasonable &ldquo;best efforts&rdquo; basis, for the Offering. The Placement Agent will be paid at the Closing,
a total cash commission of two and one half percent (2.5%) of the aggregate proceeds of the Offering and will receive warrants to purchase
a total number of shares of Common Stock equal to two and one half percent (2.5%) of the aggregate number of securities sold in this offering
(the &ldquo;<U>Placement Agent Warrants</U>&rdquo;) with such Placement Agent Warrants having an exercise price of one hundred twenty
percent (120%) of the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
I</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Definitions</U></FONT>. In addition to the terms defined elsewhere
in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section&nbsp;1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>BTC</U>&rdquo; means
the native currency of the Bitcoin blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount, and (ii)&nbsp;the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Fitzgerald Kreditor Bolduc Risbrough LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Cryptocurrencies</U>&rdquo;
means BTC and ETH.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Digital Asset Consultant</U>&rdquo;
means Ethereum Tower LLC, or any of their affiliates that execute the Digital Asset Consulting Agreement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Digital Asset Consulting
Agreement</U>&rdquo; means the Digital Asset Consulting Agreement between the Company and the Digital Asset Consultant, to be executed
on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00&nbsp;a.m. (New York City time) and before
midnight (New York City time) on any Trading Day, 9:01&nbsp;a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement is signed between midnight
(New York City time) and 9:00&nbsp;a.m. (New York City time) on any Trading Day, no later than 9:01&nbsp;a.m. (New York City time) on
the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a)&nbsp;the initial Registration Statement registering for resale all Shares and Pre-Funded Warrant
Shares has been declared effective by the Commission, (b)&nbsp;all of the Shares and Pre-Funded Warrant Shares have been sold pursuant
to Rule&nbsp;144 or may be sold pursuant to Rule&nbsp;144 without the requirement for the Company to be in compliance with the current
public information requirement of Rule&nbsp;144 and without volume or manner-of-sale restrictions, (c)&nbsp;following the one year anniversary
of the Closing Date provided that a holder of Shares or Pre-Funded Warrant Shares is not an Affiliate of the Company, or (d)&nbsp;all
of the Shares and Pre-Funded Warrant Shares may be sold pursuant to an exemption from registration under Section&nbsp;4(a)(1) of the Securities
Act without volume or manner-of-sale restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ETH</U>&rdquo; means
the native cryptocurrency of the Ethereum blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance (a)&nbsp;of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock
or option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a
majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b)&nbsp;of
shares of Common Stock upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options,
rights or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or
combinations) or to extend the term of such securities; (c)&nbsp;shares of Common Stock upon conversion or settlement of outstanding debt
as of the date hereof in an amount not to exceed $250,000; (d)&nbsp;of the Strategic Advisor Warrants, the Placement Agent Warrants, the
Strategic Advisor Warrant Shares and the Placement Agent Warrant Shares; (e) of shares of Common Stock or pre-funded warrants in a private
placement or other transaction with fundamental or technical institutional investors at a price per share greater than the Per Share Purchase
Price or Per Pre-Funded Warrant Purchase Price, as applicable; (f)&nbsp;of securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule&nbsp;144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section&nbsp;4.12(a) herein, and provided that any such issuance shall only be to a Person
(or to the equityholders of a Person) which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a
business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities; and (g)&nbsp;of any shares of Common Stock issued pursuant to an at-the-market
sales agreement entered into by the Company, the Placement Agent and any sales agents designated by the Company provided that any such
sales are at a price per share greater than the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(cc).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means the lock-up agreement, dated as of the date hereof in substantially the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Money Laundering
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(rr).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-Funded Warrant
Purchase Price</U>&rdquo; means the Per Share Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase
Price</U>&rdquo; equals $4.50, subject to any adjustments for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agency
Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent, dated ___, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means ThinkEquity LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrants</U>&rdquo; means the warrants issued to the Placement Agent pursuant to the Placement Agency Agreement as compensation for the
services of the Placement Agent in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrant Shares</U>&rdquo; means the shares underlying the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Purchase Price</U>&rdquo; means the Per Share Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section&nbsp;2.2(a)&#8239;hereof,
which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of <U>Exhibit&nbsp;C</U>
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means each resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the
Purchasers of the Shares, the Pre-Funded Warrant Shares and the Placement Agent Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such
Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such
Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Strategic Advisor Warrants, the Strategic Advisor Warrant
Shares, the Placement Agent Warrants and the Placement Agent Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor</U>&rdquo;
means Ethereum Tower Instant LLC and/or an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Agreement</U>&rdquo; means the Strategic Advisor Agreement, dated on or around July 3, 2025, by and between the Company and the Strategic
Advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means the warrants to purchase shares of Common Stock, to be issued to the Strategic Advisor (or an affiliate thereof)
in connection with the entry into the Strategic Advisor Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares (and/or Pre-Funded Warrants in lieu of Shares) purchased hereunder
as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in cash (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which
amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreement, the Registration Rights Agreement, the Pre-Funded Warrants, the Placement Agency Agreement,
the Placement Agent Warrants and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means West Coast Stock Transfer, Inc., and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30&nbsp;a.m.
(New York City time) to 4:02&nbsp;p.m. (New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
II</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Closing</U></FONT>. On the Closing Date, upon the terms and subject
to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, the
number of shares of Common Stock (and/or Pre-Funded Warrants in lieu thereof) set forth under the heading &ldquo;Subscription Amount&rdquo;
on the Purchaser&rsquo;s signature page hereto at the Per Share Purchase Price. Notwithstanding anything herein to the contrary, to the
extent that a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount (together with such Purchaser&rsquo;s
Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would cause such
Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser
may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant to Section&nbsp;2.2.
The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date.
In no event may the Beneficial Ownership Limitation exceed 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon exercise of the Pre-Funded Warrants held by the Purchaser. For the avoidance
of doubt, no Purchaser&rsquo;s Beneficial Ownership will exceed 19.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of the Pre-Funded Warrants held by the Purchaser. In each
case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser shall deliver as instructed
by the Placement Agent, via wire transfer,  funds in cash equal to such Purchaser&rsquo;s Subscription Amount as set forth
on the signature page hereto executed by such Purchaser. The Company shall deliver to each Purchaser its respective Shares and Warrants
as determined pursuant to Section&nbsp;2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2
deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections&nbsp;2.2 and 2.3, the Closing shall
take place remotely by electronic transfer of the Closing documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding anything herein to the contrary, if at any time on or
after the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately
prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the
Securities to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Securities</U>&rdquo;),
such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to
be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Securities to
such Purchaser at the Closing; <U>provided</U>, that the Company shall not be required to deliver any Pre-Settlement Securities to such
Purchaser prior to the Company&rsquo;s receipt of the Subscription Amount for such Pre-Settlement Securities hereunder; and <U>provided
further</U> that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such
Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and
that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to
effect any such sale, if any</FONT>. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Warrants)
delivered on or prior to 12:00&nbsp;p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of
execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00&nbsp;p.m. (New York City
time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Warrants) for all purposes
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subscription Amount shall be
paid in cash as indicated in Purchaser&rsquo;s signature page of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Deliveries</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">On or prior to the Closing Date, the Company shall deliver or cause to
be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">a legal opinion of Company Counsel, directed to the Placement Agent and
the Purchasers, in a form reasonably acceptable to the Placement Agent and Purchasers and their respective counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Company shall have provided each Purchaser with the wire instructions
executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">[reserved];</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">a copy of the irrevocable instructions to the Transfer Agent instructing
the Transfer Agent to deliver, on an expedited basis, in book entry form (unless otherwise requested by the Purchasers) a number of Shares
equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">if applicable, a Pre-Funded Warrant registered in the name of such Purchaser
to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to
Pre-Funded Warrants divided by the Per Pre-Funded Warrant Purchase Price, with an exercise price equal to $0</FONT>.0001, subject to adjustment
therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>the Lock-Up Agreement, in form and substance reasonably acceptable to the Placement Agents and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">evidence regarding the effective formation of BMNR Subsidiary One, LLC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Registration Rights Agreement, Strategic Advisory Agreement, and Digital
Asset Consulting Agreement, each duly executed by the Company</FONT>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the delivery of the Board of Directors&rsquo; nomination materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">On or prior to the Closing Date, each Purchaser shall deliver or cause
to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Registration Rights Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">such Purchaser&rsquo;s Subscription Amount by wire transfer to the account
specified by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">[reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Closing Conditions</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The obligations of the Company hereunder in connection with the Closing
are subject to the following conditions being satisfied or waived by the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and
warranties of the Purchasers contained herein (unless as of a specific date therein, in which case they shall be accurate in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as
of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>approval of the NYSE American stock exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">all obligations, covenants and agreements of each Purchaser required to
be performed at or prior to the Closing Date shall have been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)
of this Agreement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The respective obligations of the Purchasers hereunder in connection with
the Closing are subject to the following conditions being satisfied or, severally and not jointly, waived by each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and
warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as
of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">all obligations, covenants and agreements of the Company required to be
performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the delivery by the Company of the items set forth in Section&nbsp;2</FONT>.2(a)
of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Digital Asset Consulting Agreement and the Strategic Advisor Agreement shall have been duly executed by the Company and the
Digital Asset Consultant and the Strategic Advisor, respectively, and shall continue to be effective as of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Strategic Committee shall have been formed and the members appointed in accordance with the terms of the Digital Asset Consulting
Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-size: 10pt">
</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>approval of the NYSE American stock exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>the concurrent closing of the sales of securities in the offering generated aggregate gross proceeds of at least the Minimum Offering
Amount and resulted in at least 44,444,444 shares of Common Stock outstanding as of the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>each Purchaser which is party to this Agreement shall have delivered an executed Lock-Up Agreement to the Company and each such
Lock-Up Agreement shall remain in full force and effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">from the date hereof to and including the Closing Date, trading in the
Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading Market and to the knowledge of the
Company, there shall have been no initiation or threatening of any proceedings for any of such purposes, and, at any time prior to the
Closing Date, trading in securities generally as reported by Bloomberg L.P</FONT>. shall not have been suspended or limited, or minimum
prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a
banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred after the
date of this Agreement any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
III</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Representations and Warranties of the Company</U></FONT>. The Company
hereby makes the following representations and warranties to each Purchaser as of the date hereof and as of the Closing Date (unless as
of a specific date, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Subsidiaries</U></FONT>. All of the direct and indirect Subsidiaries
of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers by the Company. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no Subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Organization and Qualification</U></FONT>. The Company and each of
the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on
its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its
respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction
in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to
be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse
effect on the legality, validity or enforceability of any Transaction Document, the Digital Asset Consulting Agreement or the Strategic
Advisor Agreement; (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole; or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability
to perform in any material respect on a timely basis its obligations under any Transaction Document, the Digital Asset Consulting Agreement
or the Strategic Advisor Agreement (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); <U>provided</U> that a
change in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material
Adverse Effect. The foregoing representation is based on the Company&rsquo;s determination that the placement of equipment with a hosting
firm for the purpose of &ldquo;mining&rdquo; bitcoin, where all on-site service and maintenance is provided by hosting firm personnel,
does not constitute business activity within such jurisdiction sufficient to result in an obligation to register the Company as a foreign
corporation with the state or require a business license from the state, county or city in which the equipment is located. No Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Authorization; Enforcement</U></FONT>. The Company has the requisite
corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction
Documents, the Digital Asset Consulting Agreement or the Strategic Advisor Agreement and otherwise to carry out its obligations hereunder
and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents and the Digital Asset Consulting
Agreement or the Strategic Advisor Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby
have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board
of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.
This Agreement, the Digital Asset Consulting Agreement, the Strategic Advisor Agreement and each other Transaction Document to which it
is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof
and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions
may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Conflicts</U></FONT>. The execution, delivery and performance by
the Company of this Agreement, the Digital Asset Consulting Agreement, the Strategic Advisor Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar
adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or
other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses&nbsp;(ii)
and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Filings, Consents and Approvals</U></FONT>. The Company is not required
to obtain any consent, waiver, authorization, approval, registration, license, qualification, certification, permit or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or regulatory
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other
than: (i)&nbsp;the filings required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the notice and/or additional listing application(s)
to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required
thereby; (iii)&nbsp;the registration statement required to be filed by the Registration Rights Agreement; and (iv)&nbsp;the filing of
Form&nbsp;D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the
&ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Issuance of the Securities</U></FONT>. The Shares are duly authorized
and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens other than restrictions on transfer provided for in the Transaction Documents. The Pre-Funded
Warrants are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued and constitute the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms free and clear of all Liens
other than restrictions on transfer provided for in the Transaction Documents. The Pre-Funded Warrant Shares, when issued in accordance
with the terms of the Pre-Funded Warrants, will be duly authorized, validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Placement Agent Warrants
are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued and constitute the legal, valid
and binding obligations of the Company, enforceable against the Company in accordance with their terms free and clear of all Liens imposed
by the Company. The Placement Agent Warrant Shares, when issued in accordance with the terms of the Placement Agent Warrants, will be
duly authorized, validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents. The Strategic Advisor Warrant Shares, when issued in accordance with the terms
of the Strategic Advisor Warrants, will be duly authorized, validly issued, fully paid and nonassessable, free and clear of all Liens
imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its
duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement, the Warrants, the Placement
Agent Warrants and the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Capitalization</U></FONT>. The capitalization of the Company as of
the date hereof is as set forth in the SEC Reports including the number of shares of Common Stock owned beneficially, and of record, by
Affiliates of the Company as of the date hereof. Except as disclosed in the SEC Reports, the Company has not issued any capital stock
since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees, consultants and directors pursuant to the
Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as
of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set
forth in the SEC Reports or as a result of the purchase and sale of the Securities (and the issuance of the Strategic Advisor Warrants),
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares
of Common Stock or other securities to any Person (other than the Purchasers). The Company does not have any outstanding class of non-voting
stock or any securities that are convertible into or exchangeable for any class of non-voting stock. There are no outstanding securities
or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such
security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities or the shares of Common Stock underlying the
Strategic Advisor Warrants. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SEC Reports; Financial Statements</U></FONT>. The Company has filed
all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange
Act, including pursuant to Section&nbsp;13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as
the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or
has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.
As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Material Changes; Undisclosed Events, Liabilities or Developments</U></FONT>.
Since the date of the latest audited financial statements included within the SEC Reports, except as set forth in the SEC Reports, (i)&nbsp;there
has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not required to be reflected in the
Company&rsquo;s financial statements prepared in accordance with GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the
Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared or made any dividend or distribution of cash
or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock
and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement and the entry into the Digital Asset Consulting Agreement and the Strategic
Advisor Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected
to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets
or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation
is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is
made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Litigation</U></FONT>. There is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). There is no Action that: (i)&nbsp;adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could,
if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor
any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Labor Relations</U></FONT>. No labor dispute exists or, to the knowledge
of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material
Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining
agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the
Company, no executive officer of the Company or any Subsidiary is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does
not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its
Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment
and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Compliance</U></FONT>. Neither the Company nor any Subsidiary: (i)&nbsp;is
in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would
result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it
is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which
it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii)&nbsp;is
in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)&nbsp;is or has been in
violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment
and labor matters, except in each case of clauses&nbsp;(i) through (iii), such as could not, have or reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Environmental Laws</U></FONT>. The Company and its Subsidiaries (i)&nbsp;are
in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including
ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous
Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<U>Environmental Laws</U>&rdquo;); (ii)&nbsp;have received all permits licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii)&nbsp;are in compliance with all terms and conditions of any such
permit, license or approval where in each clause&nbsp;(i), (ii) and (iii), the failure to so comply could be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Regulatory Permits</U></FONT>. The Company and the Subsidiaries possess
all certificates, authorizations, approvals, consents, registrations, licenses, qualifications, certifications and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Title to Assets</U></FONT>. The Company and the Subsidiaries have good
and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by
them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i)&nbsp;Liens
as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate
reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent nor subject to penalties. Any
real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable
leases with which the Company and the Subsidiaries are in compliance, except where the failure to be in compliance would not reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Intellectual Property</U></FONT>. The Company and the Subsidiaries
have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets,
inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection
with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect
(collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received
a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected
to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except where the failure to be in compliance
would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date
of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge
of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has
no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary
to conduct its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Insurance</U></FONT>. The Company and the Subsidiaries are insured
by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the
businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage
at least equal to the aggregate Subscription Amount, or in commercially reasonable amounts. Neither the Company nor any Subsidiary has
any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transactions with Affiliates and Employees</U></FONT>. Except as set
forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none
of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than
for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option
agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Sarbanes-Oxley; Internal Accounting Controls</U></FONT>. The Company
and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are
effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective
as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization,
and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined
in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures
to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying
officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end
of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Fees</U></FONT>. Except for the fees and expenses payable by
the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary
to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Private Placement</U></FONT>. Assuming the accuracy of the Purchasers&rsquo;
representations and warranties set forth in Section&nbsp;3.2, no registration under the Securities Act is required for the offer and sale
of the Securities by the Company to the Purchasers as contemplated hereby. Upon receipt of approval of the NYSE American, the issuance
and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Investment Company</U></FONT>. The Company is not, and is not an Affiliate
of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo;
within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will
not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended. However,
no assurances can be given that a federal or state regulatory will agree with the Company&rsquo;s interpretation and application of their
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration Rights</U></FONT>. Other than to each of the Purchasers
pursuant to the Registration Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary that have not been waived, rendered moot, or are immaterial
or are subject to lock-up agreements except as disclosed in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Listing and Maintenance Requirements</U></FONT>. The Common Stock is
registered pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its
knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company
received any notification that the Commission is contemplating terminating such registration. Except as set forth in the SEC Reports,
the Company has not, in the 12&nbsp;months preceding the date hereof, received notice from any Trading Market on which the Common Stock
is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. Except as set forth in the SEC Reports, the Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Application of Takeover Protections</U></FONT>. The Company and the
Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate
of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers
as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents,
including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Disclosure</U></FONT>. Except for the material terms and conditions
of the transactions contemplated by the Transaction Documents, the Digital Asset Consulting Agreement and the Strategic Advisor Agreement,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information (other than knowledge of the transactions
contemplated hereby, which will be publicly disclosed in a press release pursuant to Section 4.4. below). The Company understands and
confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of
the disclosure furnished by or on behalf of the Company to any of the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby and by the Digital Asset Consulting Agreement and the Strategic Advisor Agreement,
in writing or otherwise, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section&nbsp;3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Integrated Offering</U></FONT>. Assuming the accuracy of the Purchasers&rsquo;
representations and warranties set forth in Section&nbsp;3.2, neither the Company, nor any of its Affiliates, nor any Person acting on
its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes
of (i)&nbsp;the Securities Act which would require the registration of any such securities under the Securities Act, or (ii)&nbsp;any
applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Financial Condition</U>. Based on the consolidated financial condition
of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities
hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in
respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the
Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted
including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated
and projected capital requirements and capital availability thereof, and (iii)&nbsp;the current cash flow of the Company, together with
the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the
cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid</FONT>. The
Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts
of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one (1) year
from the Closing Date. All outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or
any Subsidiary has commitments, is set forth in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Indebtedness</U></FONT>. The SEC Reports set forth as of the date hereof
all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x)&nbsp;any liabilities for borrowed money or amounts owed
in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties, endorsements
and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000
due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect
to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Tax</U></FONT>. Except for the matters that would not, individually
or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has
made or filed all United States federal, state and local and all foreign tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate
for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim. The Company is not aware of any facts or circumstances that could cause the
purchases in the Offering not to qualify as an exchange pursuant to Section 351(a) of the Code. The Company is not an &ldquo;investment
company&rdquo; within the meaning of Section 351(e)(1) of the Code, subject to the proviso contained in the last sentence of Section 3(v).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No General Solicitation</U></FONT>. Neither the Company nor any Person
acting on behalf of the Company has offered or sold any of the Securities by any form of &ldquo;general solicitation&rdquo; or &ldquo;general
advertising&rdquo; (as such terms are defined in Regulation&nbsp;D under the Securities Act). Assuming the accuracy of the Purchasers&rsquo;
representations and warranties under this Agreement, the Company has offered the Securities for sale only to the Purchasers and certain
other &ldquo;accredited investors&rdquo; within the meaning of Rule&nbsp;501(a) of Regulation&nbsp;D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Foreign Corrupt Practices</U></FONT>. Neither the Company nor any Subsidiary,
nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has
(i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to
foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or
to any foreign or domestic political parties or campaigns from corporate funds, (iii)&nbsp;failed to disclose fully any contribution made
by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law,
or (iv)&nbsp;violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Accountants</U></FONT>. The Company&rsquo;s independent registered
public accounting firm is Bush &amp; Associates CPA LLC. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is
a registered public accounting firm as required by the Exchange Act, and (ii)&nbsp;shall express its unqualified opinion with respect
to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending August 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Disagreements with Accountants and Lawyers</U></FONT>. There are
no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants
and lawyers formerly or presently employed by the Company. The Company is current with respect to any fees owed to its accountants and
lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U></FONT>.
The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with
respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is
acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection
with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the
Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other
Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its
representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U></FONT>.
Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections&nbsp;3.2(f) and 4.14 hereof), it is
understood and acknowledged by the Company that: (i)&nbsp;with the exception of the Lock-Up Agreements to be entered into in connection
with this Agreement by and between the Company and each of the Purchasers, none of the Purchasers has been asked by the Company to agree,
nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii)&nbsp;past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv)&nbsp;each Purchaser
shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may engage in hedging activities (in
compliance with applicable laws) at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z)&nbsp;such
hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the
time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents. For the avoidance of doubt, the Lock-Up Agreements to be entered into by and between the
Company and each Purchaser shall govern the limitations on Short Sales and &ldquo;derivative&rdquo; transactions in connection with the
Securities pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Regulation M Compliance</U></FONT>. The Company has not, and to its
knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold,
bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to
any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses&nbsp;(ii)
and (iii), compensation paid to the Placement Agent pursuant to the Placement Agency Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Cybersecurity</U></FONT>. (i)&nbsp;To the Company&rsquo;s knowledge,
in the three (3) years before the date of this Agreement, there has been no unauthorized access, acquisition, or loss or disclosure of
security breach or other compromise of the Company&rsquo;s or any Subsidiary&rsquo;s information in the possession or control of the Company
or any Subsidiary; (ii)&nbsp;the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all
judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of all information in their possession or control, except as would not, individually
or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially
reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy
and security of all (x)&nbsp;information in their possession or control and (y)&nbsp;their software, computer systems, and networks (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;); and (iv)&nbsp;the Company and the Subsidiaries have implemented backup and disaster recovery
technology for the IT Systems and Data consistent with commercially reasonable industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT><FONT STYLE="font-size: 10pt">
</FONT></FONT>[<U>Reserved</U>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Stock Option Plans</U></FONT>. Each stock option or other equity award
granted by the Company under the Company&rsquo;s stock option plan, or as an inducement grant outside of a stock option plan, was granted
(i)&nbsp;in accordance with the terms of the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to
the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No
stock option or other equity award granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly
granted, and there is no and has been no Company policy or practice to knowingly grant, stock options or other equity award prior to,
or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding
the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Office of Foreign Assets Control</U></FONT>. Neither the Company nor
any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or Affiliate of the Company or any Subsidiary,
is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;),
the U.S. Department of State, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authority..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Bank Holding Company Act</U></FONT>. Neither the Company nor any of
its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;), or to regulation
by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its
Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class
of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA or to
regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over
the management or policies of a bank or any entity that is subject to the BHCA or to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(rr)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Money Laundering</U></FONT>. The operations of the Company and its
Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements
of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules
and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any
court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering
Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ss)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Disqualification Events</U></FONT>. With respect to the Securities
to be offered and sold hereunder in reliance on Rule&nbsp;506(b) of Regulation&nbsp;D under the Securities Act, none of the Company, any
of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering
hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on the basis of
voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the Securities Act) connected with the Company in any capacity
at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;) is
subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification
Event</U>&rdquo;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2) or (d)(3). The Company has exercised reasonable
care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable,
with its disclosure obligations under Rule&nbsp;506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(tt)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Other Covered Persons</U></FONT>. Other than the Placement Agent and
a fee that may be payable in connection with purchases by certain parties referenced in the Placement Agency Agreement, the Company is
not aware of any Person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection
with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(uu)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notice of Disqualification Events</U></FONT>. The Company will notify
the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i)&nbsp;any Disqualification Event relating to any Issuer
Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become a Disqualification Event
relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Representations and Warranties of the Purchasers</U></FONT>. Each Purchaser,
for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company
as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Organization; Authority</U></FONT>. Such Purchaser is either an individual
or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the
part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered
by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable
against it in accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Understandings or Arrangements</U></FONT>. Such Purchaser is acquiring
the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to
distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the
Securities are &ldquo;restricted securities&rdquo; and have not been registered under the Securities Act or any applicable state securities
law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling
such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell such Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Purchaser Status</U></FONT>. At the time such Purchaser was offered
the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be either: (i)&nbsp;an
&ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, (ii)&nbsp;a
&ldquo;qualified purchaser&rdquo; as defined in the Securities Act or (iii)&nbsp;a &ldquo;qualified institutional buyer&rdquo; as defined
in Rule&nbsp;144A(a)(1) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Experience of Such Purchaser</U></FONT>. Purchaser represents that
(i) Purchaser was contacted regarding the sale of the Securities by the Placement Agent or the Company (or authorized representative thereof)
and the Purchaser had a prior pre-existing relationship with the Company or the Placement Agent under the U.S. securities laws and interpretations,
(ii) to the knowledge of such Purchaser, no Securities were offered or sold to it by means of any form of general solicitation, and such
Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present
time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>General Solicitation</U></FONT>. Such Purchaser is not purchasing the
Securities as a result of any &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as such terms are defined in Regulation&nbsp;D
under the Securities Act), including, without limitation, any advertisement, article, notice or other communication regarding the Securities
published in any newspaper, magazine or similar media or the internet or broadcast over television or radio or the internet or any seminar
or meeting whose attendees have been invited by general solicitation or general advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Access to Information</U></FONT>. Such Purchaser acknowledges that
it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and
has been afforded (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives
of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii)&nbsp;access to information about the Company and its financial condition, results of operations, business, properties, management
and prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information
that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision
with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement
Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Neither the Placement Agent nor any Affiliate of the Placement Agent has made or makes any representation as to the Company
or the quality of the Securities and the Placement Agent and any Affiliate of the Placement Agent may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, none of the Placement Agent or any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.
Each Purchaser acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by the
Placement Agent or any of its affiliates or any of its or their control persons, officers, directors and employees, in making its investment
or decision to invest in the Company. Each Purchaser agrees that none of the Placement Agent, its affiliates or any of its or their control
persons, officers, directors or employees, shall be liable to any Purchaser for any action heretofore or hereafter taken or omitted to
be taken in good faith by any of them in connection with any Purchaser&rsquo;s purchase of the Securities, unless such action or omission
results from such party&rsquo;s gross negligence, willful misconduct or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Transactions and Confidentiality</U></FONT>. Other than consummating
the transactions contemplated hereunder, such Purchaser has not, directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during
the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person
representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the
execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives,
including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser
has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms
of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>[reserved].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Taxes</U>. Purchaser acknowledges (a) that Company makes no representation or warranty with respect to any tax implications
of the Transaction to Purchaser; (b) Purchaser shall be solely and exclusively responsible for the payment of any and all taxes to Purchaser
as a result of the Transaction; (c) [reserved]; (d) Purchaser has paid its own expenses, in any, incurred in connection with entering
into this Agreement; and (e) Purchaser is not a party to any binding commitments and has no current plans or intention to sell the stock
of the Company purchased pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely
on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document, or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
IV</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
OTHER AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transfer Restrictions</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Securities may only be disposed of in compliance with state and federal
securities laws</FONT>. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule&nbsp;144,
to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section&nbsp;4.1(b), the Company may
require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to
the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration under the Securities Act. As a condition of transfer (other than pursuant to an effective Registration Statement
or Rule&nbsp;144), any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement
and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Purchasers agree to the imprinting, so long as is required by this
Section&nbsp;4</FONT>.1, of a legend or book entry notation on or with respect to any of the Securities substantially in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<U>SECURITIES ACT</U>&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE&nbsp;501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule&nbsp;501(a) of Regulation&nbsp;D under the Securities Act and, if required under the terms of such arrangement, such Purchaser
may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval
of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith.
Further, no notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver
such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer
of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation
and filing of any required prospectus supplement under Rule&nbsp;424(b) under the Securities Act or other applicable provision of the
Securities Act to appropriately amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Certificates (or book entries) evidencing the Shares and Pre-Funded Warrant
Shares shall not contain any legend (including the legend set forth in Section&nbsp;4.1(b) hereof), (i)&nbsp;while a registration statement
(including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii)&nbsp;following
any sale of such Shares or Pre-Funded Warrant Shares pursuant to Rule&nbsp;144, (iii)&nbsp;if such Shares or Pre-Funded Warrant Shares
may be sold under Rule&nbsp;144 without the requirement for the Company to be in compliance with the current public information required
under Rule&nbsp;144 as to such Shares or Pre-Funded Warrant Shares and without volume or manner-of-sale restrictions, or (iv)&nbsp;if
such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission)</FONT>. The Company shall, at its expense, cause its counsel to issue a legal opinion to the Transfer
Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder,
or if requested by a Purchaser, respectively. If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective
registration statement to cover the resale of the Pre-Funded Warrant Shares, or if the Shares or Pre-Funded Warrant Shares may be sold
under Rule&nbsp;144 and the Company is then in compliance with the current public information required under Rule&nbsp;144, or if the
Shares or Pre-Funded Warrant Shares may be sold under Rule&nbsp;144 without the requirement for the Company to be in compliance with the
current public information required under Rule&nbsp;144 as to such Shares or Pre-Funded Warrant Shares or if such legend is not otherwise
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Commission), then such Shares or Pre-Funded Warrant Shares shall be issued free of all legends. The Company shall, at its expense,
cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date
or at such time as such legend is no longer required under this Section&nbsp;4.1(c), it will, no later than the earlier of (i)&nbsp;two
(2) Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery
by a Purchaser to the Company or the Transfer Agent of a certificate (or a request in the case of Shares or Pre-Funded Warrant Shares
held in book entry) representing Shares or Pre-Funded Warrant Shares, as the case may be, issued with a restrictive legend (such date,
the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate or evidence of book entry
position representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records
or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section&nbsp;4.1. Certificates
for Securities (or evidence of book entry position) subject to legend removal hereunder shall be transmitted by the Transfer Agent to
the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with The Depository Trust Company through its Deposit or
Withdrawal at Custodian system as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the
standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common
Stock as in effect on the date of delivery of a certificate or evidence of book entry position representing Shares or Pre-Funded Warrant
Shares, as the case may be, issued with a restrictive legend. The Purchaser shall provide the Company written notice of a removal request
(the &ldquo;<U>Request Notice</U>&rdquo;) at least two (2) Trading Days prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">In addition to such Purchaser&rsquo;s other available remedies, the Company
shall pay to a Purchaser, in cash, (i)&nbsp;as partial liquidated damages and not as a penalty, for each $2,500 of Shares or Pre-Funded
Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal
of the restrictive legend and subject to Section&nbsp;4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading
Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four (4) days after the
Request Notice date) until such certificate (or evidence of book entry position) is delivered without a legend and (ii)&nbsp;if the Company
fails to (a)&nbsp;issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate (or book entry
notation) representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends
and (b)&nbsp;if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock
to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number
of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving
from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including
brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions
and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of (A)&nbsp;such number of Shares or
Pre-Funded Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B)&nbsp;the
lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser
to the Company of the applicable Shares or Pre-Funded Warrant Shares and ending on the date of such delivery and payment under this clause
(ii)</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Each Purchaser, severally and not jointly with the other Purchasers, agrees
with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act,
including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration
Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section&nbsp;4.1 is predicated upon the Company&rsquo;s reliance
upon this understanding</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Furnishing of Information; Public Information</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Until the time that no Purchaser owns Securities, the Company covenants
to maintain the registration of the Common Stock under Section&nbsp;12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">At any time during the period commencing from the six (6) month anniversary
of the date hereof and ending at such time that all of the Securities of a Purchaser may be sold without the requirement for the Company
to be in compliance with Rule&nbsp;144(c)(1) and otherwise without restriction or limitation pursuant to Rule&nbsp;144, if the Company
(i)&nbsp;shall fail for any reason to satisfy the current public information requirement under Rule&nbsp;144(c) or (ii)&nbsp;has ever
been an issuer described in Rule&nbsp;144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any
condition set forth in Rule&nbsp;144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information
Failure until the earlier of (a) the date such Public Information Failure is cured, and (b)&nbsp;such time that such public information
is no longer required for that Purchaser to transfer the Shares or Pre-Funded Warrant Shares pursuant to Rule&nbsp;144</FONT>. The payments
to which a Purchaser shall be entitled pursuant to this Section&nbsp;4.2(b) are referred to herein as &ldquo;<U>Public Information Failure
Payments</U>.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i)&nbsp;the last day of the calendar month during
which such Public Information Failure Payments are incurred and (ii)&nbsp;the third (3rd) Business Day after the event or failure giving
rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in
a timely manner, other than during the pendency of any bona fide dispute over whether an alleged Public Information Failure has occurred,
such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in
full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser
shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Integration</U></FONT>. The Company shall not sell, offer for sale
or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2 of the Securities Act) that would
be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the
sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Securities Laws Disclosure; Publicity</U></FONT>. The Company shall
(a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby (including
the entry into and the material terms of the Digital Asset Consulting Agreement and the Strategic Advisor Agreement), and (b)&nbsp;file
a Current Report on Form&nbsp;8-K, including the Transaction Documents as exhibits thereto (and a summary of the material terms of the
Digital Asset Consulting Agreement and the Strategic Advisor Agreement) with the Commission within the time required by the Exchange Act.
From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all
material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no
further force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases
with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor
otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law or the rules of any Trading Market, in which case the disclosing
party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;as required by federal
securities law in connection with (i)&nbsp;any registration statement contemplated by this Agreement and (ii)&nbsp;the filing of the final
Transaction Documents with the Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations,
in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause&nbsp;(b) and reasonably
cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Stockholder Rights Plan</U></FONT>. No claim will be made or enforced
by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover
plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of
any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the
Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Non-Public Information</U></FONT>. Except with respect to the material
terms and conditions of the transactions contemplated by the Transaction Documents, the Digital Asset Consulting Agreement and the Strategic
Advisor Agreement, which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide any Purchaser (other than Purchasers who are then directors or officers of the Company if any)
or its agents or counsel with any information that constitutes, or that the Company reasonably believes constitutes, material non-public
information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed in writing
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or
any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of such material, non-public information,
provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction
Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form&nbsp;8-K. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Use of Proceeds</U></FONT>. The Company shall use the net proceeds
from the sale of the Securities hereunder to fund the acquisition of Cryptocurrency and the establishment of the Company&rsquo;s Cryptocurrency
treasury operations, as provided in <U>Section 4.21</U> hereof, as well as pay all transaction fees and expenses. At least 20% of the
net proceeds must be used in activities carried on for the production of income from performing services, including but not limited to
blockchain validation services, blockchain lending services or other decentralized finance services. Five percent of the net proceeds
(after the payment of such fees and expenses) of the Transaction are expected to be invested into approved validator, wrapping and staking
technology in furtherance of the Company&rsquo;s business and its treasury management. The Company shall not use such proceeds: (a)&nbsp;for
the redemption of any Common Stock or Common Stock Equivalents, (b)&nbsp;for the settlement of any outstanding litigation or (c)&nbsp;in
violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Indemnification of Purchasers and Strategic Advisor</U></FONT>. Subject
to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders,
members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section&nbsp;15 of the Securities
Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any
other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title)
of such controlling persons, as well as the Strategic Advisor and its affiliates (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless
from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by
the Company in this Agreement or in the other Transaction Documents, or the Strategic Advisor Agreement or the Digital Asset Consulting
Agreement, (b)&nbsp;any action instituted against the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s status as
an investor), or any of them or their respective Affiliates, by the Company or any stockholder of the Company who is not an Affiliate
of such Purchaser Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents, or the Strategic
Advisor Agreement or the Digital Asset Consulting Agreement, or (c)&nbsp;in connection with any registration statement of the Company
providing for the resale by the Purchasers of the Shares or Warrant Shares issued and issuable upon exercise of the Warrants, the Company
will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages,
liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating
to (i)&nbsp;any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any
form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus
or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to
the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing
to the Company by such Purchaser Party expressly for use therein, or (ii)&nbsp;any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. For the avoidance
of doubt, the indemnification provided herein is intended to, and shall also cover, direct claims brought by the Company against the Purchaser
Parties; <U>provided</U>, <U>however</U>, that, in the case of any indemnification pursuant to clause (a) or (b) above, such indemnification
shall not cover any loss, claim, damage or liability to the extent it is finally judicially determined to be attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in any Transaction
Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct.
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct claims brought by the Company, the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i)&nbsp;the employment thereof
has been specifically authorized by the Company in writing, (ii)&nbsp;the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (iii)&nbsp;in such action there is, in the reasonable opinion of counsel to the applicable Purchaser
Party (which may be internal counsel), an actual conflict on any issue between the position of the Company and the position of such Purchaser
Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.
The Company may not settle, compromise or consent to the entry of any judgment in any pending or threatened action in which indemnification
may be sought by any Purchaser Party hereunder (whether or not any Purchaser Party is an actual or potential party thereto), without the
prior written consent of each such Purchaser Party (which will not be unreasonably delayed or withheld) unless such settlement, compromise
or consent provides for an unconditional and irrevocable release of each such Purchaser Party from any and all liability arising out of
such Claim. The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a Purchaser Party effected
without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In addition, if any Purchaser
Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions of any Transaction Documents,
then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement or action, including, but not limited
to, attorneys&rsquo; fees and disbursements. The indemnification and other payment obligations required by this Section 4.8 shall be made
by periodic payments of the amount thereof during the course of the investigation, defense, collection, enforcement or action, as and
when bills are received or are incurred; <U>provided</U>, that if any Purchaser Party is finally judicially determined not to be entitled
to indemnification or payment under this Section 4.8, such Purchaser Party shall promptly reimburse the Company for any payments that
are advanced under this sentence. The indemnity agreements contained herein shall be in addition to any cause of action or similar right
of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Reservation of Common Stock</U></FONT>. As of the date hereof, the
Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement, Warrant Shares issuable
pursuant to any exercise of the Warrants and Placement Agent Warrant Shares issuable pursuant to any exercise of the Placement Agent Warrants,
and Strategic Advisor Warrant Shares issuable pursuant to any exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Listing of Common Stock</U></FONT>. The Company hereby agrees to use
its reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed,
and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market
and secure the listing of all of the Shares and Warrant Shares on such Trading Market as soon as reasonably practicable. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all
of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be
listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue
the listing and trading of its Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common
Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>[Reserved</U></FONT>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Subsequent Equity Sales</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">From the date hereof until thirty (30) days after the Effective Date,
neither the Company nor any Subsidiary shall (i)&nbsp;issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any shares of Common Stock or Common Stock Equivalents or (ii)&nbsp;file any registration statement or amendment or supplement thereto,
other than (A)&nbsp;a registration statement on Form&nbsp;S-8 in connection with any employee benefit plan; <U>provided</U>, <U>however</U>,
the Company will be permitted to enter into a sales agreement with the Placement Agent and such other sales agents as the Company may
designate (the &ldquo;<U>Sales Agreement</U>&rdquo;) providing for the sale of up to $1 billion of shares of Common Stock in an &ldquo;at-the-market&rdquo;
offering, and file any such prospectus supplement or registration statement with the Commission in connection with such sales agreement
or (B) the registration statement described in the Registration Rights Agreement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding the foregoing, this Section&nbsp;4.12 shall not apply
in respect of an Exempt Issuance</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Equal Treatment of Purchasers</U></FONT>. No consideration (including
any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of
any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.
In addition, the Company agrees that the terms and conditions extended to each Purchaser under this Agreement shall be no less favorable
than the most favorable terms offered to any similarly situated Purchasers. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the
Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Transactions and Confidentiality</U></FONT>. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to
any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&rsquo;s securities during
the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4. Each Purchaser, severally and not
jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality
of the existence and terms of this transaction (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no
Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of
the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions in
any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4 and (iii)&nbsp;no
Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates, or agents, including, without limitation, the Placement Agent,
after the issuance of the initial press release as described in Section&nbsp;4.4. Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Form D; Blue Sky Filings</U></FONT>. The Company agrees to timely file
a Form&nbsp;D with respect to the Securities as required under Regulation&nbsp;D and to provide a copy thereof, promptly upon request
of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption
for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws
of the states of the United States and shall provide evidence of such actions promptly upon request of any Purchaser. Each Purchaser acknowledges
and agrees to promptly provide to the Company or its representatives any such information as may be reasonably requested so as to allow
the Company to comply with the provisions of this <U>Section 4.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment of Dilution</U></FONT>. The Company acknowledges that
the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under
certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents are unconditional and
absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any
claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of
the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Exercise Procedures</U></FONT>. The form of Notice of Exercise included
in the Warrants sets forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional
legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the
preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the
Pre-Funded Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Lock-Up Agreement</U></FONT>. The Company shall not amend, modify,
waive or terminate any provision of any of the Lock-Up Agreement without the prior written consent of the Placement Agent, except to extend
the term of the lock-up period, and shall enforce the provisions of the Lock-Up Agreement in accordance with its terms. If any party to
a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance
of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Capital Changes</U></FONT>. Until the one (1) year anniversary of the
Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior
written consent of the Purchasers holding a majority in interest of the Shares, provided that no consent shall be required in the event
the Company undertakes a reverse stock split for purposes of maintaining the listing of the Common Stock on the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.20</FONT><FONT STYLE="font-size: 10pt">
</FONT><U>Board Nomination Right.</U> Upon Closing, the Strategic Advisor shall have the right to nominate one member to the Board of
Directors, who shall act as chairman of the Board of Directors. In addition, the Company shall reduce its Board of Directors to a total
of five members within 90 days of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Treasury Reserve Policy</U>. In connection with the Closing, the Company shall adopt a policy (the &ldquo;<U>Treasury Reserve
Policy</U>&rdquo;), under which the Company&rsquo;s treasury reserve assets will consist of: (i)&nbsp;cash and cash equivalents and short-term
investments (&ldquo;<U>Cash Assets</U>&rdquo;) that exceed working capital requirements; and (ii)&nbsp;ETH, which will serve as the primary
treasury reserve asset of the Company on an ongoing basis, subject to market conditions and oversight by a designated strategic committee,
as will be defined in the Digital Asset Consulting Agreement entered into as of the Closing Date (the &ldquo;<U>Strategic Committee</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
V</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Termination</U></FONT>. This Agreement may be terminated by any Purchaser,
as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the
other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5th) Trading
Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for
any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Fees and Expenses</U></FONT>. Except as expressly set forth in the
Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of
this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing
of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities to the Purchasers, as well as fees and expenses of the Digital Asset Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Entire Agreement</U></FONT>. The Transaction Documents, together with
the exhibits and schedules thereto, contain the entire understanding of the Parties with respect to the subject matter hereof and thereof
and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the Parties acknowledge have
been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notices</U></FONT>. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest
of: (a)&nbsp;the time of transmission, if such notice or communication is delivered email attachment at the email address as set forth
on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after
the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature
pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)&nbsp;the
second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set
forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes,
or contains material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Amendments; Waivers</U></FONT>. No provision of this Agreement may
be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers
which purchased at least fifty and one tenth percent (50.1%) in interest of the Shares based on the initial Subscription Amounts hereunder
(or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such
waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser
(or group of Purchasers), the consent of at least fifty and one tenth percent (50.1%) in interest of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding
upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Headings</U></FONT>. The headings herein are for convenience only,
do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Successors and Assigns</U></FONT>. This Agreement shall be binding
upon and inure to the benefit of the Parties and their successors and permitted assigns. The Company may not assign this Agreement or
any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign
any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that
such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents
that apply to the &ldquo;Purchasers&rdquo; (other than in respect of a transfer pursuant to an effective registration statement) or Rule
144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties
of the Company in Section&nbsp;3.1 and 4.18 and the representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement
is intended for the benefit of the Parties and their respective successors and permitted assigns and is not for the benefit of, nor may
any provision hereof be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Governing Law</U></FONT>. All questions concerning the construction,
validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with
the internal laws of the State of New York, without regard to the principles of conflicts of law thereof that would otherwise require
the application of the laws of any other jurisdiction. Each party agrees that all legal Proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any
of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue
for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents,
then, in addition to the obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding shall be
reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Survival</U></FONT>. The representations and warranties contained herein
shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Execution</U></FONT>. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts
have been signed by each Party and delivered to each other Party, it being understood that the Parties need not sign the same counterpart.
In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create
a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as
if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Severability</U></FONT>. If any term, provision, covenant or restriction
of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired
or invalidated, and the Parties shall use their commercially reasonable efforts to find and employ an alternative means to achieve the
same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and
declared to be the intention of the Parties that they would have executed the remaining terms, provisions, covenants and restrictions
without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Rescission and Withdrawal Right</U></FONT>. Notwithstanding anything
to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser
exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations
within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written
notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights;
<U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the
aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares
pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Replacement of Securities</U></FONT>. If any certificate or instrument
evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution
for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument,
but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with
the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Remedies</U></FONT>. In addition to being entitled to exercise all
rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific
performance under the Transaction Documents. The Parties agree that monetary damages may not be adequate compensation for any loss incurred
by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action
for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Payment Set Aside</U></FONT>. To the extent that the Company makes
a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder,
and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared
to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal
law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended
to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff
had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U></FONT>.
The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser,
and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under
any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant
hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its
rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall
not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been
represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through the legal counsel of the
Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision
contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the
Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Liquidated Damages</U></FONT>. The Company&rsquo;s obligations to pay
any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall
not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument
or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Saturdays, Sundays, Holidays, </U></FONT><U>etc.</U> If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then
such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.20</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Construction</U></FONT>. The Parties agree that each of them and/or
their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction
to the effect that any ambiguities are to be resolved against the drafting Party shall not be employed in the interpretation of the Transaction
Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction
Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>WAIVER OF JURY TRIAL</U></B></FONT><B>. IN ANY ACTION, SUIT, OR
PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Bitmine Immersion Technologies, Inc.</FONT><FONT STYLE="font-size: 10pt"></FONT></P>
                                            <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                            <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">By:_____________________________<U><BR> </U>Name: <BR> Title: Chief Executive Officer</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for Notice</U>:&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Purchaser:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Signature of Authorized Signatory of Purchaser</U></I><U><BR>
    </U>Name of Authorized Signatory:<BR>
    Title of Authorized Signatory:<BR>
    Email Address of Authorized Signatory:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for Notice to Purchaser</U>:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as
address for notice):</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="3" STYLE="font-size: 10pt">Subscription Amount:</TD>
    <TD ROWSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$_________________ (in USD)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$_________________ (in ETH)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$_________________ (in BTC)</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrant Shares: _______________ Beneficial Ownership Blocker
&#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)&nbsp;the
Closing shall occur on the first (1st) Trading Day following the date of this Agreement and (iii)&nbsp;any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause&nbsp;(i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registration Rights Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Lock-Up Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Pre-Funded Warrant</P>
<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>bitmine_ex1002.htm
<DESCRIPTION>FORM OF CRYPTOCURRENCY SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June 30, 2025, between Bitmine Immersion Technologies, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder (the &ldquo;<U>Securities Act</U>&rdquo;), and Rule&nbsp;506(b) of Regulation&nbsp;D promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, Shares and/or Pre-Funded Warrants as more fully described in this Agreement (the &ldquo;<U>Offering</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the securities hereunder, the parties hereto (the &ldquo;<U>Parties</U>&rdquo;) will execute and deliver a Registration
Rights Agreement, in the form attached hereto as <U>Exhibit&nbsp;A</U> (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;), pursuant
to which the Company will agree to provide certain registration rights in respect of the Shares (as hereinafter defined), the Pre-Funded
Warrants (as hereinafter defined), the Pre-Funded Warrant Shares (as hereinafter defined), the Strategic Advisor Warrants (as hereinafter
defined) and the Strategic Advisor Warrant Shares (as hereinafter defined) under the Securities Act, and the rules and regulations promulgated
thereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, each Purchaser and
the Company intend that each purchase pursuant to the Offering will be treated as part of an integrated transaction described under Section
351(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, ThinkEquity LLC (the
&ldquo;<U>Placement Agent</U>&rdquo;), a U.S.-registered broker-dealer, has been engaged by the Company as the Company&rsquo;s exclusive
placement agent, on a reasonable &ldquo;best efforts&rdquo; basis, for the Offering. The Placement Agent will be paid at the Closing,
a total cash commission of two and one half percent (2.5%) of the aggregate proceeds of the Offering and will receive warrants to purchase
a total number of shares of Common Stock equal to two and one half percent (2.5%) of the aggregate number of securities sold in this offering
(the &ldquo;<U>Placement Agent Warrants</U>&rdquo;) with such Placement Agent Warrants having an exercise price of one hundred twenty
percent (120%) of the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
I</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Definitions</U></FONT>. In addition to the terms defined elsewhere
in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section&nbsp;1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>BTC</U>&rdquo; means
the native currency of the Bitcoin blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount, and (ii)&nbsp;the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Fitzgerald Kreditor Bolduc Risbrough LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Cryptocurrencies</U>&rdquo;
means BTC and ETH.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Digital Asset Consultant</U>&rdquo;
means Ethereum Tower LLC, or any of their affiliates that execute the Digital Asset Consulting Agreement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Digital Asset Consulting
Agreement</U>&rdquo; means the Digital Asset Consulting Agreement between the Company and the Digital Asset Consultant, to be executed
on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00&nbsp;a.m. (New York City time) and before
midnight (New York City time) on any Trading Day, 9:01&nbsp;a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement is signed between midnight
(New York City time) and 9:00&nbsp;a.m. (New York City time) on any Trading Day, no later than 9:01&nbsp;a.m. (New York City time) on
the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a)&nbsp;the initial Registration Statement registering for resale all Shares and Pre-Funded Warrant
Shares has been declared effective by the Commission, (b)&nbsp;all of the Shares and Pre-Funded Warrant Shares have been sold pursuant
to Rule&nbsp;144 or may be sold pursuant to Rule&nbsp;144 without the requirement for the Company to be in compliance with the current
public information requirement of Rule&nbsp;144 and without volume or manner-of-sale restrictions, (c)&nbsp;following the one year anniversary
of the Closing Date provided that a holder of Shares or Pre-Funded Warrant Shares is not an Affiliate of the Company, or (d)&nbsp;all
of the Shares and Pre-Funded Warrant Shares may be sold pursuant to an exemption from registration under Section&nbsp;4(a)(1) of the Securities
Act without volume or manner-of-sale restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ETH</U>&rdquo; means
the native cryptocurrency of the Ethereum blockchain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance (a)&nbsp;of shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock
or option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a
majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b)&nbsp;of
shares of Common Stock upon the exercise or exchange or conversion of any Securities issued hereunder and/or securities (including options,
rights or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or
combinations) or to extend the term of such securities; (c)&nbsp;shares of Common Stock upon conversion or settlement of outstanding debt
as of the date hereof in an amount not to exceed $250,000; (d)&nbsp;of the Strategic Advisor Warrants, the Placement Agent Warrants, the
Strategic Advisor Warrant Shares and the Placement Agent Warrant Shares; (e) of shares of Common Stock or pre-funded warrants in a private
placement or other transaction with fundamental or technical institutional investors at a price per share greater than the Per Share Purchase
Price or Per Pre-Funded Warrant Purchase Price, as applicable; (f)&nbsp;of securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule&nbsp;144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section&nbsp;4.12(a) herein, and provided that any such issuance shall only be to a Person
(or to the equityholders of a Person) which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a
business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities; and (g)&nbsp;of any shares of Common Stock issued pursuant to an at-the-market
sales agreement entered into by the Company, the Placement Agent and any sales agents designated by the Company provided that any such
sales are at a price per share greater than the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(cc).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means the lock-up agreement, dated as of the date hereof in substantially the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Money Laundering
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(rr).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-Funded Warrant
Purchase Price</U>&rdquo; means the Per Share Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase
Price</U>&rdquo; equals $4.50, subject to any adjustments for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agency
Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent, dated ___, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means ThinkEquity LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrants</U>&rdquo; means the warrants issued to the Placement Agent pursuant to the Placement Agency Agreement as compensation for the
services of the Placement Agent in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent
Warrant Shares</U>&rdquo; means the shares underlying the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Purchase Price</U>&rdquo; means the Per Share Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section&nbsp;2.2(a)&#8239;hereof,
which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of <U>Exhibit&nbsp;C</U>
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means each resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the
Purchasers of the Shares, the Pre-Funded Warrant Shares and the Placement Agent Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such
Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such
Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Strategic Advisor Warrants, the Strategic Advisor Warrant
Shares, the Placement Agent Warrants and the Placement Agent Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor</U>&rdquo;
means Ethereum Tower Instant LLC and/or an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Agreement</U>&rdquo; means the Strategic Advisor Agreement, dated on or around July 3, 2025, by and between the Company and the Strategic
Advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means the warrants to purchase shares of Common Stock, to be issued to the Strategic Advisor (or an affiliate thereof)
in connection with the entry into the Strategic Advisor Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid in ETH or BTC for Shares (and/or Pre-Funded Warrants in lieu of Shares) purchased
hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants,
which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreement, the Registration Rights Agreement, the Pre-Funded Warrants, the Placement Agency Agreement,
the Placement Agent Warrants and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means West Coast Stock Transfer, Inc., and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30&nbsp;a.m.
(New York City time) to 4:02&nbsp;p.m. (New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
II</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Closing</U></FONT>. On the Closing Date, upon the terms and subject
to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, the
number of shares of Common Stock (and/or Pre-Funded Warrants in lieu thereof) set forth under the heading &ldquo;Subscription Amount&rdquo;
on the Purchaser&rsquo;s signature page hereto at the Per Share Purchase Price. Notwithstanding anything herein to the contrary, to the
extent that a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount (together with such Purchaser&rsquo;s
Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would cause such
Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser
may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant to Section&nbsp;2.2.
The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date.
In no event may the Beneficial Ownership Limitation exceed 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon exercise of the Pre-Funded Warrants held by the Purchaser. For the avoidance
of doubt, no Purchaser&rsquo;s Beneficial Ownership will exceed 19.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of the Pre-Funded Warrants held by the Purchaser. In each
case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser shall deliver as instructed
by the Placement Agent ETH or BTC equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed
by such Purchaser. The Company shall deliver to each Purchaser its respective Shares and Warrants as determined pursuant to Section&nbsp;2.2(a),
and the Company and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections&nbsp;2.2 and 2.3, the Closing shall take place remotely by electronic transfer of
the Closing documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding anything herein to the contrary, if at any time on or
after the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately
prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the
Securities to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Securities</U>&rdquo;),
such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to
be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Securities to
such Purchaser at the Closing; <U>provided</U>, that the Company shall not be required to deliver any Pre-Settlement Securities to such
Purchaser prior to the Company&rsquo;s receipt of the Subscription Amount for such Pre-Settlement Securities hereunder; and <U>provided
further</U> that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such
Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and
that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to
effect any such sale, if any</FONT>. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Warrants)
delivered on or prior to 12:00&nbsp;p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of
execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00&nbsp;p.m. (New York City
time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Warrants) for all purposes
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Subscription Amount shall be paid in either of the Cryptocurrencies
in such amounts as indicated in Purchaser&rsquo;s signature page of this Agreement</FONT>. The amount of Cryptocurrency to be paid
to the Company shall equal (a)&nbsp;the Subscription Amount, divided by (b)&nbsp;the spot exchange rate for that Cryptocurrency (i.e.,
either BTC or ETH, as applicable) as published by Coinbase.com at 8:00&nbsp;p.m. (New York City time) on June 27, 2025 (the &ldquo;<U>Cryptocurrency
Amount</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Deliveries</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">On or prior to the Closing Date, the Company shall deliver or cause to
be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">a legal opinion of Company Counsel, directed to the Placement Agent and
the Purchasers, in a form reasonably acceptable to the Placement Agent and Purchasers and their respective counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">[reserved];</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Company shall have provided each Purchaser with an applicable wallet
address maintained by Payward Financial Inc. (d/b/a/ Kraken Financial), in the name of BMNR Subsidiary One, LLC, a wholly owned subsidiary
of the Company (the &ldquo;<U>Custodial Account</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">a copy of the irrevocable instructions to the Transfer Agent instructing
the Transfer Agent to deliver, on an expedited basis, in book entry form (unless otherwise requested by the Purchasers) a number of Shares
equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">if applicable, a Pre-Funded Warrant registered in the name of such Purchaser
to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to
Pre-Funded Warrants divided by the Per Pre-Funded Warrant Purchase Price, with an exercise price equal to $0</FONT>.0001, subject to adjustment
therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>the Lock-Up Agreement, in form and substance reasonably acceptable to the Placement Agents and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">evidence regarding the effective formation of BMNR Subsidiary One, LLC;
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Registration Rights Agreement, Strategic Advisory Agreement, and Digital
Asset Consulting Agreement, each duly executed by the Company</FONT>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the delivery of the Board of Directors&rsquo; nomination materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">On or prior to the Closing Date, each Purchaser shall deliver or cause
to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the Registration Rights Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">[reserved]; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">such Purchaser&rsquo;s Subscription Amount by transfer of the Cryptocurrency
Amount to the Custodial Account</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Closing Conditions</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The obligations of the Company hereunder in connection with the Closing
are subject to the following conditions being satisfied or waived by the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and
warranties of the Purchasers contained herein (unless as of a specific date therein, in which case they shall be accurate in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as
of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>approval of the NYSE American stock exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">all obligations, covenants and agreements of each Purchaser required to
be performed at or prior to the Closing Date shall have been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)
of this Agreement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The respective obligations of the Purchasers hereunder in connection with
the Closing are subject to the following conditions being satisfied or, severally and not jointly, waived by each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and
warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as
of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">all obligations, covenants and agreements of the Company required to be
performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">the delivery by the Company of the items set forth in Section&nbsp;2</FONT>.2(a)
of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Digital Asset Consulting Agreement and the Strategic Advisor Agreement shall have been duly executed by the Company and the
Digital Asset Consultant and the Strategic Advisor, respectively, and shall continue to be effective as of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Strategic Committee shall have been formed and the members appointed in accordance with the terms of the Digital Asset Consulting
Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-size: 10pt">
</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-size: 10pt">
</FONT>approval of the NYSE American stock exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii) [reserved];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>each Purchaser which is party to this Agreement shall have delivered an executed Lock-Up Agreement to the Company and each such
Lock-Up Agreement shall remain in full force and effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">from the date hereof to and including the Closing Date, trading in the
Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading Market and to the knowledge of the
Company, there shall have been no initiation or threatening of any proceedings for any of such purposes, and, at any time prior to the
Closing Date, trading in securities generally as reported by Bloomberg L.P</FONT>. shall not have been suspended or limited, or minimum
prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a
banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred after the
date of this Agreement any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
III</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Representations and Warranties of the Company</U></FONT>. The Company
hereby makes the following representations and warranties to each Purchaser as of the date hereof and as of the Closing Date (unless as
of a specific date, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Subsidiaries</U></FONT>. All of the direct and indirect Subsidiaries
of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers by the Company. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no Subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Organization and Qualification</U></FONT>. The Company and each of
the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on
its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its
respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction
in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to
be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse
effect on the legality, validity or enforceability of any Transaction Document, the Digital Asset Consulting Agreement or the Strategic
Advisor Agreement; (ii)&nbsp;a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole; or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability
to perform in any material respect on a timely basis its obligations under any Transaction Document, the Digital Asset Consulting Agreement
or the Strategic Advisor Agreement (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;); <U>provided</U> that a
change in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself, to constitute a Material
Adverse Effect. The foregoing representation is based on the Company&rsquo;s determination that the placement of equipment with a hosting
firm for the purpose of &ldquo;mining&rdquo; bitcoin, where all on-site service and maintenance is provided by hosting firm personnel,
does not constitute business activity within such jurisdiction sufficient to result in an obligation to register the Company as a foreign
corporation with the state or require a business license from the state, county or city in which the equipment is located. No Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Authorization; Enforcement</U></FONT>. The Company has the requisite
corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction
Documents, the Digital Asset Consulting Agreement or the Strategic Advisor Agreement and otherwise to carry out its obligations hereunder
and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents and the Digital Asset Consulting
Agreement or the Strategic Advisor Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby
have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board
of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.
This Agreement, the Digital Asset Consulting Agreement, the Strategic Advisor Agreement and each other Transaction Document to which it
is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof
and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions
may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Conflicts</U></FONT>. The execution, delivery and performance by
the Company of this Agreement, the Digital Asset Consulting Agreement, the Strategic Advisor Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar
adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or
other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses&nbsp;(ii)
and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Filings, Consents and Approvals</U></FONT>. The Company is not required
to obtain any consent, waiver, authorization, approval, registration, license, qualification, certification, permit or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or regulatory
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other
than: (i)&nbsp;the filings required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the notice and/or additional listing application(s)
to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required
thereby; (iii)&nbsp;the registration statement required to be filed by the Registration Rights Agreement; and (iv)&nbsp;the filing of
Form&nbsp;D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the
&ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Issuance of the Securities</U></FONT>. The Shares are duly authorized
and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens other than restrictions on transfer provided for in the Transaction Documents. The Pre-Funded
Warrants are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued and constitute the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms free and clear of all Liens
other than restrictions on transfer provided for in the Transaction Documents. The Pre-Funded Warrant Shares, when issued in accordance
with the terms of the Pre-Funded Warrants, will be duly authorized, validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Placement Agent Warrants
are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued and constitute the legal, valid
and binding obligations of the Company, enforceable against the Company in accordance with their terms free and clear of all Liens imposed
by the Company. The Placement Agent Warrant Shares, when issued in accordance with the terms of the Placement Agent Warrants, will be
duly authorized, validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents. The Strategic Advisor Warrant Shares, when issued in accordance with the terms
of the Strategic Advisor Warrants, will be duly authorized, validly issued, fully paid and nonassessable, free and clear of all Liens
imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its
duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement, the Warrants, the Placement
Agent Warrants and the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Capitalization</U></FONT>. The capitalization of the Company as of
the date hereof is as set forth in the SEC Reports including the number of shares of Common Stock owned beneficially, and of record, by
Affiliates of the Company as of the date hereof. Except as disclosed in the SEC Reports, the Company has not issued any capital stock
since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under
the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees, consultants and directors pursuant to the
Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as
of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set
forth in the SEC Reports or as a result of the purchase and sale of the Securities (and the issuance of the Strategic Advisor Warrants),
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares
of Common Stock or other securities to any Person (other than the Purchasers). The Company does not have any outstanding class of non-voting
stock or any securities that are convertible into or exchangeable for any class of non-voting stock. There are no outstanding securities
or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such
security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities or the shares of Common Stock underlying the
Strategic Advisor Warrants. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SEC Reports; Financial Statements</U></FONT>. The Company has filed
all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange
Act, including pursuant to Section&nbsp;13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as
the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or
has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.
As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule&nbsp;144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Material Changes; Undisclosed Events, Liabilities or Developments</U></FONT>.
Since the date of the latest audited financial statements included within the SEC Reports, except as set forth in the SEC Reports, (i)&nbsp;there
has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not required to be reflected in the
Company&rsquo;s financial statements prepared in accordance with GAAP or disclosed in filings made with the Commission, (iii)&nbsp;the
Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared or made any dividend or distribution of cash
or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock
and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement and the entry into the Digital Asset Consulting Agreement and the Strategic
Advisor Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected
to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets
or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation
is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is
made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Litigation</U></FONT>. There is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). There is no Action that: (i)&nbsp;adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could,
if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor
any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Labor Relations</U></FONT>. No labor dispute exists or, to the knowledge
of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material
Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining
agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the
Company, no executive officer of the Company or any Subsidiary is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does
not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its
Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment
and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Compliance</U></FONT>. Neither the Company nor any Subsidiary: (i)&nbsp;is
in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would
result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it
is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which
it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii)&nbsp;is
in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)&nbsp;is or has been in
violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment
and labor matters, except in each case of clauses&nbsp;(i) through (iii), such as could not, have or reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Environmental Laws</U></FONT>. The Company and its Subsidiaries (i)&nbsp;are
in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including
ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous
Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions,
judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo;<U>Environmental Laws</U>&rdquo;); (ii)&nbsp;have received all permits licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (iii)&nbsp;are in compliance with all terms and conditions of any such
permit, license or approval where in each clause&nbsp;(i), (ii) and (iii), the failure to so comply could be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Regulatory Permits</U></FONT>. The Company and the Subsidiaries possess
all certificates, authorizations, approvals, consents, registrations, licenses, qualifications, certifications and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Title to Assets</U></FONT>. The Company and the Subsidiaries have good
and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by
them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i)&nbsp;Liens
as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate
reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent nor subject to penalties. Any
real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable
leases with which the Company and the Subsidiaries are in compliance, except where the failure to be in compliance would not reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Intellectual Property</U></FONT>. The Company and the Subsidiaries
have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets,
inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection
with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect
(collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received
a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected
to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except where the failure to be in compliance
would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date
of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge
of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has
no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary
to conduct its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Insurance</U></FONT>. The Company and the Subsidiaries are insured
by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the
businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage
at least equal to the aggregate Subscription Amount, or in commercially reasonable amounts. Neither the Company nor any Subsidiary has
any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transactions with Affiliates and Employees</U></FONT>. Except as set
forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none
of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than
for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option
agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Sarbanes-Oxley; Internal Accounting Controls</U></FONT>. The Company
and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are
effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective
as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability, (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization,
and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined
in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures
to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying
officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end
of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Fees</U></FONT>. Except for the fees and expenses payable by
the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary
to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Private Placement</U></FONT>. Assuming the accuracy of the Purchasers&rsquo;
representations and warranties set forth in Section&nbsp;3.2, no registration under the Securities Act is required for the offer and sale
of the Securities by the Company to the Purchasers as contemplated hereby. Upon receipt of approval of the NYSE American, the issuance
and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Investment Company</U></FONT>. The Company is not, and is not an Affiliate
of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo;
within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will
not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended. However,
no assurances can be given that a federal or state regulatory will agree with the Company&rsquo;s interpretation and application of their
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration Rights</U></FONT>. Other than to each of the Purchasers
pursuant to the Registration Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration
under the Securities Act of any securities of the Company or any Subsidiary that have not been waived, rendered moot, or are immaterial
or are subject to lock-up agreements except as disclosed in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Listing and Maintenance Requirements</U></FONT>. The Common Stock is
registered pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its
knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company
received any notification that the Commission is contemplating terminating such registration. Except as set forth in the SEC Reports,
the Company has not, in the 12&nbsp;months preceding the date hereof, received notice from any Trading Market on which the Common Stock
is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. Except as set forth in the SEC Reports, the Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Application of Takeover Protections</U></FONT>. The Company and the
Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate
of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers
as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents,
including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Disclosure</U></FONT>. Except for the material terms and conditions
of the transactions contemplated by the Transaction Documents, the Digital Asset Consulting Agreement and the Strategic Advisor Agreement,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information (other than knowledge of the transactions
contemplated hereby, which will be publicly disclosed in a press release pursuant to Section 4.4. below). The Company understands and
confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of
the disclosure furnished by or on behalf of the Company to any of the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby and by the Digital Asset Consulting Agreement and the Strategic Advisor Agreement,
in writing or otherwise, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section&nbsp;3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Integrated Offering</U></FONT>. Assuming the accuracy of the Purchasers&rsquo;
representations and warranties set forth in Section&nbsp;3.2, neither the Company, nor any of its Affiliates, nor any Person acting on
its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes
of (i)&nbsp;the Securities Act which would require the registration of any such securities under the Securities Act, or (ii)&nbsp;any
applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Financial Condition</U>. Based on the consolidated financial condition
of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities
hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in
respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii)&nbsp;the
Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted
including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated
and projected capital requirements and capital availability thereof, and (iii)&nbsp;the current cash flow of the Company, together with
the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the
cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid</FONT>. The
Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts
of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one (1) year
from the Closing Date. All outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or
any Subsidiary has commitments, is set forth in the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Indebtedness</U></FONT>. The SEC Reports set forth as of the date hereof
all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x)&nbsp;any liabilities for borrowed money or amounts owed
in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y)&nbsp;all guaranties, endorsements
and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000
due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect
to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Tax</U></FONT>. Except for the matters that would not, individually
or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has
made or filed all United States federal, state and local and all foreign tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate
for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim. The Company is not aware of any facts or circumstances that could cause the
purchases in the Offering not to qualify as an exchange pursuant to Section 351(a) of the Code. The Company is not an &ldquo;investment
company&rdquo; within the meaning of Section 351(e)(1) of the Code, subject to the proviso contained in the last sentence of Section 3(v).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No General Solicitation</U></FONT>. Neither the Company nor any Person
acting on behalf of the Company has offered or sold any of the Securities by any form of &ldquo;general solicitation&rdquo; or &ldquo;general
advertising&rdquo; (as such terms are defined in Regulation&nbsp;D under the Securities Act). Assuming the accuracy of the Purchasers&rsquo;
representations and warranties under this Agreement, the Company has offered the Securities for sale only to the Purchasers and certain
other &ldquo;accredited investors&rdquo; within the meaning of Rule&nbsp;501(a) of Regulation&nbsp;D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Foreign Corrupt Practices</U></FONT>. Neither the Company nor any Subsidiary,
nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has
(i)&nbsp;directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to
foreign or domestic political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or
to any foreign or domestic political parties or campaigns from corporate funds, (iii)&nbsp;failed to disclose fully any contribution made
by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law,
or (iv)&nbsp;violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Accountants</U></FONT>. The Company&rsquo;s independent registered
public accounting firm is Bush &amp; Associates CPA LLC. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is
a registered public accounting firm as required by the Exchange Act, and (ii)&nbsp;shall express its unqualified opinion with respect
to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending August 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Disagreements with Accountants and Lawyers</U></FONT>. There are
no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants
and lawyers formerly or presently employed by the Company. The Company is current with respect to any fees owed to its accountants and
lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U></FONT>.
The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with
respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is
acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection
with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the
Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other
Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its
representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U></FONT>.
Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections&nbsp;3.2(f) and 4.14 hereof), it is
understood and acknowledged by the Company that: (i)&nbsp;with the exception of the Lock-Up Agreements to be entered into in connection
with this Agreement by and between the Company and each of the Purchasers, none of the Purchasers has been asked by the Company to agree,
nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii)&nbsp;past or future open market
or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s
publicly-traded securities, (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser
is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv)&nbsp;each Purchaser
shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may engage in hedging activities (in
compliance with applicable laws) at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z)&nbsp;such
hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the
time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents. For the avoidance of doubt, the Lock-Up Agreements to be entered into by and between the
Company and each Purchaser shall govern the limitations on Short Sales and &ldquo;derivative&rdquo; transactions in connection with the
Securities pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Regulation M Compliance</U></FONT>. The Company has not, and to its
knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold,
bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to
any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses&nbsp;(ii)
and (iii), compensation paid to the Placement Agent pursuant to the Placement Agency Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Cybersecurity</U></FONT>. (i)&nbsp;To the Company&rsquo;s knowledge,
in the three (3) years before the date of this Agreement, there has been no unauthorized access, acquisition, or loss or disclosure of
security breach or other compromise of the Company&rsquo;s or any Subsidiary&rsquo;s information in the possession or control of the Company
or any Subsidiary; (ii)&nbsp;the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all
judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of all information in their possession or control, except as would not, individually
or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially
reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy
and security of all (x)&nbsp;information in their possession or control and (y)&nbsp;their software, computer systems, and networks (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;); and (iv)&nbsp;the Company and the Subsidiaries have implemented backup and disaster recovery
technology for the IT Systems and Data consistent with commercially reasonable industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT><FONT STYLE="font-size: 10pt">
</FONT></FONT>[<U>Reserved</U>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Stock Option Plans</U></FONT>. Each stock option or other equity award
granted by the Company under the Company&rsquo;s stock option plan, or as an inducement grant outside of a stock option plan, was granted
(i)&nbsp;in accordance with the terms of the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to
the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No
stock option or other equity award granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly
granted, and there is no and has been no Company policy or practice to knowingly grant, stock options or other equity award prior to,
or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding
the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Office of Foreign Assets Control</U></FONT>. Neither the Company nor
any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or Affiliate of the Company or any Subsidiary,
is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;),
the U.S. Department of State, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authority..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Bank Holding Company Act</U></FONT>. Neither the Company nor any of
its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;), or to regulation
by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its
Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class
of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA or to
regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over
the management or policies of a bank or any entity that is subject to the BHCA or to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(rr)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Money Laundering</U></FONT>. The operations of the Company and its
Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements
of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules
and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any
court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering
Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ss)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Disqualification Events</U></FONT>. With respect to the Securities
to be offered and sold hereunder in reliance on Rule&nbsp;506(b) of Regulation&nbsp;D under the Securities Act, none of the Company, any
of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering
hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on the basis of
voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the Securities Act) connected with the Company in any capacity
at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;) is
subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification
Event</U>&rdquo;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2) or (d)(3). The Company has exercised reasonable
care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable,
with its disclosure obligations under Rule&nbsp;506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(tt)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Other Covered Persons</U></FONT>. Other than the Placement Agent and
a fee that may be payable in connection with purchases by certain parties referenced in the Placement Agency Agreement, the Company is
not aware of any Person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection
with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(uu)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notice of Disqualification Events</U></FONT>. The Company will notify
the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i)&nbsp;any Disqualification Event relating to any Issuer
Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become a Disqualification Event
relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Representations and Warranties of the Purchasers</U></FONT>. Each Purchaser,
for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company
as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Organization; Authority</U></FONT>. Such Purchaser is either an individual
or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the
part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered
by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable
against it in accordance with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Understandings or Arrangements</U></FONT>. Such Purchaser is acquiring
the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to
distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the
Securities are &ldquo;restricted securities&rdquo; and have not been registered under the Securities Act or any applicable state securities
law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling
such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell such Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Purchaser Status</U></FONT>. At the time such Purchaser was offered
the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be either: (i)&nbsp;an
&ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act, (ii)&nbsp;a
&ldquo;qualified purchaser&rdquo; as defined in the Securities Act or (iii)&nbsp;a &ldquo;qualified institutional buyer&rdquo; as defined
in Rule&nbsp;144A(a)(1) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Experience of Such Purchaser</U></FONT>. Purchaser represents that
(i) Purchaser was contacted regarding the sale of the Securities by the Placement Agent or the Company (or authorized representative thereof)
and the Purchaser had a prior pre-existing relationship with the Company or the Placement Agent under the U.S. securities laws and interpretations,
(ii) to the knowledge of such Purchaser, no Securities were offered or sold to it by means of any form of general solicitation, and such
Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present
time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>General Solicitation</U></FONT>. Such Purchaser is not purchasing the
Securities as a result of any &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as such terms are defined in Regulation&nbsp;D
under the Securities Act), including, without limitation, any advertisement, article, notice or other communication regarding the Securities
published in any newspaper, magazine or similar media or the internet or broadcast over television or radio or the internet or any seminar
or meeting whose attendees have been invited by general solicitation or general advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Access to Information</U></FONT>. Such Purchaser acknowledges that
it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and
has been afforded (i)&nbsp;the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives
of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii)&nbsp;access to information about the Company and its financial condition, results of operations, business, properties, management
and prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information
that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision
with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement
Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Neither the Placement Agent nor any Affiliate of the Placement Agent has made or makes any representation as to the Company
or the quality of the Securities and the Placement Agent and any Affiliate of the Placement Agent may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, none of the Placement Agent or any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.
Each Purchaser acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by the
Placement Agent or any of its affiliates or any of its or their control persons, officers, directors and employees, in making its investment
or decision to invest in the Company. Each Purchaser agrees that none of the Placement Agent, its affiliates or any of its or their control
persons, officers, directors or employees, shall be liable to any Purchaser for any action heretofore or hereafter taken or omitted to
be taken in good faith by any of them in connection with any Purchaser&rsquo;s purchase of the Securities, unless such action or omission
results from such party&rsquo;s gross negligence, willful misconduct or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Transactions and Confidentiality</U></FONT>. Other than consummating
the transactions contemplated hereunder, such Purchaser has not, directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during
the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person
representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the
execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives,
including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser
has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms
of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Cryptocurrency Subscriptions</U>. (i)&nbsp;Purchaser has all rights,
title and interest in and to the Cryptocurrency to be contributed by it to the Company pursuant to this Agreement, (ii)&nbsp;such Cryptocurrency
is held in a digital wallet held or operated by or on behalf of the Purchaser at or by an appropriately regulated custodian and/or in
accordance with industry-standard security practices (the &ldquo;<U>Purchaser Digital Wallet</U>&rdquo;) and neither such Cryptocurrency
nor such Purchaser Digital Wallet is subject to any liens, encumbrances or other restrictions, (iii)&nbsp;Purchaser has taken commercially
reasonable steps to protect its Purchaser Digital Wallet and such Cryptocurrency and (iv)&nbsp;Purchaser has the exclusive ability to
control such Purchaser Digital Wallet, including by use of &ldquo;private keys&rdquo; or other equivalent means or through custody arrangements
or other equivalent means</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Taxes</U>. Purchaser acknowledges (a) that Company makes no representation or warranty with respect to any tax implications
of the Transaction to Purchaser; (b) Purchaser shall be solely and exclusively responsible for the payment of any and all taxes to Purchaser
as a result of the Transaction; (c) Purchaser represents that (i) Purchaser will not retain any rights in the ETH or BTC transferred by
Purchaser to the Company are subject to liabilities that are assumed by the Company, (ii) none of the ETH or BTC transferred by Purchaser
to the Company are subject to liabilities that are assumed by the Company, (iii) the fair market value of the ETH or BTC contributed to
the Company is at least equal to or greater than Purchaser&rsquo;s tax basis in applicable ETH or BTC; (d) Purchaser has paid its own
expenses, in any, incurred in connection with entering into this Agreement; and (e) Purchaser is not a party to any binding commitments
and has no current plans or intention to sell the stock of the Company purchased pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely
on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document, or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
IV</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
OTHER AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transfer Restrictions</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Securities may only be disposed of in compliance with state and federal
securities laws</FONT>. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule&nbsp;144,
to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section&nbsp;4.1(b), the Company may
require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to
the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration under the Securities Act. As a condition of transfer (other than pursuant to an effective Registration Statement
or Rule&nbsp;144), any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement
and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The Purchasers agree to the imprinting, so long as is required by this
Section&nbsp;4</FONT>.1, of a legend or book entry notation on or with respect to any of the Securities substantially in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<U>SECURITIES ACT</U>&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE&nbsp;501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule&nbsp;501(a) of Regulation&nbsp;D under the Securities Act and, if required under the terms of such arrangement, such Purchaser
may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval
of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith.
Further, no notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver
such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer
of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation
and filing of any required prospectus supplement under Rule&nbsp;424(b) under the Securities Act or other applicable provision of the
Securities Act to appropriately amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Certificates (or book entries) evidencing the Shares and Pre-Funded Warrant
Shares shall not contain any legend (including the legend set forth in Section&nbsp;4.1(b) hereof), (i)&nbsp;while a registration statement
(including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii)&nbsp;following
any sale of such Shares or Pre-Funded Warrant Shares pursuant to Rule&nbsp;144, (iii)&nbsp;if such Shares or Pre-Funded Warrant Shares
may be sold under Rule&nbsp;144 without the requirement for the Company to be in compliance with the current public information required
under Rule&nbsp;144 as to such Shares or Pre-Funded Warrant Shares and without volume or manner-of-sale restrictions, or (iv)&nbsp;if
such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission)</FONT>. The Company shall, at its expense, cause its counsel to issue a legal opinion to the Transfer
Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder,
or if requested by a Purchaser, respectively. If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective
registration statement to cover the resale of the Pre-Funded Warrant Shares, or if the Shares or Pre-Funded Warrant Shares may be sold
under Rule&nbsp;144 and the Company is then in compliance with the current public information required under Rule&nbsp;144, or if the
Shares or Pre-Funded Warrant Shares may be sold under Rule&nbsp;144 without the requirement for the Company to be in compliance with the
current public information required under Rule&nbsp;144 as to such Shares or Pre-Funded Warrant Shares or if such legend is not otherwise
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Commission), then such Shares or Pre-Funded Warrant Shares shall be issued free of all legends. The Company shall, at its expense,
cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder or if reasonably required by a Purchaser. The Company agrees that following the Effective Date
or at such time as such legend is no longer required under this Section&nbsp;4.1(c), it will, no later than the earlier of (i)&nbsp;two
(2) Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery
by a Purchaser to the Company or the Transfer Agent of a certificate (or a request in the case of Shares or Pre-Funded Warrant Shares
held in book entry) representing Shares or Pre-Funded Warrant Shares, as the case may be, issued with a restrictive legend (such date,
the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate or evidence of book entry
position representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records
or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section&nbsp;4.1. Certificates
for Securities (or evidence of book entry position) subject to legend removal hereunder shall be transmitted by the Transfer Agent to
the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with The Depository Trust Company through its Deposit or
Withdrawal at Custodian system as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the
standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common
Stock as in effect on the date of delivery of a certificate or evidence of book entry position representing Shares or Pre-Funded Warrant
Shares, as the case may be, issued with a restrictive legend. The Purchaser shall provide the Company written notice of a removal request
(the &ldquo;<U>Request Notice</U>&rdquo;) at least two (2) Trading Days prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">In addition to such Purchaser&rsquo;s other available remedies, the Company
shall pay to a Purchaser, in cash, (i)&nbsp;as partial liquidated damages and not as a penalty, for each $2,500 of Shares or Pre-Funded
Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal
of the restrictive legend and subject to Section&nbsp;4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading
Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, if later, four (4) days after the
Request Notice date) until such certificate (or evidence of book entry position) is delivered without a legend and (ii)&nbsp;if the Company
fails to (a)&nbsp;issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate (or book entry
notation) representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends
and (b)&nbsp;if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock
to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number
of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving
from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including
brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions
and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of (A)&nbsp;such number of Shares or
Pre-Funded Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B)&nbsp;the
lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser
to the Company of the applicable Shares or Pre-Funded Warrant Shares and ending on the date of such delivery and payment under this clause
(ii)</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Each Purchaser, severally and not jointly with the other Purchasers, agrees
with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act,
including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration
Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section&nbsp;4.1 is predicated upon the Company&rsquo;s reliance
upon this understanding</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Furnishing of Information; Public Information</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Until the time that no Purchaser owns Securities, the Company covenants
to maintain the registration of the Common Stock under Section&nbsp;12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">At any time during the period commencing from the six (6) month anniversary
of the date hereof and ending at such time that all of the Securities of a Purchaser may be sold without the requirement for the Company
to be in compliance with Rule&nbsp;144(c)(1) and otherwise without restriction or limitation pursuant to Rule&nbsp;144, if the Company
(i)&nbsp;shall fail for any reason to satisfy the current public information requirement under Rule&nbsp;144(c) or (ii)&nbsp;has ever
been an issuer described in Rule&nbsp;144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any
condition set forth in Rule&nbsp;144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to $1,000 per day of a Public Information
Failure until the earlier of (a) the date such Public Information Failure is cured, and (b)&nbsp;such time that such public information
is no longer required for that Purchaser to transfer the Shares or Pre-Funded Warrant Shares pursuant to Rule&nbsp;144</FONT>. The payments
to which a Purchaser shall be entitled pursuant to this Section&nbsp;4.2(b) are referred to herein as &ldquo;<U>Public Information Failure
Payments</U>.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i)&nbsp;the last day of the calendar month during
which such Public Information Failure Payments are incurred and (ii)&nbsp;the third (3rd) Business Day after the event or failure giving
rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in
a timely manner, other than during the pendency of any bona fide dispute over whether an alleged Public Information Failure has occurred,
such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in
full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser
shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Integration</U></FONT>. The Company shall not sell, offer for sale
or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2 of the Securities Act) that would
be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the
sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Securities Laws Disclosure; Publicity</U></FONT>. The Company shall
(a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby (including
the entry into and the material terms of the Digital Asset Consulting Agreement and the Strategic Advisor Agreement), and (b)&nbsp;file
a Current Report on Form&nbsp;8-K, including the Transaction Documents as exhibits thereto (and a summary of the material terms of the
Digital Asset Consulting Agreement and the Strategic Advisor Agreement) with the Commission within the time required by the Exchange Act.
From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all
material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no
further force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases
with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor
otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law or the rules of any Trading Market, in which case the disclosing
party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;as required by federal
securities law in connection with (i)&nbsp;any registration statement contemplated by this Agreement and (ii)&nbsp;the filing of the final
Transaction Documents with the Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations,
in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause&nbsp;(b) and reasonably
cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Stockholder Rights Plan</U></FONT>. No claim will be made or enforced
by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover
plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of
any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the
Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Non-Public Information</U></FONT>. Except with respect to the material
terms and conditions of the transactions contemplated by the Transaction Documents, the Digital Asset Consulting Agreement and the Strategic
Advisor Agreement, which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide any Purchaser (other than Purchasers who are then directors or officers of the Company if any)
or its agents or counsel with any information that constitutes, or that the Company reasonably believes constitutes, material non-public
information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed in writing
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or
any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of such material, non-public information,
provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction
Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form&nbsp;8-K. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Use of Proceeds</U></FONT>. The Company shall use the net proceeds
from the sale of the Securities hereunder to fund the acquisition of Cryptocurrency and the establishment of the Company&rsquo;s Cryptocurrency
treasury operations, as provided in <U>Section 4.21</U> hereof, as well as pay all transaction fees and expenses. At least 20% of the
net proceeds must be used in activities carried on for the production of income from performing services, including but not limited to
blockchain validation services, blockchain lending services or other decentralized finance services. Five percent of the net proceeds
(after the payment of such fees and expenses) of the Transaction are expected to be invested into approved validator, wrapping and staking
technology in furtherance of the Company&rsquo;s business and its treasury management. The Company shall not use such proceeds: (a)&nbsp;for
the redemption of any Common Stock or Common Stock Equivalents, (b)&nbsp;for the settlement of any outstanding litigation or (c)&nbsp;in
violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Indemnification of Purchasers and Strategic Advisor</U></FONT>. Subject
to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders,
members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section&nbsp;15 of the Securities
Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any
other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title)
of such controlling persons, as well as the Strategic Advisor and its affiliates (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless
from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by
the Company in this Agreement or in the other Transaction Documents, or the Strategic Advisor Agreement or the Digital Asset Consulting
Agreement, (b)&nbsp;any action instituted against the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s status as
an investor), or any of them or their respective Affiliates, by the Company or any stockholder of the Company who is not an Affiliate
of such Purchaser Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents, or the Strategic
Advisor Agreement or the Digital Asset Consulting Agreement, or (c)&nbsp;in connection with any registration statement of the Company
providing for the resale by the Purchasers of the Shares or Warrant Shares issued and issuable upon exercise of the Warrants, the Company
will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages,
liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating
to (i)&nbsp;any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any
form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus
or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to
the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing
to the Company by such Purchaser Party expressly for use therein, or (ii)&nbsp;any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. For the avoidance
of doubt, the indemnification provided herein is intended to, and shall also cover, direct claims brought by the Company against the Purchaser
Parties; <U>provided</U>, <U>however</U>, that, in the case of any indemnification pursuant to clause (a) or (b) above, such indemnification
shall not cover any loss, claim, damage or liability to the extent it is finally judicially determined to be attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in any Transaction
Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct.
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct claims brought by the Company, the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i)&nbsp;the employment thereof
has been specifically authorized by the Company in writing, (ii)&nbsp;the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (iii)&nbsp;in such action there is, in the reasonable opinion of counsel to the applicable Purchaser
Party (which may be internal counsel), an actual conflict on any issue between the position of the Company and the position of such Purchaser
Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.
The Company may not settle, compromise or consent to the entry of any judgment in any pending or threatened action in which indemnification
may be sought by any Purchaser Party hereunder (whether or not any Purchaser Party is an actual or potential party thereto), without the
prior written consent of each such Purchaser Party (which will not be unreasonably delayed or withheld) unless such settlement, compromise
or consent provides for an unconditional and irrevocable release of each such Purchaser Party from any and all liability arising out of
such Claim. The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a Purchaser Party effected
without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In addition, if any Purchaser
Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions of any Transaction Documents,
then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement or action, including, but not limited
to, attorneys&rsquo; fees and disbursements. The indemnification and other payment obligations required by this Section 4.8 shall be made
by periodic payments of the amount thereof during the course of the investigation, defense, collection, enforcement or action, as and
when bills are received or are incurred; <U>provided</U>, that if any Purchaser Party is finally judicially determined not to be entitled
to indemnification or payment under this Section 4.8, such Purchaser Party shall promptly reimburse the Company for any payments that
are advanced under this sentence. The indemnity agreements contained herein shall be in addition to any cause of action or similar right
of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Reservation of Common Stock</U></FONT>. As of the date hereof, the
Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement, Warrant Shares issuable
pursuant to any exercise of the Warrants and Placement Agent Warrant Shares issuable pursuant to any exercise of the Placement Agent Warrants,
and Strategic Advisor Warrant Shares issuable pursuant to any exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Listing of Common Stock</U></FONT>. The Company hereby agrees to use
its reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed,
and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market
and secure the listing of all of the Shares and Warrant Shares on such Trading Market as soon as reasonably practicable. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all
of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be
listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue
the listing and trading of its Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common
Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>[Reserved</U></FONT>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Subsequent Equity Sales</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">From the date hereof until thirty (30) days after the Effective Date,
neither the Company nor any Subsidiary shall (i)&nbsp;issue, enter into any agreement to issue or announce the issuance or proposed issuance
of any shares of Common Stock or Common Stock Equivalents or (ii)&nbsp;file any registration statement or amendment or supplement thereto,
other than (A)&nbsp;a registration statement on Form&nbsp;S-8 in connection with any employee benefit plan; <U>provided</U>, <U>however</U>,
the Company will be permitted to enter into a sales agreement with the Placement Agent and such other sales agents as the Company may
designate (the &ldquo;<U>Sales Agreement</U>&rdquo;) providing for the sale of up to $1 billion of shares of Common Stock in an &ldquo;at-the-market&rdquo;
offering, and file any such prospectus supplement or registration statement with the Commission in connection with such sales agreement
or (B) the registration statement described in the Registration Rights Agreement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding the foregoing, this Section&nbsp;4.12 shall not apply
in respect of an Exempt Issuance</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Equal Treatment of Purchasers</U></FONT>. No consideration (including
any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of
any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.
In addition, the Company agrees that the terms and conditions extended to each Purchaser under this Agreement shall be no less favorable
than the most favorable terms offered to any similarly situated Purchasers. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the
Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Certain Transactions and Confidentiality</U></FONT>. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to
any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&rsquo;s securities during
the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4. Each Purchaser, severally and not
jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality
of the existence and terms of this transaction (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no
Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of
the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions in
any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4 and (iii)&nbsp;no
Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates, or agents, including, without limitation, the Placement Agent,
after the issuance of the initial press release as described in Section&nbsp;4.4. Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Form D; Blue Sky Filings</U></FONT>. The Company agrees to timely file
a Form&nbsp;D with respect to the Securities as required under Regulation&nbsp;D and to provide a copy thereof, promptly upon request
of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption
for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws
of the states of the United States and shall provide evidence of such actions promptly upon request of any Purchaser. Each Purchaser acknowledges
and agrees to promptly provide to the Company or its representatives any such information as may be reasonably requested so as to allow
the Company to comply with the provisions of this <U>Section 4.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Acknowledgment of Dilution</U></FONT>. The Company acknowledges that
the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under
certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents are unconditional and
absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any
claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of
the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Exercise Procedures</U></FONT>. The form of Notice of Exercise included
in the Warrants sets forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional
legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the
preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the
Pre-Funded Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Lock-Up Agreement</U></FONT>. The Company shall not amend, modify,
waive or terminate any provision of any of the Lock-Up Agreement without the prior written consent of the Placement Agent, except to extend
the term of the lock-up period, and shall enforce the provisions of the Lock-Up Agreement in accordance with its terms. If any party to
a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance
of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Capital Changes</U></FONT>. Until the one (1) year anniversary of the
Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior
written consent of the Purchasers holding a majority in interest of the Shares, provided that no consent shall be required in the event
the Company undertakes a reverse stock split for purposes of maintaining the listing of the Common Stock on the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.20</FONT><FONT STYLE="font-size: 10pt">
</FONT><U>Board Nomination Right.</U> Upon Closing, the Strategic Advisor shall have the right to nominate one member to the Board of
Directors, who shall act as chairman of the Board of Directors. In addition, the Company shall reduce its Board of Directors to a total
of five members within 90 days of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Treasury Reserve Policy</U>. In connection with the Closing, the Company shall adopt a policy (the &ldquo;<U>Treasury Reserve
Policy</U>&rdquo;), under which the Company&rsquo;s treasury reserve assets will consist of: (i)&nbsp;cash and cash equivalents and short-term
investments (&ldquo;<U>Cash Assets</U>&rdquo;) that exceed working capital requirements; and (ii)&nbsp;ETH, which will serve as the primary
treasury reserve asset of the Company on an ongoing basis, subject to market conditions and oversight by a designated strategic committee,
as will be defined in the Digital Asset Consulting Agreement entered into as of the Closing Date (the &ldquo;<U>Strategic Committee</U>&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: none">ARTICLE
V</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B><BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Termination</U></FONT>. This Agreement may be terminated by any Purchaser,
as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the
other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5th) Trading
Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for
any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Fees and Expenses</U></FONT>. Except as expressly set forth in the
Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of
this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing
of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities to the Purchasers, as well as fees and expenses of the Digital Asset Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Entire Agreement</U></FONT>. The Transaction Documents, together with
the exhibits and schedules thereto, contain the entire understanding of the Parties with respect to the subject matter hereof and thereof
and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the Parties acknowledge have
been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notices</U></FONT>. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest
of: (a)&nbsp;the time of transmission, if such notice or communication is delivered email attachment at the email address as set forth
on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after
the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature
pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)&nbsp;the
second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set
forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes,
or contains material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Amendments; Waivers</U></FONT>. No provision of this Agreement may
be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers
which purchased at least fifty and one tenth percent (50.1%) in interest of the Shares based on the initial Subscription Amounts hereunder
(or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such
waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser
(or group of Purchasers), the consent of at least fifty and one tenth percent (50.1%) in interest of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section&nbsp;5.5 shall be binding
upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Headings</U></FONT>. The headings herein are for convenience only,
do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Successors and Assigns</U></FONT>. This Agreement shall be binding
upon and inure to the benefit of the Parties and their successors and permitted assigns. The Company may not assign this Agreement or
any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign
any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that
such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents
that apply to the &ldquo;Purchasers&rdquo; (other than in respect of a transfer pursuant to an effective registration statement) or Rule
144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties
of the Company in Section&nbsp;3.1 and 4.18 and the representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement
is intended for the benefit of the Parties and their respective successors and permitted assigns and is not for the benefit of, nor may
any provision hereof be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Governing Law</U></FONT>. All questions concerning the construction,
validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with
the internal laws of the State of New York, without regard to the principles of conflicts of law thereof that would otherwise require
the application of the laws of any other jurisdiction. Each party agrees that all legal Proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any
of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue
for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents,
then, in addition to the obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding shall be
reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Survival</U></FONT>. The representations and warranties contained herein
shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Execution</U></FONT>. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts
have been signed by each Party and delivered to each other Party, it being understood that the Parties need not sign the same counterpart.
In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create
a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as
if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Severability</U></FONT>. If any term, provision, covenant or restriction
of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired
or invalidated, and the Parties shall use their commercially reasonable efforts to find and employ an alternative means to achieve the
same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and
declared to be the intention of the Parties that they would have executed the remaining terms, provisions, covenants and restrictions
without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Rescission and Withdrawal Right</U></FONT>. Notwithstanding anything
to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser
exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations
within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written
notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights;
<U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the
aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares
pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Replacement of Securities</U></FONT>. If any certificate or instrument
evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution
for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument,
but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with
the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Remedies</U></FONT>. In addition to being entitled to exercise all
rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific
performance under the Transaction Documents. The Parties agree that monetary damages may not be adequate compensation for any loss incurred
by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action
for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Payment Set Aside</U></FONT>. To the extent that the Company makes
a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder,
and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared
to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal
law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended
to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff
had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U></FONT>.
The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser,
and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under
any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant
hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its
rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall
not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been
represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through the legal counsel of the
Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision
contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the
Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Liquidated Damages</U></FONT>. The Company&rsquo;s obligations to pay
any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall
not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument
or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Saturdays, Sundays, Holidays, </U></FONT><U>etc.</U> If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then
such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.20</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Construction</U></FONT>. The Parties agree that each of them and/or
their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction
to the effect that any ambiguities are to be resolved against the drafting Party shall not be employed in the interpretation of the Transaction
Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction
Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>WAIVER OF JURY TRIAL</U></B></FONT><B>. IN ANY ACTION, SUIT, OR
PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Bitmine Immersion Technologies, Inc.</FONT><FONT STYLE="font-size: 10pt"></FONT></P>
                                            <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                            <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">By:_____________________________<U><BR> </U>Name: <BR> Title: Chief Executive Officer</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for Notice</U>:&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Purchaser:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Signature of Authorized Signatory of Purchaser</U></I><U><BR>
    </U>Name of Authorized Signatory:<BR>
    Title of Authorized Signatory:<BR>
    Email Address of Authorized Signatory:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for Notice to Purchaser</U>:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as
address for notice):</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="3" STYLE="font-size: 10pt">Subscription Amount:</TD>
    <TD ROWSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$_________________ (in ETH)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$_________________ (in BTC)</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrant Shares: _______________ Beneficial Ownership Blocker
&#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i)&nbsp;the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)&nbsp;the
Closing shall occur on the first (1st) Trading Day following the date of this Agreement and (iii)&nbsp;any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause&nbsp;(i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registration Rights Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Lock-Up Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit C</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Pre-Funded Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>bitmine_ex1003.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF JUNE 30, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 0.64in; width: 3.16in"></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 154.1pt 0pt 0">June 27, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 154.1pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 326.7pt 0pt 0"><B>CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Jonathan Robert Bates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bitmine Immersion Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10845 Griffith Peak Drive, Suite 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Las Vegas, NV 89135</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Re:</FONT><U>Private Placement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U></U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Bates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement between Bitmine Immersion Technologies, Inc. (the &ldquo;<B>Company</B>&rdquo;) and ThinkEquity LLC (&ldquo;<B>ThinkEquity</B>&rdquo;)
that ThinkEquity shall serve as the lead placement agent and investment banker (the &ldquo;<B>Services</B>&rdquo;) for the Company, on
a best efforts basis, in connection with the proposed offer and placement (the &ldquo;<B>Offering</B>&rdquo;) by the Company of approximately
$200 million of securities of the Company (the &ldquo;<B>Securities</B>&rdquo;). The terms of the Offering and the Securities shall be
mutually agreed upon by the Company and the investors and nothing herein implies that ThinkEquity would have the power or authority to
bind the Company or an obligation for the Company to issue any Securities or complete the Offering. The Company expressly acknowledges
and agrees that the execution of this Agreement does not constitute a commitment by ThinkEquity to purchase the Securities and does not
ensure the successful placement of the Securities or any portion thereof or the success of ThinkEquity with respect to securing any other
financing on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.15in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">A.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <U>Fees and Expenses</U>. In connection with the Services described above, the Company shall pay to ThinkEquity the following
compensation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Placement Agent&rsquo;s Fee</U>. The Company shall pay to ThinkEquity a cash placement fee (the &ldquo;<B>Placement Agent&rsquo;s
Fee</B>&rdquo;) equal to 2.5% of the aggregate purchase price paid by each purchaser of Securities in the Offering. The Placement Agent&rsquo;s
Fee shall be paid at the closing of the Offering (the &ldquo;<B>Closing</B>&rdquo;) from the gross proceeds of the Securities sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Warrants</U>. As additional compensation for the Services, the Company shall issue to ThinkEquity or its designees at the Closing,
warrants (the &ldquo;<B>ThinkEquity Warrants</B>&rdquo;) to purchase that number of shares of common stock of the Company (&ldquo;<B>Shares</B>&rdquo;)
equal to 2.5% of the aggregate number of Shares placed in the Offering, plus any Shares underlying any convertible Securities placed in
the Offering to such purchasers. The ThinkEquity Warrants shall have the same terms, including exercise price and registration rights,
as the warrants issued to investors (&ldquo;<B>Investors</B>&rdquo;) in the Offering. If no warrants are issued to Investors, the ThinkEquity
Warrants shall have an exercise price equal to 120% of the price at which Shares are issued to Investors or, if no Shares are issued,
120% of the current market price of the Shares at Closing, an exercise period of five years and registration rights for the Shares underlying
the ThinkEquity Warrants equivalent to those granted with respect to the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Expenses</U>. In addition to any fees payable to ThinkEquity hereunder, the Company hereby agrees to reimburse ThinkEquity for
all reasonable travel and other out-of-pocket expenses incurred in connection with ThinkEquity&rsquo;s engagement, including the reasonable
fees and expenses of ThinkEquity&rsquo;s counsel and due diligence analysis. Such reimbursement shall be limited to $300,000 without prior
written approval by the Company and shall be paid at the earlier of the Closing from the gross proceeds of the Securities sold or upon
the expiration or termination of this Agreement (provided, however, that such expense cap in no way limits or impairs the indemnification
and contribution provisions of this Agreement). The Company shall pay to ThinkEquity a $50,000 advance towards expenses (the &ldquo;<B>Advance</B>&rdquo;)
due and payable immediately upon signing this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">B.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Term and Termination of Engagement</U>. The term (the &ldquo;<B>Term</B>&rdquo;) of ThinkEquity&rsquo;s engagement will begin
on the date hereof and end on the earlier of the consummation of the Offering or 15 days after the receipt by either party hereto of written
notice of termination; provided that no such notice may be given by the Company for a period of 180 days after the date hereof, except
in the case of termination by the Company for Cause, (as defined below). Notwithstanding anything to the contrary contained herein, the
provisions concerning confidentiality, indemnification, contribution, future transactions and the Company&rsquo;s obligations to pay fees
and reimburse expenses contained herein will survive any expiration or termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">C.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> If the Company elects to terminate its further participation in the proposed transactions contemplated hereby and the engagement
by the Company of ThinkEquity, other than for Cause, due to a proposed or completed merger or acquisition transaction whereby the Company
will be merged into or acquired by another company or entity and for which ThinkEquity hereby has the right to serve as an investment
banker and/or financial advisor to the Company (a &ldquo;<B>M&amp;A Transaction</B>&rdquo;), the Company agrees that it or the surviving
entity or company will pay to ThinkEquity at the closing of the M&amp;A Transaction a cash fee equal to 3% of the aggregate consideration
paid and payable to the Company in the M&amp;A Transaction. If the Company receives non-cash consideration in the M&amp;A Transaction
(including but not limited to equity or debt securities), the value of such non-cash consideration will be included in the calculation
of the fee payable to ThinkEquity. Notwithstanding any of the foregoing, if such M&amp;A Transaction is consummated with an acquiring
party (an &ldquo;<B>Acquirer</B>&rdquo;) introduced to the Company by ThinkEquity, the Company agrees that it or the surviving entity
or company will pay to ThinkEquity a fee equal to the greater of (a) 5.0% of the aggregate consideration, including non-cash consideration
(including but not limited to debt or equity securities, upfront payments and milestone payments), paid and payable to the Acquirer by
the Company, and paid and payable to the Company by the Acquirer, in the M&amp;A Transaction, and (b) $500,000. &ldquo;Cause&rdquo; means
ThinkEquity&rsquo;s gross negligence or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">D.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fee Tail</U>. Following the termination or expiration of the engagement by the Company of ThinkEquity prior to the Closing,
ThinkEquity shall be entitled to a cash fee and warrants (&ldquo;<B>Tail Fee</B>&rdquo;), calculated in the manner provided in Section
(A)1. and (A)2., with respect to any public or private offering or other financing or capital-raising transaction of any kind (&ldquo;<B>Tail
Financing</B>&rdquo;) if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination
of this Agreement (the &ldquo;<B>Tail Period</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">E.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>Future
Transactions</U>. Subject to consummation of an Offering that is no less than $100,000,000 in aggregate gross proceeds, ThinkEquity
agrees with the Company to amend the right of first refusal (as amended, the &ldquo;<B>ROFR</B>&rdquo;) granted pursuant to Section
7.3 of that certain Underwriting Agreement, dated June 4, 2025, by and between the Company and ThinkEquity (the
&ldquo;<B>UA</B>&rdquo;) such that (i) in connection with an &rdquo;at the market&rdquo; offering program (each, an
&ldquo;<B>ATM</B>&rdquo;), the Company may grant 50% economics to other banks on the first $1 billion of such ATM with ThinkEquity
retaining no less than 50% economics, and up to 66 2/3% amounts of the economics to other banks with respect to an ATM above $1
billion with ThinkEquity retaining no less than 33 1/3% economics, and (ii) for each and every other future public and private
equity and debt offering, including all equity linked financings other than ATMs, as well as disposal or acquisition of business
units, entering into a merger, consolidation or other business combination, share purchase or capital exchange, asset sale or
acquisition, tender offer, recapitalization, reorganization, consolidation, amalgamation or similar business combination, the
Company may grant up to 66 2/3% economics to other banks with ThinkEquity retaining no less than 33 1/3% economics in any such
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">F.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Waiver of Prior Contractual Provisions</U>. Notwithstanding the prohibition under Section 3.18.1 of the UA, ThinkEquity
consents to the Company entering into documentation related to, and consummating, the Offering. Subject to consummation of an Offering
that is no less than $100,000,000 in aggregate gross proceeds, notwithstanding the prohibition under Sections 3.18.1 and 3.18.2 of the
UA, ThinkEquity consents to the Company entering into documentation related to, and consummating, the establishment of an ATM, subject
to the terms of Section E hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">G.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Information</U>.&#9;The Company will furnish ThinkEquity such written information as ThinkEquity reasonably requests
in connection with the performance of its services hereunder. The Company understands, acknowledges and agrees that, in performing its
services hereunder, ThinkEquity will use and rely entirely upon such information as well as publicly available information regarding the
Company and other potential parties to an Offering and that ThinkEquity does not assume responsibility for independent verification of
the accuracy or completeness of any information, whether publicly available or otherwise furnished to it, concerning the Company or otherwise
relevant to an Offering, including, without limitation, any financial information, forecasts or projections considered by ThinkEquity
in connection with the provision of its services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">H.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Publicity</U>. In the event of the consummation or public announcement of any Offering, ThinkEquity shall have the right to
disclose its participation in such Offering, including, without limitation, the placement at its cost of &ldquo;tombstone&rdquo; advertisements
in financial and other newspapers and journals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">I.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Securities Matters</U>. The Company shall be responsible for any and all compliance with the securities laws applicable to it,
including Regulation D and the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and Rule 506 promulgated thereunder,
and unless otherwise agreed in writing, all state securities (&ldquo;blue sky&rdquo;) laws. ThinkEquity agrees to cooperate with counsel
to the Company in that regard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">J.</FONT> <U>Indemnity</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> In connection with the Company&rsquo;s engagement of ThinkEquity as placement agent, the Company hereby agrees to indemnify and
hold harmless ThinkEquity and its affiliates, and the respective controlling persons, directors, officers, members, shareholders, agents
and employees of any of the foregoing (collectively the &ldquo;Indemnified Persons&rdquo;), from and against any and all claims, actions,
suits, proceedings (including those of shareholders), damages, liabilities and expenses incurred by any of them (including the reasonable
fees and expenses of counsel), as incurred, (collectively a &ldquo;Claim&rdquo;), that are (A) related to or arise out of (i) any actions
taken or omitted to be taken (including any untrue statements made or any statements omitted to be made) by the Company, or (ii) any actions
taken or omitted to be taken by any Indemnified Person in connection with the Company&rsquo;s engagement of ThinkEquity, or (B) otherwise
relate to or arise out of ThinkEquity&rsquo;s activities on the Company&rsquo;s behalf under ThinkEquity&rsquo;s engagement, and the Company
shall reimburse any Indemnified person for all expenses (including the reasonable fees and expenses of counsel) as incurred by such Indemnified
Person in connection with investigating, preparing or defending any such claim, action, suit or proceeding, whether or not in connection
with pending or threatened litigation in which any Indemnified Person is a party. The Company will not, however, be responsible for any
Claim that is finally judicially determined to have resulted from the gross negligence or willful misconduct of any person seeking indemnification
for such Claim. The Company further agrees that no Indemnified Person shall have any liability to the Company for or in connection with
the Company&rsquo;s engagement of ThinkEquity except for any Claim incurred by the Company as a result of such Indemnified Person&rsquo;s
gross negligence or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company further agrees that it will not, without the prior written consent of ThinkEquity, settle, compromise or consent to
the entry of any judgment in any pending or threatened Claim in respect of which indemnification may be sought hereunder (whether or not
any indemnified Person is an actual or potential party to such Claim), unless such settlement, compromise or consent includes an unconditional,
irrevocable release of each Indemnified Person from any and all liability arising out of such Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Promptly upon receipt by an Indemnified Person of notice of any complaint or the assertion or institution of any Claim with respect
to which indemnification is being sought hereunder, such Indemnified Person shall notify the Company in writing of such complaint or of
such assertion or institution but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder,
except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company
so elects or is requested by such Indemnified Person, the Company will assume the defense of such Claim, including the employment of counsel
reasonably satisfactory to such Indemnified Person and the payment of the fees and expenses of such counsel. In the event, however, that
legal counsel to such Indemnified Person reasonably determines that having common counsel would present such counsel with a conflict of
interest or if the defendant in, or target of, any such Claim, includes an Indemnified Person and the Company, and legal counsel to such
Indemnified Person reasonably concludes that there may be legal defenses available to it or other Indemnified Persons different from or
in addition to those available to the Company, then such Indemnified Person may employ its own separate counsel to represent or defend
him, her or it in any such Claim and the Company shall pay the reasonable fees and expenses of such counsel. Notwithstanding anything
herein to the contrary, if the Company fails timely or diligently to defend, contest, or otherwise protect against any Claim, the relevant
Indemnified Party shall have the right, but not the obligation, to defend, contest, compromise, settle, assert crossclaims, or counterclaims
or otherwise protect against the same, and shall be fully indemnified by the Company therefor, including without limitation, for the reasonable
fees and expenses of its counsel and all amounts paid as a result of such Claim or the compromise or settlement thereof. In addition,
with respect to any Claim in which the Company assumes the defense, the Indemnified Person shall have the right to participate in such
Claim and to retain his, her or its own counsel therefor at his, her or its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees that if any indemnity sought by an Indemnified Person hereunder is held by a court to be unavailable for any
reason then (whether or not ThinkEquity is the Indemnified Person), the Company and ThinkEquity shall contribute to the Claim for which
such indemnity is held unavailable in such proportion as is appropriate to reflect the relative benefits to the Company, on the one hand,
and ThinkEquity on the other, in connection with ThinkEquity&rsquo;s engagement referred to above, subject to the limitation that in no
event shall the amount of ThinkEquity&rsquo;s contribution to such Claim exceed the amount of fees actually received by ThinkEquity from
the Company pursuant to ThinkEquity&rsquo;s engagement. The Company hereby agrees that the relative benefits to the Company, on the one
hand, and ThinkEquity on the other, with respect to ThinkEquity&rsquo;s engagement shall be deemed to be in the same proportion as (a)
the total value paid or proposed to be paid or received by the Company or its stockholders as the case may be, pursuant to the Offering
(whether or not consummated) for which ThinkEquity is engaged to render services bears to (b) the fee paid or proposed to be paid to ThinkEquity
in connection with such engagement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> The Company&rsquo;s indemnity, reimbursement and contribution obligations under his Agreement (a) shall be in addition to, and
shall in no way limit or otherwise adversely affect any rights that any Indemnified Party may have at law or at equity and (b) shall be
effective whether or not the Company is at fault in any way.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">K.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Limitation of Engagement to the Company</U>. The Company acknowledges that ThinkEquity has been retained only by the Company,
that ThinkEquity is providing services hereunder as an independent contractor (and not in any fiduciary or agency capacity) and that the
Company&rsquo;s engagement of ThinkEquity is not deemed to be on behalf of, and is not intended to confer rights upon, any shareholder,
owner or partner of the Company or any other person not a party hereto as against ThinkEquity or any of its affiliates, or any of its
or their respective officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;)), employees or agents. Unless otherwise expressly agreed
in writing by ThinkEquity, no one other than the Company is authorized to rely upon this Agreement or any other statements or conduct
of ThinkEquity, and no one other than the Company is intended to be a beneficiary of this Agreement. The Company acknowledges that any
recommendation or advice, written or oral, given by ThinkEquity to the Company in connection with ThinkEquity&rsquo;s engagement is intended
solely for the benefit and use of the Company&rsquo;s management and directors in considering a possible Offering, and any such recommendation
or advice is not on behalf of, and shall not confer any rights or remedies upon, any other person or be used or relied upon for any other
purpose. ThinkEquity shall not have the authority to make any commitment binding on the company. The Company, in its sole discretion,
shall have the right to reject any investor introduced to it by ThinkEquity. The Company agrees that it will perform and comply with the
covenants and other obligations set forth in the purchase agreement and related transaction documents between the Company and the investors
in the Offering, and that ThinkEquity will be entitled to rely on the representation, warranties, agreements and covenants of the Company
contained in such purchase agreement and related transaction documents as if such representations, warranties, agreements and covenants
were made directly to ThinkEquity by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">L.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Limitation of ThinkEquity&rsquo;s Liability to the Company</U>. ThinkEquity and the Company further agree that neither ThinkEquity
nor any of its affiliates or any of its or their respective officers, directors, controlling persons (within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act), employees or agents shall have any liability to the Company, its security holders
or creditors, or any person asserting claims on behalf of or in the right of the Company (whether direct or indirect, in contract, tort,
for an act of negligence or otherwise) for any losses, fees, damages, liabilities, costs, expenses or equitable relief arising out of
or relating to this Agreement or the Services rendered hereunder, except for losses, fees, damages, liabilities, costs or expenses that
arise out of or are based on any action of or failure to act by ThinkEquity and that are finally judicially determined to have resulted
solely from the gross negligence or willful misconduct of ThinkEquity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">M.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to agreements made and to be fully performed therein. Any disputes that arise under this Agreement, even after the termination of this
Agreement, will be heard only in the state or federal courts located in the City of New York, State of New York. The parties hereto expressly
agree to submit themselves to the jurisdiction of the foregoing courts in the City of New York, State of New York. The parties hereto
expressly waive any rights they may have to contest the jurisdiction, venue or authority of any court sitting in the City and State of
New York. In the event of the bringing of any action, or suit by a party hereto against the other party hereto, arising out of or relating
to this Agreement, the party in whose favor the final judgment or award shall be entered shall be entitled to have and recover from the
other party the costs and expenses incurred in connection therewith, including its reasonable attorneys&rsquo; fees. Any rights to trial
by jury with respect to any such action, proceeding or suit are hereby waived by ThinkEquity and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">N.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;&nbsp;<U>Notices</U>. All notices hereunder will be in writing and sent by certified mail, hand delivery, overnight delivery or email,
if sent to ThinkEquity, to the address set forth on the first page hereof, or email address notices@think-equity.com, Attention: Head
of Investment Banking. Notices sent by certified mail shall be deemed received five days thereafter, notices sent by hand delivery or
overnight delivery shall be deemed received on the date of the relevant written record of receipt, and notices delivered by electronic
mail transmission and confirmed shall be deemed given when so delivered and confirmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">O.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;&nbsp;<U>Miscellaneous</U>. The Company represents that it is free to enter into this Agreement and the transactions contemplated hereby,
that it will act in good faith, and that it will not hinder ThinkEquity&rsquo;s efforts hereunder. This Agreement shall not be modified
or amended except in writing signed by ThinkEquity and the Company. This agreement shall be binding upon and inure to the benefit of ThinkEquity
and the Company and their respective assigns, successors, and legal representatives. This Agreement constitutes the entire agreement of
ThinkEquity and the Company, and supersedes any prior agreements, with respect to the subject matter hereof. Subject to the consummation
of the Offering and the other conditions set forth in Section (E) hereof, the parties hereto agree to amend the Right of First Refusal
defined and described in in the UA solely to the extent that the ROFR in this Agreement conflicts therewith, and the other provisions
of the Right of First Refusal set forth in the UA shall otherwise in full force and effect in accordance with the terms of the Underwriting
Agreement. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not
affect such provision in any other respect, and the remainder of the Agreement shall remain in full force and effect. This Agreement may
be executed in counterparts (including facsimile or .pdf counterparts), each of which shall be deemed an original but all of which together
shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<B><I>Signature Page Follows</I></B>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In acknowledgment that the foregoing
correctly sets forth the understanding reached by ThinkEquity and the Company, please sign and return to us one copy of this engagement
letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">Yours truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 207pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">THINKEQUITY LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 207pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">By: <U>/s/ Eric Lord&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Name: Eric Lord</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Title: Head of Investment Banking</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45in 0pt 0">Accepted and agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45in 0pt 0">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BITMINE IMMERSION TECHNOLOGIES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Jonathan Bates&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Name: Jonathan Bates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">Title: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>
<P STYLE="margin: 0"><B></B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>bitmine_ex1004.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">REGISTRATION RIGHTS
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of June 30, 2025, between Bitmine Immersion Technologies, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of June 30, 2025, between the Company and the Purchasers named therein (the &ldquo;<U>Purchase
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Definitions</U></FONT>. Capitalized terms used and not otherwise defined
herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this
Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness Date</U>&rdquo;
means, when the Company is notified by the Commission that one or more of the Registration Statements will not be reviewed or is no longer
subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following
the date on which the Company is so notified, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day,
then the Effectiveness Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness Period</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event Date</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing Date</U>&rdquo;
means, with respect to the Initial Registration Statement required hereunder, the 20th calendar day following the Closing Date. With respect
to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), &ldquo;Filing Date&rdquo; means
the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to
the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial Registration
Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of Distribution</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section&#8239;2.2(a)&#8239;of
the Purchase Agreement, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form
of <U>Exhibit&#8239;C</U> attached to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issued or issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable Securities</U>&rdquo;
means, as of any date of determination, (a) the Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Strategic Advisor
Warrants and the Strategic Advisor Warrant Shares, and (b) any securities issued or then issuable upon any share split, dividend or other
distribution, recapitalization or similar event with respect to the foregoing; <U>provided</U>, <U>however</U>, that any such Registrable
Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file
another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of
such Registrable Securities has been declared effective by the Commission under the Securities Act and such Registrable Securities have
been sold, transferred, exchanged, or disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable
Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or
manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such
effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders and any restrictive legend is removed to permit
the delivery of the securities via the facilities of DTC (assuming that such securities and any securities issuable upon exercise, conversion
or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate
of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated
by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement
or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling Shareholder
Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrants</U>&rdquo; means the warrants to purchase shares of Common Stock, to be issued to Ethereum Tower Instant LLC (or an affiliate
thereof) in connection with the entry into the Strategic Advisor Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Strategic Advisor
Warrant Shares</U>&rdquo; means the shares of Common Stock issued or issuable upon exercise of the Strategic Advisor Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415 (or any successor or similar provision adopted by the Commission then in effect). Each Registration
Statement filed hereunder shall be on Form S-3 or such other appropriate form of registration statement as is then available to effect
a registration of Registrable Securities and shall contain a Prospectus in such form as to permit the Holders to sell such Registrable
Securities pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the SEC then in effect) beginning
on the effective date for such Registration Statement. Each Registration Statement shall contain substantially the &ldquo;<U>Plan of Distribution</U>&rdquo;
and &ldquo;<U>Selling Shareholder</U>&rdquo; sections attached hereto as <U>Annex A</U> and <U>Annex B</U>, respectively; <U>provided</U>,
<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior
written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed
under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly
as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts
to keep such Registration Statement continuously effective under the Securities Act, and to be supplemented and amended to the extent
necessary to ensure that such Registration Statement is available or, if not available, that another Registration Statement is available,
for the resale of all the Registrable Securities held by the Holders until the date that all Registrable Securities covered by such Registration
Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant
to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule
144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the
Transfer Agent and the affected Holders and any restrictive legend is removed to permit the delivery of the securities via the facilities
of DTC (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration Statement
as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall promptly notify the Holders via facsimile or by e-mail of the
effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission,
which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time)
on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by
Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to file a final
Prospectus as foresaid shall be deemed an Event under Section 2(d). When effective, a Registration Statement filed pursuant to this <U>Section
2(a)</U> (including the documents incorporated therein by reference) will comply as to form in all material respects with all applicable
requirements of the Securities Act and the Exchange Act and will not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto,
in light of the circumstances under which they were made) not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to
be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, and subject to the provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>,
that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration
of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Securities Act Rules Compliance
and Disclosure Interpretation Question 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number
of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable
Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to
be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Second, the Company shall reduce Registrable Securities represented by Shares, the Pre-Funded Warrants, the Pre-Funded Warrant
Shares, the Strategic Advisor Warrants and the Strategic Advisor Warrant Shares (applied, in the case that some Shares, Pre-Funded Warrants,
Pre-Funded Warrant Shares, Strategic Advisor Warrants and/or Strategic Advisor Warrant Shares may be registered, to the Holders on a pro
rata basis based on the total number of unregistered Shares, Pre-Funded Warrants, Pre-Funded Warrant Shares, Strategic Advisor Warrants
and/or Strategic Advisor Warrant Shares held by such Holders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a cutback
hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such
Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company
will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or
to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register for
resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company
shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration
of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5)
Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration
Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of a Registration
Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in
respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that
such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering
for resale all of the Registrable Securities, subject to the cutback limitations set forth in Section 2(c) of this Agreement, is not declared
effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration
Statement, subject to the Company&rsquo;s right under Section 3(k) of this Agreement, such Registration Statement ceases for any reason
to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise
not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days
or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period (any
such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on which
such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause
(iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen
(15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other
rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event
Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each
Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure. If the Company
fails to pay any partial liquidated damages pursuant to this Section in full within seven (7) days after the date payable, the Company
will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to
the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are
paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month
prior to the cure of an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>[Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as an Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration Procedures</U></FONT>. In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review but not the express
approval of such Holders other than as set forth in the remainder of this subsection as to inquiries and objections, and (ii) cause its
officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the
reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act.
The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Holders
of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such objection
in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration Statement or one (1)
Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto, which objection
will toll any applicable deadline required by this Agreement. Each Holder agrees to furnish to the Company a completed questionnaire in
the form attached to this Agreement as <U>Annex C</U> (a &ldquo;<U>Selling Shareholder Questionnaire</U>&rdquo;) on a date that is not
less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4th) Trading Day following the date on which such
Holder receives draft materials in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in
order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended
or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to
be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect
to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies
of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information
contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply
in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of
all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this
Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior
to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of
such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be
accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably
possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
there will be a &ldquo;review&rdquo; of such Registration Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii)
of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities
or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension
of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation
or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements
included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus
or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions
to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the
case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in the light of the circumstances under
which they were made) not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the
Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of
the Company to allow continued availability of a Registration Statement or Prospectus; provided, however, that in no event shall any such
notice contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries
and the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries and shall
not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the
effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR
system (or successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting
a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall
pay the filing fee required by such filing within two (2) Business Days of receipt of a request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates or book
entry notification representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates
or book entry notification shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable
such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking
into account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its shareholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case
of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading. If the Company notifies
the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite
changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts
to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right
under this Section 3(k) to suspend the availability of a Registration Statement and Prospectus for a period not to exceed 30 consecutive
calendar days or for a total of 60 calendar days (which need not be consecutive days) in any 12-month period, which suspension, for the
avoidance of doubt, shall not require the Company to pay liquidated damages pursuant to Section 2(d) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall use its reasonable best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for
the registration of the resale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common
Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration
of the Registrable Securities solely because any Holder fails to furnish such information within three (3) Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registration Expenses</U></FONT>. All fees and expenses incident to
the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities
are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation,
(i) all registration and filing fees (including, without limitation, fees and expenses of the Company&rsquo;s counsel and independent
registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with
any Trading Market on which the shares of Common Stock are then listed for trading, and (C) in compliance with applicable state securities
or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for
the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), and (D) if not previously paid by
the Company with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable
Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in
connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its
internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without
limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual
audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required
hereunder. The Company shall also be responsible for all reasonable and documented legal fees and disbursements of one counsel incurred
by the Holders in connection with the consummation of the transactions contemplated by this Agreement (which counsel shall be selected
by the Holders of a majority of the Registrable Securities in the applicable Registration Statement). In no event shall the Company be
responsible for any broker or similar commissions of any Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Indemnification</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call), advisors and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them,
each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and
the officers, directors, members, shareholders, partners, agents and employees (and any other Persons with a functionally equivalent role
of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, and the Strategic
Advisor and its affiliates, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees), expenses, judgments, fines, penalties, charges, and amounts paid
in settlement (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred in investigating, preparing or defending against any litigation,
commence or threatened, or any claim, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained
in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities
law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent,
but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished
in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder and
was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any
amendment or supplement thereto or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the
use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing
that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of
the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any
Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive
the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in the light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information is contained in such Holder&rsquo;s Selling Shareholder
Questionnaire and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus
or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the
sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Indemnified Party shall
have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably
believe that an actual conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall
not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of
any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release
of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms of this
Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in
connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, as incurred, within ten (10) Trading Days of written notice thereof to the Indemnifying Party, provided that the
Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to
hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement,
any reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such
party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other
method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indemnity and contribution
agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Miscellaneous</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in
exercising such right or remedy, shall not operate as a waiver thereof. In the event of a breach by the Company or by a Holder of any
of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance
of its rights under this Agreement (without the necessity of showing economic loss and without any bond or other security being required).
Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason
of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are
registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not
prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new securities
are registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Piggyback Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement
covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement
relating to an offering for its own account under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8
(each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection
with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock option or other
employee benefit plans, then the Company shall deliver to the Holder a written notice of such determination and, if within ten (10) calendar
days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration
statement all or any part of such Registrable Securities such Holder requests to be registered; provided, however, that the Company shall
not be required to register any Registrable Securities pursuant to this Section 6(d) that are eligible for resale pursuant to Rule 144
(without volume restrictions or current public information requirements) promulgated by the Commission pursuant to the Securities Act
or that are the subject of a then effective Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be
in writing and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of
clarification, this includes any Registrable Securities issuable upon exercise or conversion of any security), provided that, if any amendment,
modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the prior written consent of such disproportionately
impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered
for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable
Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(e). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger, subject to any successor
entity assuming in writing all of the obligations of the Company under this Agreement) its rights or obligations hereunder without the
prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights
hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with
respect to any of its securities to any Person that have not been satisfied in full, other than with respect to the registration rights
granted to the holders of the Placement Agent Warrants (as defined in the Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or Docusign, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such
facsimile or &ldquo;.pdf&rdquo; or Docusign signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not
be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not
joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose.
The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the
action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and
a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Further Acts</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR>
<I>[Signature Pages Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">BITMINE IMMERSION TECHNOLOGIES, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 78%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="font-size: 10pt"><I><U>________________________________________________</U></I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE PAGE OF HOLDERS TO RRA]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Holder</I>:
__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Plan of Distribution</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[see attached]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder (the
&ldquo;<U>Selling Stockholders</U>&rdquo;) of the Securities and any of their pledgees, donees, transferees, assignees, and other successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal trading market or any other stock exchange,
market or trading facility on which the Securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
The Selling Stockholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such
sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or
at prices related to the then current market price or in negotiated transactions. The Selling Stockholders reserve the right to accept
and, together with their respective agents, to reject, any proposed purchase of securities to be made directly or through agents. The
Selling Stockholders and any permitted transferees may sell their securities offered by this prospectus on any stock exchange, market
or trading facility on which the securities are traded or in private transactions. A Selling Stockholder may use any one or more of the
following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through brokers or dealers (who may act as agent or principal and who may receive compensation in the form of discounts, concessions or commissions from such Selling Stockholder, the purchaser or such other persons who may be effecting such sales, which discounts, concessions or commissions as to any particular broker or dealer may be in excess of those customary to the types of transactions involved) for resale to the public or to institutional investors at various times;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through negotiated transactions, including, but not limited to, block trades in which the broker or dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through purchases by a broker or dealer as principal and resale by that broker or dealer for its account;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">on any national securities exchange or quotation service on which the shares may be listed or quoted at the time of sale at market prices prevailing at the time of sale, at prices related to such prevailing market prices, or at negotiated prices;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">in privately negotiated transactions other than exchange or quotation service transactions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">short sales, purchases or sales of put, call or other types of options, forward delivery contracts, swaps, offerings of structured equity-linked securities or other derivative transactions or securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">hedging transactions, including, but not limited to:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">transactions with a broker-dealer or its affiliate, whereby the broker-dealer or its affiliate will engage in short sales of shares and may use shares held by such selling shareholder to close out its short position;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">options or other types of transactions that require the delivery of shares to a broker-dealer or an affiliate thereof, who will then resell or transfer the shares; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">loans or pledges of shares to a broker-dealer or an affiliate, who may sell the loaned shares or, in an event of default in the case of a pledge, sell the pledged shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through offerings of securities exercisable, convertible or exchangeable for shares, including, without limitation, securities issued by trusts, investment companies or other entities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">offerings directly to one or more purchasers, including institutional investors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through ordinary brokerage transactions and transactions in which a broker solicits purchasers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through distribution to the security holders of the Selling Stockholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">by pledge to secure debts and other obligations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through a combination of any such methods of sale; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">through any other method permitted under applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that any Selling Stockholder will sell any or all of the shares of Common Stock registered pursuant to the registration statement of which
this prospectus prospectus form a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a Selling Stockholder
that is an entity may elect to make an&nbsp;in-kind&nbsp;distribution of securities to its members, partners or stockholders pursuant
to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution. Such members,
partners or stockholders would thereby receive freely tradeable securities pursuant to the distribution through a registration statement.
To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement
in order to permit the distributees to use the prospectus to resell the securities acquired in the distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders also
may transfer the securities in other circumstances, in which case the transferees, pledgees or other&nbsp;successors-in-interest&nbsp;will
be the selling beneficial owners for purposes of this prospectus. Upon being notified by the Selling Stockholders that a donee, pledgee,
transferee, other&nbsp;successor-in-interest&nbsp;intends to sell our securities, we will, to the extent required, promptly file a supplement
to this prospectus to name specifically such person as a Selling Securityholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to pay certain
fees and expenses incurred by the Company incident to the registration of the Securities. The Company has agreed to indemnify the Selling
Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. The Company shall
not be responsible for any of the Selling Stockholders&rsquo; selling costs incurred pursuant to any available method provided hereunder
for selling securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are obligated to maintain
the effectiveness of this registration statement until all of the PIPE Shares, Pre-Funded Warrants, Pre-Funded Warrant Shares, Strategic
Advisor Warrants, and Strategic Advisor Warrant Shares, registered pursuant to it (i) have been sold, thereunder or pursuant to Rule 144,
or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to
be in compliance with the current public information requirement under Rule 144. Pursuant to the terms of the Placement Agent Warrants,
we are also obligated to register the Placement Agent Warrants and Placement Agent Warrant Shares. The resale securities will be sold
only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states,
the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or
an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the shares of Common Stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act
and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the shares of Common
Stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Selling Stockholders </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Selling Stockholder Notice and Questionnaire</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>bmnr-20250627.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa2AOaPty552qYkxvmR+fZlqbysgmZiUaim4DEbmYS4M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:BMNR="http://bitmineimmersiontech.com/20250627" elementFormDefault="qualified" targetNamespace="http://bitmineimmersiontech.com/20250627">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bitmineimmersiontech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="bmnr-20250627_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bmnr-20250627_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmnr-20250627_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmnr-20250627_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="bmnr-20250627.xsd#Cover" roleURI="http://bitmineimmersiontech.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bitmineimmersiontech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !- 7P# 2(  A$! Q$!_\0
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M5XXT&\T;6_"VDWVGW2&.2-[1 >1C*L!E6'9@017XO?L9_P#)UGPN_P"PPO\
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M3[TW/V8$XWR(44E1W*G(&>#7/6PE>=2<XQTNS:GB*481BY:V1^A5?DK^W[\
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MY810_>R"O5]OTH_;9_;6;X+Z#J_A;PSHVL?\)5<J;2/6[BQDAL+-G0$M',P
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MVX5!)NX^\,=C7Y_?L:^+/^&5/VPM7\*>,F72K>\:;P_=7$YVQQR>8'MI23_
M^U<-TQ(#7H8>G*-.JOM6_ Y*TU*</Y;GZ\U^7&FZ+:Z'_P %:GM;2-8X7UB2
MY*@8&^73C*Y_%G8_C7ZC Y&1R*_,>;_E+L/^P@O_ *:166#_ .7G^%EXG['J
MCUW_ (*S*#\ O#A(!(\118/I^XGKW[]D3_DV'X9?]@*V_P#0!7@O_!6*%Y/V
M?= D5243Q%#N;L,PS ?K7M7[%&N6NO\ [*_PWGM)5E6'2DM9-ISLDC)1E/H0
M5Z43_P!SCZL(_P"\R]#YI_X+ 1J?A_\ #N3'SKJ=TH;O@P9(_0?E7VG\&?\
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MD>9CJ+DO:QZ;GA5%%%?2'BDD<\L*R+'+)&LB[9%1RH<=<,!U'L:CK[ ^#?P
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <Y\0/
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C:5"G1^%:]RKI>EVFBZ?!8V,"6UI H2.*,8"@5:HHKG-S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BITMINE
IMMERSION TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001829311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-3986354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10845
Griffith Peak Dr. #2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las
Vegas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">816-8240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMNR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="bitmine_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bitmineimmersiontech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="bitmine_8k.htm">bitmine_8k.htm</File>
    <File>bmnr-20250627.xsd</File>
    <File>bmnr-20250627_lab.xml</File>
    <File>bmnr-20250627_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bitmine_8k.htm": {
   "nsprefix": "BMNR",
   "nsuri": "http://bitmineimmersiontech.com/20250627",
   "dts": {
    "inline": {
     "local": [
      "bitmine_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "bmnr-20250627.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bmnr-20250627_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmnr-20250627_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://bitmineimmersiontech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bitmine_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bitmine_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bitmineimmersiontech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001683168-25-004929-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-004929-xbrl.zip
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M]3=OQY];5Z[_6DBDU'/-*?X[#$;VX?\#4$L#!!0    ( +**XUI7Q)ESED<
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M75/='*_49B%GECZDAD\&*>R^K<KN5KH[=?5W2?A@';IC9'LMP@<;UA[@0RW
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M-J?DN,&E]@S:7E=55L'69$6)YMC$,U+&E/"OC=:.D2-B@!4B8Z-RG*(:O,H
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M8XTIC]:TVU#Q"Q&2O/,:;_[']):>DP'ZFU)2; P=+^F2]>43%PJ[&>U8R*]
M5#]0TW'W@"#-[11DPP!41EX+H.$EM1"X4-2 @K$<#,_H4D7_G*.A8 C).F2V
MPG'IA>STL#)#U'I'.0;YX#E.X\O="Y< ]AXN$]P,2^FEQE)2N+RT9*']]^"-
MN!F6DEJM &*+4\_B\1K&)/*6448MW(8TNI0[0'<R]+I5:&)C0H*J]M-U4DY4
M3![M=EYN;JO3I*NI^RIO(:R'D$CHL@IGHL'K- TI2$67=!8>H<>:GR91&G,^
M*_=@96T R]!"I;9(J\EZ6*^2)6(KQCF9:%,-"./<K1C>1TC%LXPQVL]XE2[N
MOTI>L#/F:^]TLQE$;^'0JM?,TNE;V0QF3/.@N[\"<9#%'/B; G5+JQ\E>6^H
MCZ37@]("K=*FT8QC[^HV4X]+<)<CXYJ@U$H[F6I]28+CTANS0?/H=F1!@=4.
M%DTA.%"*0K <W>>\H2LJTS9F95#^7G*O3LW_H<+"9J50T(S$I+7_#1*TKMQ9
MN2>HFUC5#R:LRA 0<MGP([F_$$EM4=='6X<'U$[+7#$-F89T]FJ(1,HOR'U@
MX.BG*<(2'>05\I_QB&=+IS&Y20N S2R6#37/4L9I7 _(+^?+$@-8F'*C]]N9
ME(NU'"RR%'4\:W"L+U"+\G(7P'Y=8,:13O]JKL;&Z/\Z[U8@Z>?8\'SCA0>3
M+HSC6H/6JX0-45VP=IL/);](]_.5[WVL<;4@UC1U2C6<# V]J@GA)HJIOC*A
M0I$U+9DH'PKYZ5RW/6:=W"I6J36K$BEZ'E&ZL,N/'+EXP!?F/46>_^,Q\GP/
MD>?_>(P\/Y!3\A7 9P=&O)1K**DK%51+G.JVYNP^(0\)@4Q*#B)["+260,J+
M-!GC:YZU6+A3!?H/][K$_NR-&EZK)J==M*0C+'4;%FZ_3AJ,I4N8V\R2NJ4-
M*<42&+0DO@K6T^D<V]8GJ='=HUYHM1C2:IX-48Y:\D6>7EBZCH+N,S2V\#Q<
MI]&U-3?MCE3)CAJZT7Y0/+@-6]V04NTXWS#'P;R/P_*HQ<K22[N*KK1:D2CL
M%21'@HJX<589)XUGOYB&9G@*4+XJ?Y3UH/'<7!4NU748%GZD](#_+L*?-T-W
M\L,N(C%.:ZQ6J+B,6Z)&YUPU-V>^03>>(-1[I;C,=%&E4VR] H*FR>@*.K(G
M?<M#7.]*NV4/,Z6<,BAC3G^ZU1%X\-"CPSH]W#PJDYE?&NOA:DQ7,HM&(XK-
MQ0R)HM]:2Q]V*SOD,>4O;P LLEOOD2<*$T0Y "!Y._#=J*3,@'&UP')]U[.I
M[(G;8]@;<=9#X.Z)X[,!CN(&%%8ZE@ ;D),P,1S5[IIH"O[:8KVQ?+/M6V/F
M44>Y.*%]1N0$BP_=I!7+<>UX8$PVATHHB_$.4G>Y:CC'7]KW?4696?I)N@-&
MF-=>?EZ2"L!XSMBT%BBN.W7BM9W&VJ[!H/5,L-NP(NQI/GU*#Q06S>D2$2]L
M8P#%-%VA\*E>]O$"1MI^^;+N$9;?L)O!.-*DD-?43%GX"#X*6%[H+^,FB+*F
MYF=TVR_;JHG4W?_3YL_MOKC'XRFMY8]C6T.D@E6S.Z:GO)*+\C5#(VA3/2<,
M/!F(54"327).&0J4":;+?'U%(JR7X74[:F1"LU5X@G:>0F-[+*_X="KZ(W83
M5T4S.#]T[HA6>Y$ D1E= )\VUP(Z_ K$@T.0"<W+WMM5N"(J*AU?!3%UD>2I
M@Y7@B0/YV0I9@,=?]V-T +7Q:)>VD"*-#G,"XDFK 'K #HZ;!4%^TD&0#TF)
M7C\.W/ZXT8^#7#!T22J>6'VP/A*^F@JMO0X.$"Z[JK@%$G+C;E2>J\-LAW'S
MF/-9).)K"V:QF 2@0:5OJ:24DDX&:T82P(@T&H9;[ZXN#*<:RU?)_%;AI@I]
MTH,;.;2,"!WM-;\@O50GCVX&G^RHB3A_=:J,:2QI83?43G5FX"4P$82<N&K2
MJF:I 9Z\VWF^ 5I][HQ-F23B_6\&-9=EDF1R/[OHB<,Z=)KDL>IBD]?R5%,>
M5@;$H1>7Q E.@:)WS?YHQX6=,/MY"8/"Y35%/6(/-:'%6$4[/H!X-_+9#IPZ
M=LHX!VJ;:TQ96G$RKS=7G>JB7:M>,/ *D8%3=<9O2A.L:((81K/G-W/FYUR7
M<G-PMN48W9J4=*3J0$VAG<O2.OB#JA2%BZWW2V\T-8,PH$ML$L\R:?&B"Y;;
MEX:7O+1R\=LA6+-IZ.8B[ON<F_^)S38"95(*_;QP)7XD<1ZWF-,B4(TX%'40
MHJ*KR0V3P'P0])A3TEJ=.'6*(Q&3SY@"06&N;")>%$YF$SQ=,U.B2YK$B[6F
M_*.=2G9VG$35HL"4T1!]HAG]#<5QPG^+J['3%8FR6G.RF?*$>AQB?T5EYU<Z
M*DNZE#X]?,/,DT(SB+X C) D%*,(QV15,\G<N%]DA\L$[IV3\OD]XHWEO--<
M,O+X';6@E421,R!+()6[.+#U@@>\V]_#@.L$M'YY#&C=0T#KE\> U@,Y)5_A
MQ.NKF@F0E:Q.? ]FUO:Z*_V9EMJH^#'H>&@G/$IFHJUBU5HL5*Q5%%S8SNYP
M"F-I0HI#4 (T;1 H3KY2K5"3F]BBUJFO1!?MOV;7Z(0FVQ8@ZTRYR,1,JF,>
M.)IQMZ,:5'LJ<B)!IZ:. Z;MM:1Y4W:(HDDE2F0IT<@",0AS2FJ#F15G*LI)
M22L+SE/'-R4*-<MT^EUGT4[*R'J+YCVMJ#U&FJK$?XW&I8%32J4 F!D)])("
M VQR),EOK$):4P@4E29K7G05[?NU'4VN2PF+@BX9OU,E^X9V29;=9KLQ!Y@I
MYR!1&=Z4^6+3;LRW:C>;@"(F)*E3<NP>T8UK7GO7M.=11;LLCL,="UV\()T=
M?)UQ"%*$+7C3=L'W0[:D,&%P%9,6S=D/N=@"$]95[!M/ GH1DXFX)S,"P2PU
M_-$4_>.,Y$),^ 5%'Q@3&?M;^8B4 ;9 K^IA/Q?83@F*6'DLL7M+)>WF,\F!
M='_BAEG&NJ01Q',\PS(1535A M+TAH</OW^]JX)NBH$XH[*)SH236A<XJ)<1
M8=IQ_8JP$T9E;<=Z4R(!F1U+RY*Q>HNT) (#.W)+2>!>RW(D#G<ALNEV*/+%
MV;D<?1=1U@Z1,?QT:P&34Q99;_EE=\;C#CS,6*:N4D-G8:=7]BW$GTE T@=(
MF'R$UZ8"T8;[EL)4%FZ2\+#;M5Y[&! LBX,&54#IDA6Q S#T60X7]S0BOW^)
M?>B-IZ(H*)$%:<SA*XE<T2NLO%G+YE3/*&#@)L'/MJNJ6> <4@:TXHBW=DJJ
M<D[/$>I*H3,LAT*0*Q 4!1?QU'R=..Q9G,5%E%H(<Z@%G^7$2D[F)M$)78_B
MD"EBU<1U'A4N@F2;CH*]&#DJQ%4<*GF:9 L*R]4(MUCP9F.MZ4EPOCK/0:&Y
M.W>O@NJ[DNR$BEWPW2[A1SN,J84Q;G,:GW$..K'V2K'<0I"6B\N[31AZ':M^
MJ7*J&'/JN]$G"*8;V(#4O'R$Z1S6TN4NB:0FE,,_.LS+@J=4R%]+%? 510 =
M=J-\LE0)L?^",UM..$ZLKH10Z(JQ\=#59.),[:\F([(U'U/6X"PPK0:EZD>Q
M&^@RV)&.32P72#<6QF0=QV\WA.G4IFA+)=2TI42M!P9L:CW=^JK0Q<WFBV8U
M+YE@(OU+<X/-5I*4%38>O7:> U9"IL,4AWR"5\0*]GOH/'*S:/NO("J+C"R6
M_>B2/9V8K_?'(BXUN/R8'U'I1)977I7HPGG'S(UQK"%*T#=:@/I:-<<,#&(N
M34#2Z!&^3UX@VK<,VYAD2$IC1H"ZJ:2F2&2[$E\XDN_WO/ALM!6#P%F9BJ)4
M8"/R; K\43',!5HJ*GQNX:6+C<+7"QLV=E!=3</H&38O;0:#B.INJ+4#IGZ(
MD8K$(#F/=[$X8VW2\ZEQ:5K6B8X%UYFQ2_PF :@8IU&3-6'Z9)!*9B[V2";+
MYXNR@2HJ6A=-'*.)T10K?R,JDM8ECZ$VFD,'2B.D 3/ZVRQ&&8/K@'GERUB2
M%S"QMC0]N54A+TR;8)]*ZL2@,_\X2X$,DACQE-&<7^ E528,<R//[8KNH7C"
MV0MN+1 D11%?Y&,.)BU&LZ0J37Q87NT*!]4(X*:S"(.=G+5@^/!#E)UC=9EI
MO8MR>6*QF&0)SA>5C=9*PI9.CDI$4[8>0X/826ER$SC<(*OG5)/QHBRU4<_Q
MK@;JD$TA(3QA9(:AH/HHT/Q-M[L$"[)T),3P=ZA@69*9G9.#P\RIK8,4-3GU
MPA[Q#68ID3LTS@PL26I[,[X&-%8J^2'B44D1VB?919RA:RN /Q>Q,:S-;Z]B
M&R:,7@$6@!<7DLI.HY1B'NNK*]>?,^0L(T\ZW0)7+&6$&B,7WF/"V]Q@*EPD
MD9620T=73+)X0K\ASPN)?SSQ&I.!T(I-Z!CKF.6KGE:)18))UKX@N20J&Y'H
MQEFHI<1AC<YE,)\MWC$^*$6NFF>.+"6&M54.R*"%MBH!5BYNK+P[5[X!SD%F
M[E8=DD>Q!6%'9HNB_J548^K.&NP]52^3IUC0"_:]:08THH1)BAQ**B>332V-
MI1J,H/2SD#;:VV!2;TG,NQAE#68F7VGQA? #ORUQ@H2-KU!4P,RR9#9:%*7Q
MU^36Q*>6]#=.1BE_**7Y)0A *;K(Q1U;2@8>XJ=D)=F]E/8YL:_Q"]0W6$,/
MT0"+X961!CZ'R:(A[T37FX[# U;2[BG&N+WU&&2\AR#C]M9CE/&!G).O &QM
MJ! PN<<@@#YG^64:3\[4#=80WY(TX=;H@2V_J4=R95W:!MY!E4!+?F2W@YE#
M<$2"6BZ@I"=37R<GVUYRQ<@Q"MI/+D*^KKG6:O[$V6BUXZYE79ODZ)5IU]92
MG"3JQNC%BGY4*Y*HNYVULJ@#DT1]1_G3H%TT)%!_']&'F\+09J3^%NRX',A]
MSUZ%@YQT]%(TRBB5?6"@L#0B^\/"%=-[;?0OR^+)E$>XLES5XDV:QXP1AFG)
MK(\76FG@@11XU26W>XC)R+*3C=U&WFBT(GI_R7R#CN*X;$GJU>!L+I*LT7K%
MLFM"8TG\CJ5IRNY>I";*&G@)PH !D4I=9+HT!EX=OU:+%O;8L<^O)-N9?<T,
M8A9,HEET%FMCMSTFA/ D+MPCZV+D:*> @U:I+3V=YDHIC!2+%8408U1&(U1Q
M)8R5H!0DJDH_B:O43;OI/>R))!',YY3G&-L^E= HGT[\2V \4]6VRF! E<%D
M8;6*%- 7]F\:)F(573/!U#01;V0>P\H/6&/]"CPPAL_5(.<::B\D_UE<6CTH
M)]*=PLF#=#JJZKY:>6%%XVM8RW5F=:!+$S*SZAY$&P/0LJONMD;K8>Q5PFGI
M.H!+8=K]Q :S0K%MQ(JZX\69176G)@:*?D JWKO0 (UNY7PK>A_Z0!2U=?&Y
MG26.9089L$EA8 ,2?1$;R-%YD5PD:7P6ZTU4DHP9XHSJ))-2P[RE:K'N\W;=
M+LV*0H)FI;4VLZLK35#\LGN5A*5Y:4+ .]Q/MMZA&#X9 ^<FZ$[5&)@/'T'N
M1JSX+]&W63S6=&UB.=4^DV6"[L;MXT):$&:23BV>&/N6P!IQ\G:A,L*7GRC.
M/O(MPTZ-"5;2COH; 7]EEI;MY *^B1G-6:Y<#BNH%.\)"$&\LO!JAZN1V5TA
M$&)]!%Y4Y@+CBY%+B-#P ^Y"?Z3.J5G=*TGY+]7\<M:6=#DBYXC%K ?KX +K
M#CJF2#Y2(9*3&<&!#;[RR%>($15>K;72'XV1/W-1@6JD5+(JW"=4J;(&@;DV
MTHJR U5I&[K7K)"VZ<XG6RKH9YDHTR0Z1G$63Q-)GJ)-&#%JN+%-=5-(?H6Y
MAAD6J[$'_+J_D^YC?*Q7,6;!D:YLHJ]_)8Z=%2RUL/:A'58C@X@WE4VT&K2+
M$>"N6?BC\6G*:=28L(6JC9:X=72?63[AF %*H1EOB[H>S2Z*H2RY9EJ[4@ ]
M$NYHXQ_AC1^,QC.6!?&%#Q#Z":F%]M <)'I"0(@DNUL-. O71L6 +7 @B3Q$
M"FS%8$(@?2E&7T=ZP L1^!^LK62ZVGHT+X='SI-1(E<JV4 K1M>A,QG66H.9
MH9>NJ.QT]2;Q\,M[*-- A?+EL\AJ,XPH,Q/+VK>E3&$]0]&15@GTH[%A1FSX
M/J9$:ENW.I>/,.FK#GZ.<E@)7AT99=V'NB+R/[+4[F((6D-H ),9H":TXFN1
M=MG<#<$? O9%<Q#A_S7\=\>O?#-\NW%"4+BH!9"3_AUUCBY[;YX-W][QV^\H
M?'8_0;3MQR#:?031MA^#: _DXEE'G&ZC,!T>!)^&IP>#DY/@T_O!\>#PG>-&
M[G80;9B:"WE8PZ*Z6#C:5N45!V(6F8+;MJO67.#@:5)@VAJE@*-U@^4'MXBE
MVTB'&K7-B;9/L'_"KST3ZX _(19:?::?*#8#KK<.@/XPV#W$^1W\[<ES9S*N
MV'AW>'"JOJ6U<VD&6/FOP&X$2P\C@D_>[@Q//PP/!L'PPX?!\<GP\" X'>R^
M/SC</_QU.#@)@^'!+NP"#O;6',-KK:%EBE>=]^LL]XK=O=&TF^=RK??O+%]]
MS<_O>_HDUMT![GU.I^C@6VM2<E-\,]GQX$3_XX /<L"U]-;GCWKK?>BMSQ_U
MUJ\\)SOZU3MW;:C"NPX.3X>[@^#P73#X^^!X=W@RN-7W?AMM'"ZU0SBF:^EA
MWU0;_C[(UV3,;&SW*)!'[DT!@Y< 2XR9(B67SZK0]?_(?[6,,@]WT,+;\XJ&
M8]-=2)?FD(LMF5K@3=+%1-#(*%*"@29=]*%P 61('1GE&+9NZN*!Z:>I[<!U
M^P^IMNH/V#6Z_J8^[X&L9@H):B$6\4I-,G>.VX MP$IB0X]1_J7WZCM?O<#*
M."8=W;?3:):DRU>KWPAS_K^__/SRY6LQXRAE*HTN@9DHJJUS*#YF%"&@*KSR
M=9 7#Y=LTB/\YS:'\6T2:VIG-9W'S9"![8W;2RJ.4D6M85M!)++P(HW<FGUL
M9F;#@8;MJ3@TD(+9$ $UB[XDL\6L?7(B 9U."1I_WD]0YG2\R0+;;;3,,L!)
M_A"RY@7(&FZFRN7[U-S$2W%JZIYFWSB<:TCLP2ES]" SA.F*-HK3_/+V)-3:
M2[P_U]>:#@'/CAGY=DS3;^_:%?#--,)Z04)#:J2<U&DN$/G=SMZG_F[0E\3Z
M SKV=\Q:_U:,]._QRML[+G)-M]_2=W.:7%'^DC-FQIR3"<=F2$6+N=64P);:
M":5^*<CNR/PLD9\IT.X(6Y9.52<EZFWQT];V1M3#N^!8 Z4%>]18<I&>1:M0
M]?%'V[^\>,$M,#A=YWLS^%K>\H^3X:\'_=./QV2IOS_<WQL<__/NE(1[$4#:
M+W0.O/*TG$?HQLORRR*:LR,=]Y<9#Y-8!IBIZD<'KA8 *]_R9OC69 W VPS4
M9L"?YYPVZ\\"<PIN=R9JO4TSN/:;V.5_>\/MP3'\Q@&$A^]96=,M_>+1+7T?
M;ND7CV[I!W).&JCJZ1R_T/)WW@[^_GZX,SP-=KXGC[3BTOX)7MD?!@>GP;O#
MXP_?UCC=)@H.WVZ<YI*&KAPDC#NH2S)#W3*3/"'<Y)V 1N;S=&GJTJSF9)O!
M7DXE$HO2_I7K58D;ZYL8HV_S=E/P[L?#012&C0U^Z^]_' 3'@]W!\+?!7MA"
M9P9\,=4YIFBA4H4H1:QK4G1#\OR'4/&NE^.R;A[%7=B)MY"#T3C]#7&$'15)
M5O5N<RXK7]MG=**'3;C[(L[1>9[%QL'SD"ET!^\9$ K6MV*0.[0#OB\YAI83
MJ&C_X_X'_P[ELUO@FUL^)QXJA+:/:ZNXBY=_LV6ID[!Z3?]>]NS]&,@O7P>'
MC'?[*MC'CE./]O(]V,LOOZF]_.VLUV<[AWN_XP%^]O[TP_[;_P]02P,$%
M  @ LHKC6K:<U:K+7   P10" !(   !B:71M:6YE7V5X,#0P,BYH=&WMO6MS
MV\BU+OR=5?P/>.<D.>0I6"/Y,LEXO%4E2_18^]B2CR1GDMJ5V@42H(0Q"#
M*)G[U[_KUE< %#66+,OB5"6V21!H=*]>O2[/>M:KMV?OW^WV>Z_>CO8.X,\
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M09#;V7K>DP<,?@B&]]#[, %3BG+68*U6%^D\!)L7GD5GM%S";L8B=SZ)JJH
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M37M55_A/74882I& ^ZZ!]:JV##G#;(20O7F0"@2_!"'X@Q4(G1/?[UT[\\'
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M9DA3SJ8, Q 7<YD4V#AY@C$C)+>@;5BEI8+NPG3/,5I,?5S]>)UQ57AM;-;
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M&EK]5IS $(,=X>A.4)<Y]H)B2C074+;L6N4:$N:,@R"*^]&*-#ANP3K 47_
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M?%B&\1RDU GS<ZJ?.47#QMCA=\R1T**T$MMV6AXI5CWJ%*L,NE3_+J6F=7#
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M2+!/V1Y4HT2L#]]31^F_/?F_-M]VX/!ON?+:TE<NB+F>G)0;D?@3'#C))^1
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M'FW2^L76SM;.EZB57WD[@\#3;#I.AFQP%9:)DQGN0FR P+[. 7_ 6'9-9.)
M/085?:"AI2]V-).:"=7D\8_L=O1[;,A1S,?;LP-YZ/OH]X)8-O@!E?&LB(.D
MXJ9UO,U"0J/G5*0?<7,_(=*T.\&[XY'G.4-QACO B+;B)V3S0(:FI!,U@]G(
M:H!;P;%H.C,:-QT%0R-$6N2DKY&20]EFNOC<@J=-BLM$0W3:AZ!2757Z&2D\
M?MH>,JZ7\;G$P3'GM&7@K"EI780N$\6HQ;HRQDID,#YA!FG"#?V:;7^:<4L%
M0>STYI.\)"E@&HF#)?)C;F5".E^%[\P$_!(T>S8%C<:)G2E+VZ[R7]]KVH*9
M25R@^+H54C15#@Q?D<BX'2_GZ?GY<HPIEQ;(0FL/NA=;3P,+<,&.PDOV%*SG
M$#5]IJ&Z7@L$O+"0=G@L01SH$*AKZR(JHUPQ'71<QK22E?0TX[--J9!YF<X(
MC*\>C8@!RP_P L2&;_^F8]4\KK@><1E=<;!5W3!%G._@F;L/>&^J!Z4V%V;,
M>E$T8'.E1+P4C5JBJ&BFZ91\PIQ2QOSFTA/5@FFV&.I.K ??.5>JTE)S6'#O
M!\T+)C&V]S3<P17K,8$Z^CVCHJ6\AL,TC1!2M4)E7Z-Q<&2#'7>>O=<7ID8S
M6&Y]88_X^[*#-F.XXVSXSO8F'7X/Z?"=[4T^_)'M1G0_G@9?XG^<89?7K7ZO
MF:L98_4:_F6:2-X7:X9R9+.)\,2++4B7<R++8=5Q,+6;5.!%A<%X4=LFE,I>
M*A"D0J1JBX;M$66'&M"L'J<<:%ER'F78=A8^S)"TGJTR)VQ3J6;;%(^A8<S:
MXLL4D)8.IMUOZ=H/QF(06SY88<I+K2(9+QDA [6U;)"!C<(O;<T+!OC?"Q"?
MZ9)#,3KGUKDH*C-^6C/Q..?O+8(V'$-2$<VU,VU@O'3;_RE:15($(P::-2N>
M'[#F,",>([4==4KL+ %D4FF:R)=^FP])+PHQF?=HF"UI%4&%8(5AVG8F2#I!
MS-*:C.SS)$]*K%Q.RDLQ 6%&)HV?A=J"=_'+5)[64;3<,MJDFI3%%5ZER^U:
M& &](HN5]*L=-CR[6O9^K2T;G,QNJ@_7 339SOT>[6>>6:Z_TG+*=)BF>D0'
M)NJK)(/O!SM/AURT,EG0#V:@32\:EJL7SZ]6[T8LM%O+:T&AGZ8E#,>0YQ9$
M2[S(4V;FQ;"FJL=F[D9OT[NZJ\AA\\B&II0!.:8+5$ZZ2,_+;ZN'M$1MUWL-
M1:")@&>+N'&"O5 H9JO6W0PGF"[*/*TNFJ/Q7/ HODRKQ 8,\UHP@-S<#[,F
ML/>S(L=R>!#A!>)D8T9?1X$J-NSW4'G;'FXAVKR!D&XI:W H2.@HO+Y?9]3F
M1$JPJ>6&',#"5@XY"N=0QXX,Y>:M.*5:M'76L^F4!H,(RQFF#(I(LN)JV(86
M>G-X=+)'^;,J>+&SLSTX'P[^-D1F"1RF]<G^=]LBF0+8+[:>$O+C"XPCN(N$
M%C]@F.C):_!%-+>F'0O?PB?=R8M\&U;FTUL.<A_FNA%!Z[E"->?6?HH3)A&)
M[=HGV* ZW]78]FY#BM Y>&@DH)U,@Y$I'C6#%\-@"49O)=B?:Z-$.'0NAA*>
M1=;2[8'KT+_:.JOZ/<O(B2I.C(GQ:L>$C(%M!>WXF/;4MMV[N@TEX?2P0<1/
M,IMGD;+O)/G^8A -R;)<9&Q]=.7)A-=%VPE4D7WZY&\JTF^Q4Q/[S0J3$=82
M'/T$:<H[T!TJAND&-AE:H*.'"D>ETI<MO"&(6HC.B6=$W4F"<78-?TCC\&SV
M. 5Q3!@RFLX(J!79G2)$T5]+MNG!5$DV= &4K5_8@)R19P*V/UINH38NW>'_
MI:Q0/\&.CL_9&IA1E;$D9EDNF&H93I-TPAE4O(_=ZJ(*8-[!@HV8(1ZNQ[)&
MO)1G&BD_;**/6K4";K#M.+:KDG\U]/9WY!/7C FM4#=7U+5WKHW^:S^&AU(I
MV+1@9-BPL294XQ:U)\0-T+:"/4J[JWM@6+G#:7$99D'P@Q*;VE-'"\>&K9+D
MDW MJ7GJ]H.P7$FUR[!AMZQE.T92+*13M"UNRIB48=PTG<-\L6Q0=BV+567F
MYG+0U)8;L&]O\]K:5"'X4\M%$IH:4-\T!,N^,\NJR6FJII_;)7=EZSWUFIF;
MZUA A___G1I6-S0:[CLTI1S[:[*S'5D^R[SXGB)3A]*EX5)*99FWD!4*.FFV
MJ=%6$2&N(L\'Z7W+";?W[XK,%&TQTZ*OD1#TDFH._Y4>J*Y;X$"9?I=VKQ@+
M2AJT+>YRHAV4Y@M5N,(Q -V0:F64Q$J+TU39K!U713!XRJ:EBGR8KCEXQ:%4
M9&CVC0-\,Z]M/ 7E# ]<Q^2BV8LF @P<S"A/DCA <;%.R,14ORBR'(VRH(SY
MD[%QA72R7 4T<,HX5DG6I#1^]-:T-4%I /DJ(6E-JE@VE9=J37/D0)*#L 6_
M88D -M52Q2J&<*>++2ED2] <X!C00'ND:=_5I$TM.P-M.K$UW,&0BI!2&UO7
M/.T^=YM"+1/>$5^HL)M'W!9@\ 6MWT-)VQQ6FS'<)+N[L\GNWD=V=V>3W?T>
M=J/$)I_]\=@D_/Y73CF!;8PV\G<>?'SV9<''0[C?+->\D:T.12K7>*G-:VPD
M(6E$.\NG2N^"Q9E00Q[W>V17SJDSL.JN$B(A$M?@%5GE>.:&,"4)9DF4B\VK
MK(B=%]VP>=VW=#O F)Y<-Y(R8:HN"J)S9(*LR<C,B@KY.;,HG85@F<U@.X;*
M>>$LJ?!<66Q0@1,H270E=Z4B4MI9XQB4]H7LUH1P-RP6(ELLS2_!?*+^4<@U
M!0[0/"HEC(5,G-+]1@V;Z:+3&3%M5P4:4$,3 S(DE3,)N%$&70%>.XNN0F>F
MU'QJXS$,8$@511PQ9KPJN8C=YBBPI1KT4?\J)O#4'>_,%[JQ5>T5&S6:N#?B
M*H0WD&B(+=<?X+3EL>Q1N;VP?[I1]?_4\6[GZLG2Q+W[O68FRDY^_N&=<VU2
M4Y+>JL57Q56NS-@# BOL0[CTR($4ZJJ5WPOP$K@%NSTAAGKY"V4?QO'%PA_<
M@NPC[7"+\,,CE^M*?7!CH;?K^70>F3P__%$.#X5EF6KW7+19*(VUG/4,-#M8
M%5I]6#E](YQ?$RL,E^8KMQPFNV^XU?!)R7F!+V?VW,9#HF/XR\)Y([NUJ$(R
M4YK_@L-EEC)JJ<L=)\Q>7%+K,;OQAGMDNQ2_*%X:-:W#2"AE""AAZ5"$&":,
MM.($E[R21K3D$MC&..%&3$A,GGV1F.A.C_W>@:;JU]V'JC8DDR@=6OI(:QBK
MY(([O-I$U6:7JY1AI:!S= LK!>2V%567&WLM4LPVE&E,2B:QE(X %N.\*3VV
M;@Y:<,H8M2@/BCF((F<N5$C89;0+F<X]=D70Y:7ND-N!(GUL7B29H*I9+>(F
M54-KC/9 ["0YLL_KE&J@VWSJ?MHZ=<Y5*C%OG;J0[J.$CM/U;1.T#^# 0FRD
MBC5F28UI.?UT,*+O81Y:AM$]"TY*T9F%H2%%"E@3Q<D\H1UE5X'(\R673>=N
M6L[D;$>#3S5DQ#0!S)7=7,8)G(+!%N740$9/2.7DG5<:8':7#5/UYE*CZD-U
MAHD8--#\E.QUBZ-B_ I)IH=7<TAY*/2E_(:3R+2A4!.$NEZ97;Q.87,8E/ZH
M:/0423'X1EN(VB8L5/#8"2A"T*)EFBTU,B_5.X2"V;0PI9Y_V=5LM:9Y]X K
MJTT)PH:-PJ <YBKIK%QX2)N^C+)*MSD@UT(* :]1GX2&5  +"6ZK\]<T.*>@
M%'423F8%G+MQ9*%WR%>P>8H5!D,0>$HI*MTZ@<F4;!GE9YR'C)/Z*C&P U6/
MJ61(&_>8)%#Z%$]^L-@)_*"R=F:@W/0;1X/PW[2"%6:?JZWN4XKD03"FTP;P
M@+,8[2!3;*1,( )GNJG4TP(>$ !96DE;W@!&"H0NR3@;\27!_S@O$C8&8QOH
MCIG%>,N:>ELKR%/[J*G%;5H3Y9'CM#@P$:>6LYO<&D'I!$^$=26THN3FG-?4
MD1F!%Y"+0 LS+HI/U*B%^:)H/KEW2*I\+(W9%6=3UI)>4&.Z/:@UC9IH#X@N
M3P3$5LE*<D)V]XPRTRMA^1@F<:._Y2P1:H_<P5PT02:RNS8&)1F4S[_(H/QH
M';W]7D>)IZ0[T7[C)EBV#>!:+EH7=.#'C/:R\_GX$!W'NR#:LH[8"!XMXX1U
M;"OOD)L[##6*K#D:N^>9EJT*ME?% +"E]I!UG0!M1/.RU]X@S84'G>#09 J8
M]+I6P;ZB(^%O&W$EQ&4F(1\9L\0F70$9$[H4M>E-E:Z'A=0/%$PDALS;SW!+
M->HI4$S4"(!:S@7(+D]H>X.V*@"8/SI-$\U4N<HJ5OWVW',>C@(#[DC+KL@:
MG;S14K%NP86%:F:5*#88:2\BW'"L]->=6U4_;54K%(;P>@S^\#0UL!+'<+&,
M#ZO?NJ*I:_NY]OE.[3"XQIXAT,&I(9I%GU1%B_,^5@<O60-\=[W"SO&NNAIY
M0,#*YKE4X31V8NA0<D-;3N#![BW*7Q!D 6W:65)?%''%_5$,GG*C]TGOO[BM
M0 *'FP_LSG\Z8+05C"+RZ[TXTDVC!XU0A*."V#1*"&#->#7I$,%6=)'G$>[-
MKIH@R]IVC#E+>PFXDXQ_85YBK;!4B)^-5'T38U@+8_%T@[&X#XS%TPW&XI'M
M1CQG?OJR<X92A A4/KV@PN.&%[TJ9V#L%U#Y8M175-I$U7J&:XA;UT;+YN$@
MMS>-CS2R$;M:5KYCKDHU);<5>N<>5[W0@6=5:)E*)(8LZTH2,(&P.WIT"8]B
M)[=P;QB2E6;#Z8LQ&_4JG0>>.QUI.3?:E 0IS$I--[00!FG^^R*G*1SJ!TL*
ME,'(R,.<4$"U3.14]UZ7:(@X8D5@7UU1I7UR_JGI;45(3XIR2.M.NAF:[<R>
MS"GB2B<6VW]3\.D]1F2F>DE=FO"=<2W_,:+!GVRBP?=IA9V2N%/HHV88?-AM
M\>!<999(])M.37?VX".AVU5.&(YB++VH0460'PSJ83^J+EJ:9,1%4MD%.C;H
M6O3494%;37K%F^;4E:6U])@BNV>\'Q)TZ@Y\#O:HHR7?TT$\'*3#T'(8=3]7
MW/$M/WFV%?QF=](C[:+;W3,QH'E'0L=?-L@!,/2M,V<P>51>H0:MTF<JCD0^
MD1GQ9!@4SKU)$U)_9ND*UUXE(^]*NL_]['(H)0#A:AJ0A@^?PP31@RL2!V+9
M5C/O$35_7UKS$3;$>4=0J[,+L/Y#<,\1W#%1%M/[!2@(?3K;#5([N/DHKJ4Z
M25#YB&\G355O/SN<B7$U)R :I+KPA*%@-8\O=L<W<\;G %:DZIF)6";H^Q#X
M-''">_6%OX-#G1=464WK^0S\TB,(*;O(8+::3$#M[7>'>O'-!A0M;N1/K='
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M&&IP/-*_-/)M\,<WM1VPQ.O*TY;L##:(3E><[>MQQHF*YK C<4:">5E4<-W
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M>PJB-XTY,BQA >PBHK,HDK0.5HMUA0Z'8(JQP44 1T BR1(48/$BSG_\Q;R
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M-/HV&7B// ;]4D<;\O+)::2.9ZRPFB1_'#$N\!7Y!2SQ@8G!NM06M*KXADB
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MID59,E]>_X;9.\FYARUO$QA_? B,WT-@_/$A,/X-GSOG[F@K2#>3MK_(R;9
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MYAJ/SBO$.E^ X=!DE"/D/$ANE$T^:AD*(=T.(OMK;[^[W'VXB(D&0XE%^;0
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ML9.M0L*!!)H=3G44?MD"W;0\3W0D49_FB+>V]AO%&194JWCM4 "Q12WQ%O(
M8P3Z2^*&3J"C%:/9(_/J+A0?M:.*SW.*+L!'J(L8KZ,Y]X,^XY3C/:41%7@;
M3)&*4<XIO4TH2>'(1ZY;.@QT"GPH(1U]#4LP)O1#%:%SD].?*[QB6.RB1"$Q
M/Q<4UEI?I77!:6K11R5)33J0XK8IU[4G7%C^B$ (=4 (XSR9_7I  O'K4404
M*,R]+_B';RAP-N1%W$[9##JZY@# *]3^)?1<.J@ @B?PVEN?ZJHI43.DB\#C
M27IT\JA/H[7*#V$K>-JAL]^C,$LXR Z3DVF,CW5I3:HCVC(DTAP_3BL/4X<V
M]1NTGLH8/P<VK#^:.9%@]C#F6HJ28L !3ICUTMVZK*,^<:]$CH<XVX0VP9*9
M/ET>19Q%ZQK=6.KMB;C"KCIK0-BJY["\_,4SIS"*36*EBPF%NUZW2"=.>OU9
M1HG2L7\[L?TWV@0]$Y9[B+1"&ZWO.K3=0/WA0KC5A3#;T0OAA38..S9AYR[0
MQQ#V8"OD0PJ)Q 8<9"WB:>F(#D0)?$'0)\S(=ISJ]N"5/GXW=("[K*[E(($,
M=C?L0QC#"PEA[$9X'-6SHC"5+I!GT! RBD&YRS/TIE3'S_$L0D]$4O7.5]"9
MKMX9\J7O#7.AO>EN7(607N%XM"F^TC8!PR^)L,#7:2E1GPUSKFVN.YKTUNVP
M88;'HW[BK.Z[.IO0+&)XPV8,MMF+XQ%OQG2Y(H1^^ZJ_@^DR4*/S.?ZO'B?7
MXKK7C<H/LG5SOQM5K\=XU)<D,3"%-V^[ ;JVH24Q4SD>W<7>"[YDZ\$1_O*]
MUW5S?NG4F>28P5?>\<'5 NT_=W!=^(ZNK<DH-@*"MT^NGPY3$X3R$Q%,Y0TR
M@5 F6C]K%#F,*?CM& A][FT[U=XV1J"*NX\W$'#J1_9(NSRTNT-1Y >'*/)]
M1)$?'*+(W^JINP/;>;ZCMO,%7['BY>S8R['W=0?R6)D,.S<%/24_S\8T7Y]&
M[<;;7-*:5*X0=,\H,4E^*!6J5R%%L\]GZ&=B7JR>G@:MCIX$EQRT@&]M@G&W
MMZ'W*LYTK:TEL/;UE/&(:6P1L;<L*G2^Q9Q6QVZW%<Q]D8#^P.QA3L;@I1"H
M!N=81L=1OWP=AARN99Q*A&6YRHHULC#S3*V<3!HOON_C2.5!S-K(JU:,?7@=
MT/TI[7%\3;C"63U*#(*UU6%#0&?ZT.JUR3"F[K#CI35F: QC.^)51'>M.PM>
M+R]_;U)0CRDTX+.'&I7;\IVI6RP2YT^P;QRWA0DJXZMG:4GOG345VH4V[YH?
M"<<C\^B*HOSIRH0<.>/"S<PFDC'SF$DIN@&R/JB,VXT/QW0\VI2.3[DJ$FW3
M.9QZN3:@,29:84[;WKE!!?HH%,<V^9ORPEL\V=BAYL2 ?V&6^JHW<1WC**!#
M9)(\AT3EIKX0'5C8WC IQ$ :U56!]>E<9&E(V OK>@X-5J#TK'G>E'6*.A(E
M%MAMJ8GB-"LR_3U#\GP&(W &\5IO'[MUW('0RM BQ.37YJ#/D) L)?3:XA#H
M 4,08A4F@ ZQF9W0C_[SZN-DSY5 =$S@^,8 /D6QUAK\P?%B&!D)33?0,CR6
MX2,-<NV&0?+EM0UHR"![9%G5#4,S8^".DT!I]YPEMQ.XH(P3L]031[*3S6GH
M+(Y\*]FDJ%$TG/KC'(@X P,?1X1D#U<%9U<8!@O:)TX/*"&Q5 ,[UM^B?$2Z
MK^?9IC[VGU';H+!M:%C*S1@=R1/TP%/<:0+:5-Z]%SJW06BZ+P@/FV$Y$\Y?
MZ=8Z\/JDP47^O6>GK.T-:?=XJWGPF^SRH?1L,!RTE ADJ: 2NC@\ )(#,P]M
M3HONRW;'6_!E]GP'MS[>V%>U1&8A,^6=\5(\T)E&3#C9M.=Y2V/T7<7"4&N%
ML43^5K !P,[A9W7R*.L2V'VGOIQ_M>(CWA/0&X?>9DN2%D_1[#J@/]=7AR/'
MY'O/BPCSO +5UG@1B4#6QIYN1 *%NB5S+OI&=XT9#J9- Y$R6*:V$E.Y6_)S
M&61>.<E2IKQ Z<,NM&AW<I]82>#$J:"=-R7H/C?K2@?DM[D-Y-&!2XF.3[86
MJV4\VN *]&6#E[EE=R-L#):K_@:5ZT-FU?EN0^D,K5BW;\9><)F'UC-%0=NL
MT39&,57U->Y&7!R8C;E+Y[$I26V/'*)WX3)8[*C+P+$/G@3/#>WR.XTV&49@
MH8U$]M5XQ)S[8EY7\4*!T,1F$#!4A1:Z4MF$,PMCWHAGT8U9D\TYX.>Q!:-K
M2PY$/I>MU2Z)04S1V<-)1%C9L\>3Y,CF VH14U\7P5I%: "C/6G\&ZYS9**O
MP&I1$#B;34TR3MWN7T=^YB@(<0>H)>0".'!-H<T0R*-@0A@=0^Z@OZC"EM-%
M?5JDTY0UJU))4G1BX?@>*=)T;2F\^ ?(RL"UOEU #C\E*R.%BR55VX)TG WD
MHG-Z^$%0U>=84:RH3G@D>98**QAKA#U- (.H9QJ=A(,QV\T2&+BVK5<\5GU:
MI:5_Y>#SIAU4#+06FY9N@75<7/&@N&_G"UM"@%E?-6N?X*GT*^!NMV>CRE$"
M_"N^X\.BL"1-1^B4H.:3 OJI<N!B1 YI.CR+8H884KDO6EE6,>PS8*?B0ZUC
M24\E>KO@*VP^-?U-![1@N"/=N_;4FSTF3HE,^TK(Q$U+V*:HO""A'!]TNN;H
M",'9P;L7064AJ9++M,H4 >RZXB@GTY^4+3$%\.ZUX/*W();D\#]Z-$F/!L6*
MD*I8=AYG,"T=D<]AKZN1M\V&$NBL_%G%#Z/+35XSC8NSC0RK%2+:^4\'!NYR
MS0A4SU<NM$B@1'-A !*>%_^@G8 J3_@^?0TXPW:J+X.HCPBXV!,0]PL:..4?
M8O11X1ZU8W13F5=\ODAJH"L2:5:0,X D1]*46M"Q@,617&&"<Q),K"CZQ_GY
M&U<&V>QJ&+JD[UJZ!4DMYI6K!L<MMP%L/>5+5WDUF7A-'H$LQN'UO8-SAX6>
MADU!JDI3U/Q6]V; ,?#9GT5IF9&67A'1R] FJMV=&JR**NWU[B,8+:4]F5,X
MD$ZSQY(F%>MSJV63--0WHQ%;O:Q7C$>(J@7J0M>5)062]:I18%$9#U@5.9)&
M'N@$ SN-=O)(I<T1>9S!\TL]_I#NYF-%O""83^/D\.R1JGIH=X=B]P\/L?O[
MB-T_/,3NO]53=Q<5\7;4$#=I;Q=D$X U_B&W<>S+*[X+7Z;,CB+^K6>@\&;%
MJF.HCT?O_.JKH@U@-+&J@TW*BE5HA2ZO8WLH-]PXB H(O5R?4CE\='G!V<>A
MKEZ5<^)Q8D?#:A7^8A$EK(.1)QU3"F^51@C:AY\UU$$"Y+J@%J:1.M,]X7K8
M<V&[<O-M;0AH<JY?C87%0":L48((54\<E^B,Q1[GE6*KG-O2U3I+$.QH4&$F
M&*M$+D6L5HI)T5YAP4VI8\5NT,E3:=OMM9LD)Y8<6/493YE3V\[S^_7N"ZWV
M]\%@46NE%72!%SI-B!*">A**PE:^D^F'68LHJYG4"=$7JEX4Y".V%D382F9J
M_]X47:,(1\(AB"2EI.I$^FO)?B@:4"TL%:O-IL5 8=TB[7(\X4DHP9)64XZ[
MURTK1IX?CJUX 6!2SWWT":WKIB$ZP!5AN.^&*@MDM\0D2(WIP!X8>(TYT*ZG
MS/!BFV(77:#)IO@F5NS#G_/EV#9/.1(&]W3%*7:8VXUK4N.6JY$[0'LNTIR2
M#HDO4G .'$;O!2/8D6]!^$>.HKPF]X7XC;9@]>L@AWLXA$-'PNFSN [)]1)Z
M[HY- A 7V!3WH[AN6K$Y2O$0(P*U_.,,6/R!>7IC>6Y\$;S/LP!Y7GV/F!9
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MK,F2P;7=K"&<"W^HMS._@!![(=E<NE@,>J<MG_MX)$8=#;5+PS+8F*<*?V:
M];KG5D,RH4/T]#]U):QV]$IX 6*&' $-7OYR0#[K8L!\K"L.>+%1:0B?R)XG
M(8X.#;)ZZ1]N_:2*3'HTMLN/[K];SZ 004W'?2S((QH,_U&A$5]79&]A9%9;
M^*LU=\BJN0YW3.J.WH@'&0'Y>GP6*ZNA%K;N$HD^E,U>(2Q;B.-SU%>/]8&
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M2]L-<UWR34X+M7'W&C99<TO2"FE'#NXK??D=E,E;*9._[ZPR"8*@@\2[T;/
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M3)&V-. +$.E1S)#=^6]-Q$E@687M5^/1,SV'1)6E\6)8NHZIC/6F-)><="K
MM?3B S@_.%(4&5P(!OE04B,_])O<B3MJT[;TAT,ER?]*=5%^%FO@Q!BS]".6
MKJ$+IO5\N,UH,.BJA].SZ]O].VCGM]+.ZQW5SB_@]**N]WS -V1\$4IDL[$B
MA3I:(V;-YA'K_4T&XR?;\WRN*6>G9?&1PRH%;400,Y;262E;/Y>SV4A!<P++
MML7-+ARZ-?$C;B]T3G D5+C6I(ZP;]P7RIZ23D?<:::^8S1$E-/+\+_6@R/
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M<FR_:JM,6&[+T82L\J33+#6YDOXKM$>0(%:<MA!EJFI%/K@8: $*"?&@.#]
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MJ1*'0[?H(IJ#&1.<,K\4K+CBBFWB"='?F.GM'P2-VAW#:I6M2<E!LC^J.E&
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MU\P@4'.),^](V<8<+E8[]@",?5S0C<=XY;7@*C]MX"K? Z[RTP:N\I#?O+N
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MM[<(7L-'9YD0V*@,'/E+ ^.1C^K%-<PH\:\A!Z&O)*YUK6TJ6IID3C:K0ZJ
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M%_F$XO%)42V 3<YX:%C@&4&06*S8N0S:TF&W)D:&%"-V2EC A^BO9Y^&J-3
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M\GJ3$OG+O$_7[E+&._APT#\R^VCR 3;AX[=MW<;.["A8!71LV=*/(-4L7V(
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M2 G+G>?5H@4-1?C\]K'G$3#VPE80;]'!H9E+R;60]5E&J0>IB9&09#0XS\X
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MMIO-\-MOAJ^>?=/-\.:MZ<9E]^/N\?X?8!]_?-__[?#7_P]02P,$%     @
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M?4F!P:C,=!(Z(X=33<9<E]$R+]>-S8??ZZD=C(;IV:0Z$C!7#T\>W0U*FW&
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MXIGR!>J&50*/2>&8K=P W5AKMQ39EFV>-"2,3-DP9$'"TZ#V68R;+4?4:6,
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MY]!AKK_47-NR6EC8?/,ED3+?[=ND[F'+NX3]'AW"?C<?]GMT"/M])4?*R^:
M;H=!HB-NU$^5U,Q6DV)FP_[JYL-L1@-Z.O':"ZG12"[1TIC6NH@48X_SU TL
M92=\A&4X:_\*:HSS+[P_Q2=EL=$6C]A;GY:"M\<;0&K7G%)^')R%+QMD-_NK
M5@:Y? -'*J2QTMPH/;ZOGN<\+$;F2YSA.RW]D\U'IL)KL$"KVE"*._(^M3!6
MHOS"?S@Z3QL71O86+L]CN5L\([U+E>]W$K8)I9?U +0-=,4EEE$U6T*&VEY/
M)]CMPSYY_/#^]GT"WQ_VR=[NDW=G3^$.757UE\;^[G&.ES\?8^Q76Y6,J[2/
M>">6@='OK6-Z.QG!J(JSYZI-SZFOUW5[SC$5%Q7_/O)(A,770R$;5D#&_&SS
MT=*;8$L'15-6 P17] [3I(?" "#!7,5!?)#RJ:UI-\:1</_N7>(#]=?/NY]?
MJY*M 5_=49@Z'Y10E#QZ+!"(U051>C)KS:RJ:R8('=XP>RPYNT+K:N;X%R7=
M]PBLL?.+X1_'@2I@LL.4VBF]DO6]?W.<=O/<*B&\JN!81/^)7%</& 46[P(E
M<PU 5[B%P^KXU=D1%(4%""WR8%B,6)K]$#[57]VCD2-S/)V,X)Y@+/6&V3"N
MV#"'A>TM["[8J$_#!8RK@OL[_?V:G$,H'R:\#S4QUHN3!6QA-(@M^Q>?I562
MD[IP]OYGE(!8] 5!A.(6/)(+: B9 S\J<K/V=-['[OQF7+M F.W +%V9E.OR
MS4Q17;*AY?IG"XA&)1JVPC7'S#(8Q\5 P0B0OH0ILV+@W'!I 9DR/5\@E;F(
MJ=V>T/6P!&2&X9X:QDN0LCC*YXIG*T8VI5YG_7R&5'-;L"T.Z,0KH,!-M H)
MVRB$7^(9&IAUA,%Y<!/5PTZ:_3--][#E70*H?SL$4&\^@/JW0P#U*SE2X?5*
M+'B;0?3=AMRP_$"/R:Y!+DX4Q:!,2L14.2%CCU EJ%QMPJNE:)QAS24*B561
MW<S\;P3>C36.N"?VQ$B!Q*R;@K;GUJ*J.#3(1I/IHNV,BH;5R%=)X8H5_4(D
M>LC75ZV,Y%CP5WL_JSPU(T=&MJJO'L-LA(TF*6["R>_8"*!@-I+&!R^WS-,R
M^0$K,9P[$,,-:GL_<"3\U7^].P-%&4:<X@S@DZ^2)DM^CYXR4:-T/OCJ'T4U
MV_K-.X,@>KLEA S2E:J2(JG6GW:$1I*0'Z:F:9 J59)7W=R #EG!8/9.@=-;
MR5%R/JO2=1>SZ=W1H0L9IZ]';Q1?#:&X*D@QFFP5<S&:K?$%3D.@K +^H,%<
M@K44=L6$ OI4_=,70,_LX$F:VU8;5U2PRT+KG!=!?C(\T2(I.GFU]K9X2+B[
MYJ8>367\)]8T>UHE\+]\>NTOXNA%F9[X*O7N#/-\XSN)!K5S(^_M3/_O?W9(
M-<4C,9=H.(IIFW>$9G)F,-)*T0J)?3.S6^_62(MDW1A)_275R30_^"H)^4!"
M?D['K93K@QAYY?Z@NI'A[17++8+TOE*AZ]*@T$!="FR29-&Q[(.F7(4!NH:.
MY$8H#3I$6DRQ2CD; [\^IKJ@^'U'M=AZ!ZJ1J(LPP?(%J&#R_#TIJ@KI\1?1
MRY,W)]'1#+TPX6BQXB2A%;[_X8&JUSA2V!'$T\,?[M[GYU9C%1F/5:T$6(C7
M[Y_^KR?82?S'_]<ORZDGO#/5<%%^V;G&P7?Z$["GJ_IVP19"OGJ9>>+''YS]
MCAK2;0=$!KR3!M+H^GY^*.C&H5>[192=\28O/T2O0<^<3F1SD#?;@4FJ>I&4
M^;]<HHX0#I!TXM%CH XI,=:EIZS@5O!;[M0QK\&R(BK%E#+F\ZS'Q\R+,)T$
M76\JU^FP !^F_L']Q[=9"AM0KM1YDM>B^T58H,PP0;EK(IR8IB,9F '"K P)
M'F:H3W(,,#>DB_'%N*BJ#!N"*]%6]PR0D(K+/B\=QV2_8!\OBJZFP-6YDJ8J
M8==L,+G1K%HNZ]XM&T*#-8*F-!\Q+9M=WWRX0V]?R)B]M]?&>,KJ(4-P>*KZ
MX9;M$[:GD(I#RX>6#RW_"3&(OQ]B$#<?@_C[(0;Q!QZI&9:(_MSFV5U0U;#!
MURO0K5$S'MH(W8[1>7O^^M5[VY?NV\JJ--_\=/KV_8NG+\^FDQ<O?OP6'P]_
M1)M]GH#QL/GAJMZ/=A<Z\@3^_RU,SIM?WS[]^11=JZ]@BYV^//OQ6_A*&K[5
MT_?E9L)NEBL'?J.B6(\MRYM5D<"X\K( P^D.U<)V8H]^ 7*OJ)*6)=AC-$E:
M<Z=9)2"RR^JR3E;?_'3_Y-YUMU!/ML*D7.N5,-!??Q)R&51YY6TGT>NR1Y\8
M^Z*,:$&*!Y99(YVUEE9E)G70?-C.5N0*XGKH@B6'/1B:A2_:[ U+K%J 3HM"
M:&C07T \@<BP0S_7H#:IAJ?*& Y#HW;!W#A"03\$C^?=@H01Y)"S&ZS3H8=N
MZ<!OK,.ZW4K(=!*]JEIT2ROC>=.>XS]X@B._!G"XZDTL'TPG!HLDMN+C4R!R
MYPMHB, ''1N@&U ENA2Z1$0FOLA<?QP#@X^.VFK!C"5<Q''PE]/)J84/-LX'
MS#251,5"J2/0U45=K5?1MC?:="!;]['?2=_2<719K0NL9K=&%"1E\_2?YWIH
M*?*S4%$VY+^TKHR13>7+/.)#3_P+7KL7O%3<,%7M<J!<\UB:56(5EXAV2L\K
M*OW:&2T^Q$$R#>B\ D#F<T@Z#B"=1-#ED3J93M[#[[R!?,6P^FG0,Q,]//G^
M^[^@CRVVNYLZ+U5;@\.!#XBXB:/O\7?'SD,V=*I[3C_M5@HHK"ABO\@IWTN2
MN6QY.UL'L.^IJOH"$&;D18E%$,T%I1HGFUV6V^X,&I*KW7OM 4TG5XYH6[73
M';BB0*H46<_?=X*5T!CR>%'EQ$-&I0&S:CUK8YR=_HD:G*'+G*)Y-#?WOMCD
M3"<[+O<-30YL$(2'3B>IO9/\CF\K\@9C,9W! \O"%Q>8CXK4B^X>E)/H+$P%
MXM,F+')XPK&2:KU.R>]ON]B)JRI *M% NP2]W81\@,H9QI3*I6;CJ]23L(63
MZ+U2",)1]!.>\'*"%5LQRY[.K/<QXIV%VU%R'"-X(.LE')AM<TNK0C<1J'?+
M#C*IVX;]%0&Q0QZ_D^A7W&=(*]K,$XDXRSHC_T#I0MZ#^I1OK/&MX=/W3Q[$
M@=CB[K?)!Q-1;5Z8P65%0F0F]TA=E;9,[9P.'<?A[0MLV#S9IT)/]V[( H!=
M=PLM@$_6*A&^S65',4K)R3U6[I)U0)_.Y>@[$1;@RSL535D%5/'#$%]/]739
M1O!EVUU3@?@?9'\_:@--!J7O.U_@&_3.O,J4_G+<4[O01G'H(JNGHMDBVB?%
M_TBU$XU%Q[QT5HT'[O<$;I?K\ZC/*3HZA,$4XF-+*M@19S"1Z[9"0K>4C"O?
MIR/+9-@I$5Q;@@Z+@^G)\LB'87%!809U;B,(?P,FE!-FU.R,LL$"$ZXKD)T>
M*6\:?07;D [6/S@SU(^M4_X8:4MM<5V<2+%^^EV2Y$TW+] %=__B#MG2AZ[=
MT:E7P,VXRY<4AI4/I0[<Q2YN/]ZJ6V&N?:Q&.9W,US7>:%1&KC=:_"%&B=,/
M(,.HEJ"8:V*]V^>A#P2T4],#*\7UW+$R=&U6<%O;>X0K#? U9[>2GA%.L['$
ME_ POD\5 Q\\O[TC2SW!C;&MOG/G2&-YBK!4>&92J3)07?FR_JF03K!:-T.V
MB\SI B2[.L_3E<P[U=).V(Y@,C++WG+CW#1=V1V@'IF8U"I-=JCPDSPU1PU9
M5V=6T^V4@&]]SGAS/)UXAF++@RI;]M[]'^[>O0+%,F1*Q1*T%_8/_WY]L?1N
M%'1DC%XI8^XEK;MU:)E4R1.:XM)-#:SDPVTC@UTR-C0OQ/2'3I+UNA$]XPYN
M^,%M"\%H+WB/T),T*A'LC]7-[GUMFMGL-FIF[T<D?@AU@5UB<I:48B?7FQ7(
MHW5=FS+-<9?DDO)F,^/(1LS@^A=\SY4>RMYI<Q((^R@ICR@.==,;E039A?-8
M4G&R/1W:<.2*BZ6J$!G<#A%'-N>J:AW:/<*T5@&$H3,I[,M1?F).0".2N4++
M%YX$.S@.D6O'^.<*F6^;<V[Q*0A31/R=I-42!=1WN\F\_UR7)KK_=TYT[ZJ@
M8>=L"J56WO;%V-KCEG>)]W]WB/???+S_NT.\_VLY4C<1M[U_"W4#N$-$<12C
MW][(!SWPJ_/0O0Z-KKXQU5>LK-5## 88[10G3%!KIN/K#A)#?OC2X OZWWNX
M"G^6&/F,'MS$%LMOXQ;KN&<SY&ARJ7&AL_;Q86?<U,ZXE5LC@2XO$ RQRDOQ
MO%A9\Q2,EL84L:35CQ?=$\=:"._!C!8N&#68 ;+E74&%+':WY+6.#J;<L<-6
MO;FM>BOWZO]!+W-]8;+_>UCZ&UOZB]NX\GT5B,B(;9RCJ^N09SR,.%["CPRF
MP&49[*(&YCXOL1 N7X!OD@W5O'Z>ETE)4!9,8(Z.LF]GWR;?1O^S3CZ8TG][
M["KB,>W6/'KRRZNWD2="B5Z7H+B]?/D4^:\NSRL,9R'<+%-<* X38 ?6=2+!
MTE<9]N4T3;O^H\,!N*D#<"OW?P)WWLHQ7^1U;2XJWM<6#42!6[E3P\1]_TBY
MX&NZ\[T/H\24]5Q2_F5&'&^SI,GY,I]5U0?A>J1;_6A=%GB0/*@1XZ6F42JE
MO\>/X1AXX!<':*:3S\$F*5_Q-CAM+"5$R!CJG-6PM<-)NK&3="N5B#X]83_K
M<]>]0W$/A],E+'.PT4<BR6[?XYL%7+(%XCP(T?,W&]K^0XC#@9,R,-3NL;%7
M9X>8T77Y/^Y:5Q06#HYUE#7)<(LM*=.\97C1G[JGO]93M>58#1X57/T!MI^\
M9$$NB1Z(,B (X>[&FJH+X"3]8<5O8L5OI20U*%]XSRQ >;8(%8:VH)WN"HMN
MTY ?^XX<=LZ7-N8^WL9]@YOD"IJQ'HFUYA(CJ?,L7R 1W71RVB!T^BFHO^N"
M4HO4@V06;O-VRE (.'?8?E]Z^]WD[L-%S"RV2NRB)Q7:\/#',W)85G4C.E14
M5DNPW6FS@42"=__A%1F_NEC:K<1471E+VYH 8L-II-9WPVG:4W.(I1UB:6.Q
MM(-W89_#:5?J-H<-<PAJC06U6 L]+/\>!;8^P>6'EHM/Y.QCP1W.V&DK_0#2
MGP B^]-!@_O8\B[8X^\/V..;QQY_?\ >?RU'ZB:PQP]NX97D.:/0JR;\! <,
M\E>-0<8\KVH&\Y$XVNMNHC#GD(_4@)0-,YU@)%Z%! -'B::[F!G*)TZ0(B-G
M>O#+)+_H.6@/SI4]<ZX8##NNZR0ELG'TSEF'K46 -LPX);M+R,_"%/2&RA9(
M=51,D<=MB1%L*:2X<2_%G#YX]!?;QFD&FD5CHC,*8L6V#[;IX9Q@.2V=/C L
M5G6B2_7#!4<8@R9L'!94DPCQNA1_3)FUO[54>[FM>8 \1/BQ(E/@Z>.R/GKZ
MII-/F+_HIJ8O:0CVYBH1'(!L?XJ#;/#48G6 Z@*QX+Q1@RI04</0%<G&/83Y
M]\4_A>=7J09QA\)*%5M"4J PO*(85"@_:65J*;J7M%L#-1KD.\/*X>Z7!R?9
M_CG)@E@O4IN%N\RB8J\F;3N:'0OJ>HCMX&#7?'7QX/>DEKG$H0$31VECVZR<
MD#?O\ZV<K;3'W@(*=_C!"#H805^9$60]"Y]G 1T,H,/A_G=%"'R2/JV/BJ8C
MG)GIY$LHTX>]MU_&7%>3UOMK5S7:JLM(LSR@31\\ _]>5AFNN8"IHW$LM<OT
MZ"&SU3-=.;,->6U?.)T,-IYL:S)6.CV5"\$,%FH;U8F\7!OAIO.I"(D7ITHR
M'O;JOU7Z;+@9,*4N;UO3O]_LM2C[9VDP'X]8 -'2XJ0^T!*KF@H<^"@6%[Z1
M?3)V)J:3@ZC[<W)&Q_9$W=\!936FDO=8<P-J@1SW UV2J#=QH:##*M^"',9#
M;.+3L5]_0MN<JQ@%1"W[O!:''NR&1;QW]P!&O'DPXKV[!S3BUWK(_MVRA[N,
M3>3-S1O8&W6[8;TLR+-2&IZJ)U!Z\[+'<-!5[ES])RY(T7^>FZ@-4D,1.\(:
M_H0=FS+K/QN3AU3A?[M4X>BSW67SNEIVS0&NM-$M5=1A;*VYBBB3QTPG ?N+
M+Z+B[95F#?9(F05>DF7>-%).9:AVS*J&'N0K4(G?2VN_)/4'(VX3WOJNKHNK
M7"1OB:-1NRDO\S9/6M<R2.[6E/C^:L[5D.H*R_K!)PV7K%#U.6WI"O+)Q$&]
M#^V>AGZ,S5?CZ]HL3&DCI5@J!XER>(*>%%6%)OTB>GGRQM4JV#ZOT':!51M-
M1F6=EC#,Y7I)%:52:&OHQZ9!\A,N%% %/;L\KS#L!+V6V)#N'==S ?67^'2@
M+>+4VG26"8LIVOSC9#J9)>4'_')9U4E;U?EZJ?UH)BT2E'=2W4#VR*\E472]
M:ZG.*KP-]S&5*J"/L [4>24]]HWQPM/+JY12AS)?BV4ZR5PL+Q"_.  7@ZS6
M+5WHV*9I0/%)+,D'S$N;%U)CLY9J>IQXC[_#R#J\PWV /UU2"$WVSS)9P*#6
MF:&J%E@44 KEV,*JNAN)&/92'P*!D?C]W''X+?E T-U"H3@2_UR[47B='-V-
M 9F7+6BL/2:F&,NW?H AY6V4+U<UULEB[B4:48)>24N3X]B@R%GEMTRG1."M
M*_?]511Q_T.JN+\]>_/V[-W9J_>G[U^\?O6.BKG_\_3MV]-7[U^<O;O-)=V_
MJN29![>UX/K;/@+"LJWU 1!!6?;W_G.N_41  Q0\(<)H &.AP0I][G<?_="*
M#(6;!^,B"H5!$;X.#&-' #J_VR,=?MB3',S]2AV"'>]8O3K%*J+3PCELF4-<
M-&?Y0_^NQX9+&#L=A:8+]>QI])9T+=(O6(MQ!*2L+.5-"EN9<1(*W1>&'\/J
MQ-4E C&X5UAFE*YU^V=,"!Y;OS=9452(/<Y.Q4%H1KMA[0;41H^%5H1G<]"E
MN.IO89+::M,O<U.RNJR;X7JB7,-8U\+VA)*=CO2;P_F[@'V:@?XLY4FI$?@8
M#=L-%>Y"+;2\DS2@LK,&@X]01^&-*U3^5A@^Y8XTH#^#'LH^("EV26GJ,Z[+
MA1@4J_UX9?DD>M%))DM0'0T67Z:8IK(V<X/I[,;1V7:VB;,XX+NEW1A$:<OU
M2Z-G4M6X415&\X9)ZDQV@/E^?3!?D$&OZT52YO]B2P1WZ_]BN%Y*GXQ=L]XI
M9$MCZ\V&_BAT,<&U"H>;T Q@<U=@XM946\\>?Q(^%7< [4M[[,S'O&FYZ#+%
MG!<5%C*U9UD*!4.;17+IKN'?X-@T6>ZKAJ,1Y%L5L[Q2HXU] )L@8@VL6K2J
M+JE:;>:L0'*J@:"C#[%F#+X8;/D5.J^-@,\PUMU8#T(**@4<-.@&/CI;@WH@
MR$QFG #92&!GJD5_ JO#UJD^ZZ6<5B67<AQ.=)%78C7B(YF9)^NBM3)1IH+8
MW1L+UH8^. 0G%8' ?M/ZDAF6H N^8-D83%<,DI\GV IK/7ELE8+,JM$"MO70
M06B=\:88AJQT-PEM#8\/Q;GC>5&SAEN@Z>\"K$Y(15WA,$?=5>:[A;>?-5_#
M#>(4,28IIIJ.TFO7M%LC1@G2BELZ>K@5P:AE)9,TM=_UL8E*D^+-@'7!S4=D
M@\6ZO34;M_,D+[ YR>UI*C4#=(&&(Z5"C'R%-D9*PR+X<5UDWN]2U9J %A$\
M'U>N] @L/FX2E(-'N92)3'KN %=;5T#*5-X$)E".I0!V34F.W626%^)_$!=-
M[Q:)MZ)!E(M$_'0.H#*=]!!2CR,$I8[U/ H[SL.E#8U+9N&B?$9CM[PQ+JG@
MFJGRLF0?1$?.$4*7II-4QR/;NG,CMU3R@+8G%C  (Q->0KC&'?O?=5C*7#-G
M-B-0"8BC73H6EX$RG-R&N N0@IZDE4[?8.EYW46CF;D*UG8D,@DV74P+Z&8"
MZ<-]P881Q$E0MJ%;@YR+F2;3B7-B,62)/5?,O8U=%-_A156LET8MH'<K)T55
MFK" .==59Q!ZF8D0-<4\%@GE*WC;KM.>57WGR]+5G.Y6^H9UP=*IV=B29P8A
M599YT]437SD::=1;X<I:T1],/<X^1,19S7/8(7-9(/$LXR]DQM&%6RYD9J-9
MWJ85N@!90)$^6=ZANU!\L30'5/8#X=:IH6B3+2 "<E#:C:C9%94,+TT13R=9
M10[4H.BYE^MX&Z$(P=[;2KQ:1L,G<Y"GN42DG!!#S<)O:/Z*6>?#PZGN!]@E
MZH)PMW[3RATH"''X@>M> 0,O8=I<)(,>)KE;LB1,Y7+QUXA?$9@AT!(3OM[!
MFG*>_^D$M7BRMW([)YD]S?TIP'(5'^@.(!\\!1-JU"):N$/DK\88\H#31,#C
M1AY63TJ,H:_:T#$.;JX]TO+WK=V=\"3W#GB2/P!/<N^ )_D:#M0-N G26^HF
M..4K@XV_Q]$9FP&<!3[B(C@7N\49U_X:'K6SZ5"A.[!RQC1JG\NE)#$RDV,B
M99LP:\$L8=I=FD0G]NI\%/1;-@N5VCN=.)?79ULK WHOZ8S.O^$= NNVIXV[
MU&GV%+;N;YY*!NE8STQ(V_YI0U7./6NV[ #4WV6TP^DI?MVP<;:6I6_C2RBA
M&S<3,PSGA%DQLEO^Q0M..KLUM2,9J>C4"(@:LMC**IJ#6H3S(S_(&Y\C&(Z&
M=P71XY-/R?'CCX%+R*L,5E^&GO,P&QX'1*HG_]3^(:Z?I!RC"'MKNW8J4.[F
M9#IY'RS_KILWWFGK\CX:W4"XH05U!F8@>OH$>^8TVR-XY7I5E7[#7N8:+7-\
M98(362.E JQM33SAL)PZ0=4\YB:5X8&/DR.#QCC+V8ND#(G.5G&.#G3N+Q+4
MUH/O!WJ$AYMZ!+:/>'V\OZ6Q,!H<KB!T./Q!30@JJ; .15^F"A$N]7K5IALT
M2$&WND#.6DSE"IV9"@'C!-!T8EVDMD5Y,<L4SO*":3!>G%.,I,8J=JH,A$0N
M'+ HUOZ88&347FW01\DV"<Y9<@%&B'-C8&S31D7%GX%SB*/[;5VRDQ+>D)MY
M)TY$TU&C:6[]KLJM@E,S3RADBY?TLO3..(H=@9RI\QD+4^\@18 *^<O4$-3<
MPVCVR""Z"7TFNZ7Z#"CB("'GL-!MT]-@W+4;>Q&&FTCMU@CO)BT/>G?REQ7*
M5USJY!RT4CGR0CEV45'J-$4CD\(YPC3.ZHO<VU+ #O[(*G+]$,0B%]>:DX:I
M3'UD+T0.:QB+D^33V1')[I+MQ4;<-RJVP0'/+QK<B,5_.32(6'S(WC4HL9GI
MY(CZ&YD+NCS1ET>CA@D1)R69N318Q'O"!V!2GT>7Y.&?F;1:JM<=LP,W5OXP
M6C5$F\J4V>@XW\$^+H2831>UPCYQT*IS[_4FET:V0*&,<3"<JX:>D#L!?^Y]
ME7$$IFZ9V7)3;7XGRXNUC<M((!R+"=N*A^B83U-3&!^]27&K%A+E.K([!/^+
M&C1/6SP\:>BB9S!CXH\7WV;1/$ESCF=D9H::+>P06GDN\\H>:RG-1@$F/24J
M#B>_#N("=A/1VK@0E3N26^<WT*$J JGRK^0L2-1)UNO*Y2+?<K4N*9;$-[Q
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MO +5UCGJB)_/AW>N!-O$MB5W+H9&=XGP7M>F0R$YN%!7B6GTEOQ4_I57*E/
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M36UWP@T5!YN954[HZ6_,Y#?X:K*5Y(OD(LD+FUG9ZJQAE0A*1T9B'FG2G*.
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MFLI(0<FIYU>WS U!.4S"D)=P^0$;NII9;G$LSD'OX$*7\/?Q#_MSW>Q;N[L
MK.[?/0"L;AY@=?_N 6#U-1RH&]!7DUNJKKY6M7X?1Z?6=1]<G>\"KA%T=TA
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M%[%N6FAD^[1]E7&FSZ+4Q4 RRXX(S?+(2U(_^V36]X(<;]D.E8AW>6W(9Y?
MN'9&O_;[,,)<L^KB$:E<W&XU674[$S0,>W#42-\;1=07-S>'ZHL1V&N<F]EP
M?/T2\882QE#ER F<ZZDHH,B;B@="+M?:8DAJ:V%WY_,7 R4+W/.S#?R,IT>
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M!A3C[ GUBS?H$ >]%Q[W9)Y5L?);E4_1G<R*9<5=07K:2$3-P@R8P,][HN2
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M]46? N*RE/6I/5)/1,904"#*5<!5AY5<_ K&BA8.8@&R>[A,-%VE_*DER#X
MRZ"17/ :)VB'E4; U2_X#I26B,=_H8 #J0WR5)'U4+F>BZ*@$ZA:@F'*T; V
M3*ST7' 6!QBA @D*WAZ1@ASEAY22DJMK(5$+]._*O>A3T@!"52[E:YJ78\Z<
M@&1&'HQL(BRZZ(M%S4MBNO%<T/4!)TEISK#(+#P!MO6D7J?RN"]J+FF;3^3L
MBE>80-K7["J94%";R*>#)2!+)6A&H$QXM;$]CYA>- -$3V$<D%7%W3P.A"U
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M<X&5+F:1@)0\],6[2THFWG+8I\PV2T3?-V3ZL6=5<X?6NP[T4E?'EQ76,K<
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MQZ [-H,"B(*!_1B,<,$F^[VN78+VW=J./\7MG2U_BK+3"FD.8"D'LV)JP&$
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MHQ8%>RA+UM&_V69Y0 XR0+Y&D,9NQ$$<119![Y/(@DQ-/3-B-;#B3+'9HJR
M/L=U"=(<S71Z"%V(,7*^>_/R741$+M0Z!YNWUAR$]6S@^\U=YFRP+[#,T0I6
M']!;C>X,W+$G@@%Y&4:*"F@><?W,0(F!X]*GV\[7D-NMD3.@6>B'_6B91.BT
MCC6[WN6R1H6+'Q;%FV/=3NYZS@3@ABW/U!IF-*'4#B?=/WN]VC9 +PQ!2ST&
MM<C  O*93<@T9%Z'5DKI?$I\(M]LJV&0EXR;@#F6G.S]7F$0N*Q%!<@3S<0Z
M1CW'&9\\43L/P4C0L[Q&_N_DSZI5+?-O6@CE(<(J,6>8E]E>FEJQLMU=M8T+
M:*UNS5K.&:>$,?*S79ABX:0!>VE$<)#FQ9*#LEJ<S<@:H<]3:;1'E(?R'#"1
M<T W+U[*T"R&G>%R8-<&WD"?%7"?'"FC9?\"U(8UB"+85;]79V#7#Q1%)DF.
M9"1OV7(F?Q.%9KU4$/#*^ZAN#T5(##C1ITD#:F0?^M]@B1.#ZRL-6$0ZQ>^!
MX)MU =XA\18,A &:9_RV_:>,7YB\F.C,_QTM#H:>Z72B9WZI):C;J5ZU6**\
M92R/$>W3F/6O( PQ0XPK %6 <AZ8IW=-4GY-(7V--(>=^S2'KY#FL'.?YO#7
MIKR;5X]?WG96KKU@Y]!;LEX/*;*38,T3?.*B.*PQMUUMXA6GLG842I3SX!1-
MK!;_87/;*3$?]ENZ,$HW\O^T_#.QJ![E28VJJ&0D&C9VJYP5DT9O1YTB3O6\
MGGHOY7?_NGZ??0Y,2@<47#S]NB/PZ?=: %*W Q]3(I^PY=252+%F!<H-@PO@
MD7NO2"DE 33VD40;[YP@_RJ3_OR%'60?.&)\G(& 8$(ADO_N;S\^"]-%R.T\
MKHL,,"BN644KR.7FV&845-1C/5+2BO!7D'YE55+8NK/&U!0T3L:A=0S0E:[J
MRJ=8Q>DL]!'1(MH*0=VB:I4MDMM7)B!BPG4LCQZ3).V^+EW:>DK$:(LFEP6!
MT-J\LU;8/,)JR@L-:COEP@1/(G<I' -I%/<FX6N>5QPXY^ D)Y"%?@H..K9*
M2WWQ)=@EP"?(6$0_/AB&DFI&,?BY(?13%XA!$HP'D+-W72=)#1)A$<8>,RF4
MY)"4W\8  XZ\W.7M.NOJ$C/0!8<DH[\:A&D"D8<U> D-ZM1<B#\CV'M@3@Y\
MOAA%(YSIA!D//L 8+1@5HD27G&8%C/NC:0*[%._@@&@DNE;71+.X;&/KG6.9
MK[XP]WI+V$:5]9*N2;+N(B@#CG6 HG%79'F=-17#B"D-6BU[[GUYBPMO]WN@
MYF$\F#,(EC('B"=<&U$)C9HR_XK&3/*2UB8N+=#-AQ0K<VXP/2+SAY,IF9T&
MT73/03)S"9HE\#QFAA]S($&=WCWDO 4=_?AV=?0@"?6UQMX7Y:HZTV' XE/#
M>60B1O!K8M^6!*KG6D%?A51?EIA8"X3A(J? FA&AG+/NG9E(;%Z]Z&J;L)\0
MIF[_N+M+OCIQ6$?1E/CQQBV+P[VK8=K'6T^0E\[J=,+:;"...9VKSDA3;Z2)
MM&; +"[V80]HNZ (5-$&70QJB/D)Y?G">Z)QYYMQ(-UG:2=Y/L>PM\!,<IR]
MHAQE9NA*)/F=HRIU"V3URV90GG_,N8+"X]T>[T2.\)^Q3GY5WX1VWF807&]%
MTW79[GAS13F%RR8E?M?O37/JJE+,B%E$(V/C',P\&8]!#\;N2 //S"2<@DF@
ME(R:IRE%F(#I E<=J!'H^PD7B>;<<PQ^FQDLSRTE1( 3TU^T:$E!Q1S!?&&,
M5YO;.4IJ#?V>/'6Z""-\QRY+%EC<6UY'PS6I?H&-&VVSLHKY?:KMC"PATFF!
M?98UQ4/$?T$QEK6P\"-G.S#<QSJ& ;%;(+P'T"+3P75C62X\H>B@V]TL'OP:
M527"7==)>KA!!RW8^$S 0]Q?&-C#O(#"8'Y#X NA %&!<@+5+4R#LNL,)@8+
ML')];CC\,T,+EEX"4<H?!UM@$[,J4'J@;.$$IID>&==;)O@X'@L?:G<]&N!;
M%%R[_FH$OLLXL:I3T[4)CE=SL-XRN%#P=<"P*]D)=W AK7:RSLFE-PX[Q:XJ
M2&JE>@/R3KDLRB5SMP'!1,I:#T85?:'**B14G\3!$ 41[J3*!_/U>ZLASXFN
ME)%.9?F% <M ,F9&9FR:7$4:E0C5T2DZXS@-L"'3QK*&C]&@C^;$G%[*>N%A
M*8&0LOXPOQW)=>+M$<[;785")>8:8[)CK%R2XP-F#6J7NC7-?H](TB=-H!V"
MO;,^ O31'(%?1X8S;QBOR9Z"@>H4$;U5C'55VIQCI7+NI3'G[!AM%4CAX@C,
MM+AX:R[E.\S!S/(NX$25_PO/"A=M!RW.1GZ5-E)$R8K7$(!<U>&5>(9LB)!1
MZ@4>'0/29R4L;Z)IV/+'3$S\Z^E8M]E4Y2H\ME5 N<[=P)XJ#/4X=ZU$&I;$
M06FJ*C4#LAJ!,*WD/,C3Z/K@[,BJ6#A*!#J?$"I+&D W1W*8['-7L):*^%*+
M=%V15)G7Z&WQ=J!:B[DAJEB+YN68H6$F-X6S\K87=>$;G-"*0(,0RY(^X^VS
M*.H&@:2NTQQUAB0C_6S09@8BO<C9CD:WI91D409-!W,1-:Y1W1KV@F*78%@W
ME,V,[&X1YUV<^3J9'+OWF1Q?(9-C]SZ3XZ],=W^NAA5O07K,*Q>&# J703!U
M")M\[(J016R37UC;S-<>81ICX4(E5OJV!AG]+,'#_%/RAW8+<8MV'TJPMA@?
MK%)31=?&18X7;2^K2U-VLC!:/ 8MZ=.5.\!JI;&V*546@_C/NZ;Q\Z/LMD9B
M/E[7<L(Z:+YK*U)6R#P(_=6BQ%,8)DN]L0 X1YTO<*EN-:R]^\Z+0.!C8RFW
M=KGLI*R'&.8F54;Z='&6[9C,V'8Q(  E=U6O"(_21=^[+5LYAMC?1JJDQ)'Q
M<YDKUDG:;438[>6L&^\[#]( L.E?.=;H4VOTL0Z4<-X *1#S_K,N"U[P@B:+
MPX&M[AO]7FHFU'^0&Y=\8OY@R=Z$%3T;#IW+VZG]GQN+VSIC$V5_TOXK2FZG
M>OC4DOZ+0188%!MPX_F,&PB/-&F:Y)VI@)T9?'S0N XBL+,N^@GH1:5RG7OO
M]SZ]>0S4\TRN_7/AFQGP@ X)@]@_19*:_.H.CZ8:60R24B-4)"_,GK9QVQWV
M3D:#1EN"/[*5QX<K9&0DUV]^B?X", *X^-%#H##NP+RCIM^;(H#%VK#>MFF@
MWX9NV%7E&OZF&%M7M5Z 97"C@E8+AH'#%L^= #XEE4:E7*/+37@J9CZ\)^ZT
M -@VB-,RP,BIT" +G<F"8+P3SK]HX0B94EWQ\8&O#<6/&FXYZ%Q)8V0UMB>S
M<96@M\)YL\D"JY%<^!,JC%V]!PIR@O8VB'L#C6OT1H4V8XO+$F:/J1^C9VE=
M,7O7'_%*WS;'\IL.2;@05^K!5:L=/AQ&,)DB-D,; Y77FH^C3E4#\0JV"OR\
M\<W".O8A(7,O0^[.Y_YI;UB8#A$D0!B7_N"<@D0EN902J"G>+N")BBG2$Z*
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M5\XXH4(/Q+JHC\M8)W3_ 9F/F_/1.'H2/:18:._["K2EM<8PO9V0!88E*G3
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MOS]\=.=.M+J]O!WMH7[\K[)Z&SW-FC7%^O:91L9G>QGHBHI,9JP)3QE. DP
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M\G:-K$?.?^E[>6H_=>_W(B/[E"Q[+L3C\OD]^*-<Z7ZT.K99%Z3>7V6&6#&
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MI6[Z?D$?FN9GNB8;\'3;P'BABU2)+<;(1#X22"=V*:D.W*8*!TR+MF(1-8E
M3-@3:N5E#-I4QOK6V!@+150%Y>+)V;:Y4GBW$'@?2',5&,U[5PJW.,=+P6@^
M3J7P#G&K!:;ZC*6#&?8; ,]>:4P\QU$R*\_-"+BY,]P!</-THNAFA1=[SX>
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MA4%=8N/<H,#WBBB,>!]*@<NYWQB-8GA%[Z<3YV >B&PF>5V.+:[GUZ3S(]
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M*$J'#)3TG@ B8PL#8#T_B$UCU#.CP<>C4PBO#RG>UCU/OB4) F-&JBP-<15
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MC$"CY5IX*:77_$-8* ,*"PL]PNP0)38?]88E84DN]>VE"092X-!;$U2+3Z#
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M8_BF"% <&A_4-PJ!,52$Z:)SI.O&'G#OK2V^<;_<NUGMD?\!4$L! A0#%
M  @ LHKC6IV1,[O?&P  6ID   X              ( !     &)I=&UI;F5?
M.&LN:'1M4$L! A0#%     @ LHKC6E?$F7.61P  )7,! !(
M ( !"QP  &)I=&UI;F5?97@P-# Q+FAT;5!+ 0(4 Q0    ( +**XUJVG-6J
MRUP  ,$4 @ 2              "  =%C  !B:71M:6YE7V5X,#0P,BYH=&U0
M2P$"% ,4    " "RBN-:H#]&#>W"  !$Q 0 $@              @ ',P
M8FET;6EN95]E>#$P,#$N:'1M4$L! A0#%     @ LHKC6JM RL5CP@  S, $
M !(              ( !Z8,! &)I=&UI;F5?97@Q,# R+FAT;5!+ 0(4 Q0
M   ( +**XUJ\/5BE!R,  !RT   2              "  7Q& @!B:71M:6YE
M7V5X,3 P,RYH=&U02P$"% ,4    " "RBN-::N+_5@M5  #E-P( $@
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8;6Q02P4&      H "@"! @  $-4"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>bitmine_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bmnr-20250627.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829311</identifier>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-27" id="Fact000004">0001829311</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-27" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-27" id="Fact000010">2025-06-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-27" id="Fact000011">BITMINE IMMERSION TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-27" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-27" id="Fact000013">001-42675</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-27" id="Fact000014">84-3986354</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-27" id="Fact000015">10845 Griffith Peak Dr. #2</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-27" id="Fact000016">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-27" id="Fact000017">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-27" id="Fact000018">89135</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-27" id="Fact000019">(404)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-27" id="Fact000020">816-8240</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-27" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-27" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-27" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-27" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-27" id="Fact000025">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-27" id="Fact000026">BMNR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-27" id="Fact000027">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-27" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-06-27" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
